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All living organisms encounter a wide variety of microbial pathogens throughout their lifetime. A potent immune response is required to control or eliminate the pathogen and to ensure survival of the infected host. Mosquitoes and 
other blood-feeding insects transmit important human and animal viruses (arthropod-
borne viruses, arboviruses), some of which are associated with debilitating disease and 
worldwide epidemics. With the increasing global threat of arboviruses, it is essential to 
understand the virus-vector interactions that determine virus transmission. Insights into 
the mechanisms of antiviral immunity will help us to understand arbovirus transmission 
cycles and to define novel strategies to restrict transmission and spread of pathogenic 
viruses.
Over the last years it has become apparent that RNA interference (RNAi) is an important 
antiviral defense mechanism in insects, including the major vector mosquitoes and the 
model insect Drosophila melanogaster (fruit fly). The importance of the antiviral RNAi 
pathway is underscored by the observation that viruses have evolved sophisticated 
mechanisms to counteract this small RNA-based immune response. More recently, it 
was proposed that another small RNA silencing mechanism, the piRNA pathway, also 
processes viral RNAs in Drosophila and mosquitoes. Here, we review recent insights into 
the mechanism of antiviral RNAi, viral small RNA profiles, and viral counter-defense 
mechanisms in insects.
RNA silencing pathways
MicroRNAs (miRNAs), small interfering RNAs (siRNAs) and Piwi-interacting RNAs 
(piRNAs) are the three major classes of small regulatory RNAs that control different 
cellular processes in animals. These small RNA-mediated gene silencing pathways can 
generally be distinguished by the mechanism of small RNA biogenesis, the specific 
protein member of the Argonaute family to which the small RNA associates, as well 
as the mode of target recognition and silencing that is mediated by the protein-RNA 
effector complex.
The RNAi pathway in insects
In RNAi, small interfering RNAs (siRNA) guide the Argonaute-2 (AGO2) protein onto 
target RNAs to induce their degradation. The central trigger of the RNAi pathway is 
double-stranded (ds) RNA. Endogenous dsRNA substrates, such as those derived from 
transposons, overlapping transcripts or long structured RNA loci, are processed by the 
RNase III enzyme Dicer-2 (Dcr-2) into 21-nt siRNA duplexes with 5’ monophosphates 
and 2-nt 3’ hydroxyl overhangs (1, 2). The dsRNA-binding proteins (dsRBP) Loquacious 
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PD isoform (Loqs-PD) and R2D2 are Dcr-2 co-factors that are required for efficient 
siRNA biogenesis and loading onto AGO2 within the RNA induced silencing complex 
(RISC) (3). Arsenic resistance protein 2 (Ars2) is a Dcr-2 interacting protein that 
contributes to the efficiency of dsRNA processing (4).
The generated siRNAs are subsequently bound by the RISC loading complex (RLC), a 
heterodimer composed of Dcr-2 and its dsRBP partner R2D2 (5-9). The RLC senses 
the thermodynamic stability and intrinsic structure of the siRNA duplex and defines 
which of the two strands will be retained in RISC (5, 10-12). R2D2 binds the most 
stable 5’ end of the duplex and thereby selects the passenger strand, while the opposite 
strand that is bound by Dcr-2 at its 5’ end will become the guide strand (5-9, 12).
Loading of the siRNA duplex into Argonaute-2 (AGO2) protein, the catalytic 
component of RISC, requires the HSP70/HSP90 chaperone machinery. During this 
ATP-dependent process, AGO2 most likely undergoes a conformational change to 
facilitate efficient siRNA-loading (13-15). Correct loading of siRNA duplexes into 
AGO2 might occur in specialized cytoplasmic granules, called D2 bodies, as proposed 
for the sorting of endo-siRNAs (16).
Once loaded into RISC, one strand of the siRNA duplex (passenger strand) is eliminated 
from RISC (3). This process requires the endonuclease activity of AGO2 to cleave the 
passenger strand as well as the endonuclease complex C3PO (Component 3 Promoter 
of RISC), a multimeric complex of Translin and Trax (17, 18). The guide strand is 
retained in RISC and is 2’-O-methylated at its 3’ terminal nucleotide by the RNA 
methyltransferase DmHen1, resulting in a mature, active RISC that is competent in 
inducing sequence-specific target cleavage by AGO2 (slicing) (19, 20).
The miRNA pathway in insects
MicroRNAs (miRNAs) are another class of small regulatory RNAs that mediate post-
transcriptional gene silencing. The miRNA pathway is involved in host gene silencing to 
fine-tune gene expression during biological processes, such as developmental timing and 
cell proliferation (21). Canonical miRNA biogenesis initiates with RNA polymerase 
II-dependent production of noncoding RNAs, which contains one or more imperfect 
stem-loop structures (Figure 1) (22). The nuclear Microprocessor complex, composed of 
the RNase III enzyme Drosha and the dsRBP Pasha (DiGeorge syndrome critical region 
8, DGCR8 in humans), processes these long primary miRNA (pri-miRNAs) transcripts 
into 60-70 nt sized precursor miRNAs (pre-miRNAs). The Drosha-dependent production 
of pre-miRNAs creates a stem-loop with a 2-nt 3’ overhang, determining one end of 
the mature miRNA (23-28). Pre-miRNAs hairpins are subsequently transported to the 
cytoplasm in an Exportin-5-dependent manner (29). Within the cytoplasm, Dicer-1 
and the adaptor protein Loquacious (Loqs)-PB recognize and cleave the pre-miRNA 
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into a 22-nt mature miRNA:miRNA* 
duplex. This second cleavage step leaves 
5’ monophosphates and 2-nt 3’ hydroxyl 
overhangs, which are characteristic 
RNase III signatures (30-32). In analogy 
to duplex siRNA loading, the loading of 
imperfect miRNA duplexes depends on 
thermodynamic stability in which the least 
stable 5’ end remains incorporated in the 
AGO1-containing RISC to guide target 
recognition (10, 11). The 5’ nucleotide 
identity and internal structure of the 
small miRNA duplex serve as additional 
features for AGO1 sorting. Notably, the 
intrinsic structure of the central region of 
siRNA or miRNA duplexes appears to be 
a major determinant for proper Argonaute 
sorting, with imperfect miRNA duplexes 
being preferentially loaded into AGO1, 
and perfect complementary siRNA 
duplexes being loaded into AGO2 
(12, 33-37). In contrast to the slicing-
mediated siRNA passenger strand 
elimination, the miRNA* is discarded 
from RISC by cleavage-independent 
unwinding activities (37). Following 
duplex unwinding, the mature miRNA 
guides RISC to its target site through 
partial complementarity between mRNA 
targets (usually in the 3’ untranslated 
region of protein coding mRNAs) and the miRNA seed region (nucleotide 2 to 8 of 
the mature miRNA). In addition, the 3’ region of a miRNA (supplementary region, 
nucleotide 13-16) sometimes enhances pairing to its target (21). Target recognition 
results in inhibition of protein synthesis through translational repression, mRNA 
deadenylation and decay (38).
Next to canonical miRNA biogenesis from pri-miRNA precursor transcripts, alternative 
pathways can also generate mature miRNAs. For example, intronic pre-mRNA splicing 
products can adopt pre-miRNA structures, thus bypassing the Drosha cleavage step, 
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Figure 1. The miRNA pathway in insects.
The RNA Polymerase II (Pol II)-transcribed 
primary miRNA (pri-miRNA) is processed by 
Drosha into a precursor miRNA (pre-miRA). 
The pre-miRNA is subsequently transported 
to the cytoplasm in an Exportin-5-dependent 
manner. In the cytoplasm, the pre-miRNA is 
further processed by Dicer-1, yielding a mature 
microRNA (miRNA) duplex. Finally, the mature 
miRNA is loaded into Argonaute-1 (AGO1) 
to mediate target recognition which results in 
translational repression or mRNA decay.
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and these short hairpin introns (called mirtrons) feed into the canonical biogenesis 
pathway (39, 40). Alternatively, mature miRNA biogenesis might occur in a Dicer-1- 
independent, but in a Drosha- and AGO2-dependent manner (41-43).
Although the miRNA and siRNA biogenesis pathways are functionally separated in 
Drosophila, recent studies revealed that the miRNA* strand is preferentially sorted 
to AGO2 and becomes 2’-O-methylated at its 3’ end (33-35). Importantly, AGO2-
associated small RNAs that contain central bulges can induce translational repression 
of the target mRNA (44), suggesting that the miRNA* is not merely a byproduct of 
miRNA biogenesis. Together, these studies indicate that cross-talk between the miRNA 
and siRNA machineries occurs.
The piRNA pathway in insects
The PIWI-interacting RNA (piRNA) pathway is a small RNA-based gene regulatory 
mechanism in which 23-30 nt single-stranded (ss) RNAs associate with proteins of 
the PIWI family (45-49). In Drosophila germ cells, the PIWI proteins Piwi, Aubergine 
(Aub), and Argonaute 3 (AGO3) inhibit the mobilization of transposable elements 
(50, 51). Two mechanisms for piRNA biogenesis have been characterized: primary 
piRNA biogenesis and a complex feed-forward amplification loop, termed the ping-
pong amplification cycle (Figure 2). In contrast to the dsRNA-induced miRNA and 
siRNA pathways, the piRNA pathway is initiated by single-stranded precursor RNAs 
that are processed in a Dicer-independent manner (47). Primary precursor piRNAs are 
derived from long genomic regions that are composed of transposon remnants, called 
piRNA clusters (46, 52). In Drosophila, primary piRNAs that associate with Piwi or 
Aub are antisense to transposon transcripts and are enriched for a uridine at their 5’ 
terminus (1U). It is not clear whether this strong nucleotide bias results from piRNA 
biogenesis of primary antisense transcripts, which was suggested to be mediated by the 
endoribonuclease Zucchini, or whether Piwi and Aub selectively incorporate 1U piRNAs 
(52-57). Following 5’ end formation and incorporation of these piRNA intermediates 
into PIWI proteins, the mature 3’ end is generated by an unknown 3’-5’ exonuclease 
named Trimmer (58). As a final step in primary piRNA biogenesis, the mature Piwi-
loaded piRNA is methylated at its 3’ end by the methyltransferase DmHen1, which 
protects the piRNA from degradation (20, 58). Mature primary piRNAs guide Aub, 
but not Piwi, to complementary, sense RNA targets (mRNAs of active transposons) to 
induce the ping-pong amplification cycle. Aub subsequently cleaves the target at the 
tenth nucleotide from the 5’ end of the mature primary piRNA. Notably, Aub-mediated 
slicing not only inactivates the transposon, but also defines the 5’ end of newly generated 
secondary piRNAs that consequently harbor a typical bias for adenine at position 10 
(10A). Secondary, sense piRNAs are incorporated in AGO3 to subsequently find and 
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cleave new complementary antisense targets, leading to the production of more 1U 
piRNAs that continue the amplification process. The secondary pathway in Drosophila 
requires cytoplasmic AGO3 and Aub slicing activities, and as a consequence of this 
amplification process, AGO3- and Aub-associated piRNAs show a characteristic 10-
nt overlap at their 5’ ends (59). It is currently unknown how the 3’ ends of secondary 
piRNAs are processed to generate mature secondary piRNAs.
In contrast to germ cells where Piwi, Aub and AGO3 are all co-expressed, only Piwi is 
present in somatic follicle cells that surround the ovary. Consequently, only the primary 
piRNA pathway is active in somatic cells (60-62). In germ cells and in somatic cells, 
Piwi localizes to the nucleus upon piRNA loading and this re-localization of Piwi is 
required for transposon silencing (57). Interestingly, recent studies revealed that 
transcriptional gene silencing by nuclear Piwi does not require Slicer activity (61, 63), 
but instead relies on Piwi-induced epigenetic changes and subsequent heterochromatin 
formation (64-69). Taken together, the primary piRNA pathway silences transposons 
at the transcriptional level in the nucleus (through Piwi) and induces the secondary 
piRNA biogenesis pathway, which mediates post-transcriptional gene silencing in the 
cytoplasm (through AGO3 and Aub).
The antiviral RNAi pathway in insects
DsRNA is not detectable in uninfected, healthy cells, but accumulates upon virus 
infection (70). Viral dsRNA may thus feed into the RNAi machinery to restrict virus 
replication (Figure 3). Genetic studies underscore the essential role of the RNAi response 
in controlling virus infection. Drosophila mutants for core components of the RNAi 
pathway (Dcr-2, R2D2, or AGO2) are highly sensitive to RNA virus infection, which 
correlates with an increase in viral RNA accumulation (71-74). Similarly, in arbovirus-
infected mosquitoes, higher viral loads are observed upon knockdown or inactivation of 
RNAi pathway components (75-79). Recent studies demonstrated that DNA viruses are 
also targets of the antiviral RNAi response in insects (80-84).
Dcr-2 processes viral dsRNA into 21-nt viral small interfering RNAs (vsiRNAs). 
Interestingly however, Dcr-2 does not require its cofactors Loqs-PD and R2D2 for 
production of vsiRNAs during RNA virus infection (85, 86), but R2D2 is required 
for their loading into RISC (71, 72, 74, 85, 86). The Dcr-2 associated protein Ars2 
seems to contribute to antiviral defense, but its direct role in vsiRNA biogenesis remains 
elusive (4).
Viral dsRNA is an essential intermediate in replication of ssRNA viruses and it has been 
suggested that Dcr-2-mediated cleavage of such intermediates is sufficient to explain the 
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antiviral activity of RNAi. Several lines 
of evidence suggest that viruses are also 
restricted by RISC-mediated cleavage of 
viral ssRNAs. R2D2 and AGO2 mutant 
flies are more sensitive to virus infection 
(71, 72, 74, 85, 86), which implies a role 
for vsiRNA-loaded RISC in antiviral 
defense. Indeed, viral siRNAs are 
resistant to beta-elimination treatment 
(which shortens RNA containing non-
modified 2’- and 3’ hydoxyl groups at 
the 3’ terminus), suggesting that at least 
some vsiRNAs are AGO2-associated and 
2’-O-methylated at their 3’ end (33, 87). 
More recently, it was demonstrated that 
Slicer-incompetent AGO2 mutants are 
highly susceptible to infection with the 
negative strand (-) RNA virus Vesicular 
stomatitis virus (85). Another line of 
support comes from the observation 
that two unrelated insect RNA viruses 
(Cricket paralysis virus and Nora virus) 
have evolved antagonists that inhibit 
Slicer activity of pre-assembled RISC 
(88, 89). Together these studies indicate 
that antiviral defense depends on dicing 
and slicing of viral RNAs.
Substrates for viral siRNA biogenesis
A hallmark of an antiviral RNAi response is the Dcr-2-dependent production of vsiRNAs. 
Putative Dcr-2 substrates include viral replication intermediates of ssRNA viruses, viral 
genomes of dsRNA viruses, structured RNA elements in viral ssRNA genomes or viral 
transcripts, and dsRNA that is formed by hybridization of overlapping transcripts of 
DNA viruses. Several recent studies used deep sequencing to analyze small RNAs in 
virus-infected samples. The detection of vsiRNA provides direct support for Dicer-
mediated processing of viral dsRNA. Moreover, vsiRNA sequences can be mapped to 
AGO2
5’ P
3’ OH
2’ OCH3
RISC
Viral target 
cleavage
5’ P 3’ OH
3’ OH 5’ P
Dcr-2
Dcr-2
5’ P 3’ OH
3’ OH 5’ P
Viral dsRNA
Viral siRNA
R2D2
RISC loading 
complex
DNA & RNA viruses
Figure 3. The antiviral RNAi pathway in 
insects. Dicer-2 (Dcr-2) detects viral double-
stranded RNA, produced by RNA and DNA 
viruses, and generates viral small interfering 
RNAs (vsiRNAs). Dcr-2 and R2D2 are required 
for vsiRNA incorporation in Argonaute-2 
(AGO2), within the RNA-induced silencing 
complex (RISC). The strand that remains 
incorporated in RISC guides the recognition 
and cleavage of target viral RNA to restrict virus 
replication.
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the viral genome and this information can be used to deduce the viral substrates that are 
processed by Dcr-2.
Small RNA profiles from (+) RNA viruses
During replication of positive-strand (+) RNA viruses, the viral (+) RNA strand serves 
as a template for negative strand (-) RNA synthesis. The (-) RNA strand in turn serves 
as a template for the production of (+) viral RNA progeny (90). Viral RNA replication 
is in general asymmetric: the viral (+) RNA strand greatly outnumbers the viral (-) RNA 
strand. Nevertheless, upon infection of insect hosts with different (+) RNA viruses, 
vsiRNAs of positive and negative polarity were recovered in roughly equal numbers. 
This observation, together with the finding that vsiRNAs map along the entire length 
of the viral genome (Table 1), indicates that viral dsRNA replication intermediates are a 
major substrate for Dcr-2 during (+) RNA virus infection.
Nevertheless, in some (+) RNA virus infections, Dcr-2 may process additional substrates. 
In Flock House virus (FHV) infection of Drosophila, for example, vsiRNAs mainly 
derive from the (+) RNA strand across the two segments of the viral RNA genome 
(86). This suggests that intramolecular base pairing within viral ssRNA genomes form 
dsRNA substrates for Dicer. FHV encodes the RNAi antagonist B2 that binds dsRNA 
(Table 2, discussed below) and markedly affects vsiRNA profiles (91-93). Infection with 
a B2 deficient mutant FHV (FHV ΔB2) resulted in the production of vsiRNAs that 
mapped in similar numbers to the (+) and (-) strands at the 5’ terminal region of RNA 
segment 1 (86, 87). Similar to wildtype FHV infection, vsiRNAs also mainly derive 
from the viral (+) RNA strand in infections with the (+) RNA virus Drosophila C 
virus (DCV) (83, 94). Like FHV, DCV encodes a dsRNA binding RNAi suppressor 
protein (1A) that is thought to shield the replication intermediates from Dicer (72). 
These results might suggest that the 1A and B2 proteins shield replication intermediates 
for Dicer-mediated cleavage and that under these conditions other viral RNA substrates 
are processed into vsiRNAs. Remarkably however, infection of Aedes aegypti mosquitoes 
with recombinant Sindbis virus (which is thought not to encode an RNAi suppressor) 
engineered to encode the FHV B2 protein resulted in strongly reduced vsiRNA levels, 
without a concomitant shift towards (+) viral small RNAs (78). These data suggest that 
viral RNAi suppressor proteins might affect vsiRNA profiles, but that this might be 
virus and host species dependent.
Small RNA profiles from (-) RNA viruses
Analogous to (+) RNA viruses, the viral genomic RNA strand is template for the 
production of complementary RNA strands during (-) RNA virus replication. Due to 
asymmetric replication, the genomic strand of (-) RNA viruses is more abundant than 
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the antigenome (+) RNA during infections (95, 96). Genome replication of (-) RNA 
viruses occurs in ribonucleoprotein complexes, which requires the initial assembly of 
the viral RNA with the viral nucleocapsid protein (N) (95, 97). The formation of the 
RNA-N protein complex might explain why dsRNA is not readily detectable in (-) 
RNA virus infection (70).
An additional RNA species in (-) RNA virus infections is the viral messenger RNA, 
which may be expressed at different relative levels during infection. For example, a 
gradient of mRNA transcripts (N > P > M > G > L) is produced by the viral RNA 
polymerase of the non-segmented Vesicular stomatitis virus, which is the net result from 
the sequential mode of transcription based on gene order (95).
Small RNA profiling in (-) RNA virus infections, demonstrated that vsiRNAs are 
generally equally distributed over genomic and antigenomic RNA strands and that they 
are produced from the full-length genome (71, 83, 85, 98-100). These observations 
suggest that replication intermediates are the predominant Dcr-2 substrate in (-) RNA 
virus infection of adult flies and of Drosophila or mosquito cells (Table 1). For Vesicular 
stomatitis virus, it was suggested that viral genome-transcript hybrids provide a putative 
dsRNA template that can be recognized by Dcr-2 (85). An additional Dcr-2 substrate 
was suggested for the tri-segmented (L, M and S) Rift Valley fever virus. Here, Dcr-
2-dependent vsiRNAs were unevenly distributed across the S segment and were most 
likely derived from an intergenic hairpin (83).
Small RNA profiles from dsRNA viruses
Genome replication of most dsRNA viruses occurs within the viral capsid that 
encapsulates the viral dsRNA (101). Some dsRNA viruses, such as members of the 
Birnaviridae family, protect their genome by forming ribonucleoprotein complexes (102, 
103). Nevertheless, several studies indicate that viral dsRNA genomes are accessible for 
Dcr-2. For example, small RNA deep sequencing of persistently infected Drosophila cell 
lines revealed roughly equal numbers of (+) and (-) vsiRNAs for three different dsRNA 
viruses (Drosophila totivirus, Drosophila X virus, Drosophila birnavirus), indicating 
that the viral dsRNA genome is cleaved by Dcr-2 (94, 104). Similarly, vsiRNAs of 
both polarities were recovered in equal proportions from Aedes mosquito-derived cell 
lines infected with Bluetongue virus, with vsiRNAs evenly distributed across the viral 
genome (100).
Small RNA profiles from DNA virus infections
In contrast to RNA viruses, DNA viruses do not replicate via a dsRNA replication 
intermediate. Nevertheless, we and others showed that the RNAi machinery contributes 
to control of DNA virus infection in insects (80-82) and therefore other dsRNA sources 
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must be processed by Dcr-2 (Table 1). Indeed, overlapping bidirectional transcripts base 
pair to form dsRNA substrates for Dcr-2-dependent vsiRNA biogenesis in Drosophila 
(80, 81, 84). A number of recent publications have now analyzed vsiRNA profiles in 
DNA virus infections in different invertebrate model systems and these studies further 
underscore that convergent transcripts are a major source of vsiRNA production, but 
that other substrates, such as structured RNA elements (83), can also contribute to the 
vsiRNA profile (84).
Virus-derived piRNAs
Recent small RNA profiling studies have implicated the piRNA pathway in antiviral 
defense in mosquitoes. The potential of the piRNA pathway to process viral RNAs 
was first suggested by the detection of piRNA-sized viral RNAs in persistently infected 
Drosophila ovarian sheet cells (104, 105). Several studies that detected arboviral small 
RNAs of positive polarity within the piRNA size-range suggested that the piRNA 
pathway also processes viral RNAs in mosquitoes (98, 106, 107).
More recently, small 25-30 nt RNAs with clear features of ping-pong-dependent 
piRNAs were recovered from Aedes mosquitoes or mosquito-derived cells infected with 
(+) RNA arboviruses from the Togaviridae family (Sindbis virus, Semliki Forest virus 
and Chikungunya virus) and (-) RNA arboviruses from the Bunyaviridae family (La 
Crosse virus, Schmallenberg virus and Rift Valley fever virus). Virus-derived piRNAs 
(vpiRNAs) of positive polarity showed a non-uniform distribution across the viral 
genome and presented an 10A bias, whereas vpiRNAs of negative polarity were enriched 
for 1U (99, 100, 108-110). Together, these results indicate that de novo vpiRNAs are 
produced in a ping-pong-dependent manner upon RNA virus infection of major vector 
mosquitoes (Table 1). In Aedes mosquitoes, the PIWI gene family greatly expanded 
and expression of at least some of the eight PIWI family members does not seem to be 
restricted to germ line tissues (108, 109, 111), raising the possibility that the piRNA 
pathway has functionally diversified in mosquitoes.
The intriguing identification of viral piRNAs in mosquitoes raises important questions 
about their biogenesis and functions. Interestingly, knockdown of Piwi4 in Aedes aegypti 
cells resulted in increased Semliki Forest virus viral loads, suggesting a role of the 
piRNA pathway in restricting virus replication (110). Similarly, knockdown of AGO3 
in Anopheles mosquitoes lead to increased O’nyong-nyong virus titers (75), although 
production of vpiRNAs has yet to be demonstrated in this mosquito species.
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Viral suppression of RNAi 
Viruses have evolved suppressors of RNAi (VSRs) to antagonize the RNAi-based antiviral 
immune response. These VSRs may target different critical steps of the antiviral RNAi 
pathway (Table 2). It is not surprising that many VSRs sequester dsRNA or siRNAs, 
as these molecules are the initiators and sequence specificity determinants of RNAi. 
For example, the natural fly pathogen DCV encodes the 1A protein that binds long 
dsRNA and protects it from Dcr-2 processing. It was thus proposed that 1A protects 
replication intermediates from Dcr-2-mediated processing (72), although more recently 
it was reported that DCV 1A may also interfere with RISC loading (88). Members of 
the Alphanodavirus genus (Nodaviridae family), including FHV, Nodamura virus (NoV) 
and Wuhan nodavirus (WhNV), encode the B2 protein that suppresses RNAi via a 
multimode mechanism. B2 binds long dsRNA and siRNAs, thereby inhibiting Dcr-2 
processing and RISC loading, respectively (93, 112-114). Additionally, the FHV and 
WhNV B2 proteins directly associate with Dcr-2, which likely contributes to their RNAi 
suppressive activity (115, 116). Despite the similar mechanism of action, only limited 
amino acid identity exists between the B2 proteins of these viruses (23.5% identity 
between WhNV and FHV; 26.4% identity between NoV and FHV). Nevertheless, the 
structures of NoV and FHV are strikingly similar (117), suggesting that they derive 
from a common ancestral sequence.
An alternative mechanism to interfere with the initiation of the antiviral RNAi response 
is used by Heliothis virescens ascovirus-3e. This virus encodes an RNase III enzyme 
(orf 27) that degrades dsRNA (118). Thus, the orf27 protein may compete with Dcr-2 
for dsRNA substrates or degrade siRNA duplexes to prevent their incorporation into 
AGO2 in a manner analogous to the RNase III protein of the plant virus sweet potato 
chlorotic stunt virus (119). Viruses may also target the effector phase of the antiviral 
RNAi response. For example, Nora virus VP1 and Cricket paralysis virus 1A interact 
with AGO2 and thereby inhibit RISC-mediated slicing of target RNAs (88, 89).
The transmission of arboviruses relies on mosquito vectors that support a productive virus 
infection. Despite a functional RNAi-response, arboviruses establish a persistent, non-
pathogenic infection in mosquitoes. Although Nodamura virus, a putative arbovirus, 
was known to encode an RNAi suppressor (Table 2), it was for a long time believed that 
most arboviruses do not encode a VSR, as this would lead to pathology and killing of the 
vector thus preventing efficient virus transmission. Indeed, the introduction of a VSR 
(FHV B2) in recombinant Sindbis virus induced pathogenicity and led to mortality of 
infected mosquitoes (78, 79).
Recently, it was suggested that the Dengue virus NS4B protein suppresses RNAi by 
inhibiting Dicer processing independent of dsRNA-binding (120). Alternatively, 
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flaviviruses may use non-coding ssRNA molecules to counteract RNAi in mammals 
and insects. West Nile virus and Dengue virus, for example, produce large amounts 
of subgenomic flavivirus (sf ) RNA that contains extensive secondary structures. It was 
proposed that sfRNAs compete with other dsRNA substrates, such as essential viral 
replication intermediates, for Dicer-mediated cleavage to inhibit an antiviral RNAi 
response (121).
Strong genetic evidence supports the importance of B2 protein in FHV infection. 
Indeed, in the absence of a suppressor protein (ΔB2), abundant vsiRNAs are produced 
and, as a consequence, no potent FHV infection was established in wildtype embryos 
and adult flies. Importantly, the replication defect of FHV ΔB2 was rescued by genetic 
inactivation of RNAi genes (74, 86, 87, 122). However, such genetic evidence is lacking 
for VSRs of most other viruses, in some cases due to the lack of a reverse genetics system 
to engineer these viruses. For some VSRs, proof-of-concept for a role in suppressing 
RNAi was provided by rescuing replication of the FHV ΔB2 replicon or by analyzing 
virus replication of a recombinant Alphavirus engineered to express the VSR of interest 
(Table 2). Nevertheless, future studies are needed to provide insights into the role of the 
identified VSRs in viral pathogenesis and transmission.
Many insect viruses encode suppressors of RNAi; yet in other viruses, including some 
well-characterized arboviruses, attempts to identify RNAi suppressive activities have 
not been successful (unpublished observations). Although this might mean that those 
viruses do not encode RNAi suppressors, an alternative explanation might be that 
RNAi reporter assays that are frequently used to detect RNAi suppressive activity fail to 
identify bona fide VSRs. This could be due to technical limitations of the assay, the use 
of non-host systems, or the inability of reporter assays to identify suppressors that work 
in cis (123). Also, RNAi reporter assays may not address all aspects of the antiviral RNAi 
response that are putative targets for viral interference. For example, systemic spread was 
proposed to be essential for efficient antiviral RNAi (124), but no reporter assays have 
been established that would identify suppressors of systemic antiviral RNAi responses.
Outline of this thesis
Research over the last several years revealed that RNAi is the major antiviral defense 
mechanism in insects and that viruses and their hosts co-evolve during their ongoing 
arms race. In this thesis we study the cellular small RNA-based antiviral responses 
in insects as well as viral counter-defense mechanisms. In chapter 2 we analyzed 
the interaction between Nora virus and the RNAi machinery. By performing high-
throughput sequencing of small RNAs, recovered from Drosophila laboratory strains 
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Family Virus (abbr.) Host/Vector a,b
Experimental 
insect host c
Suppressor Mechanism 
Ascoviridae
Heliothis 
virescens 
ascovirus-3e 
Heliothis 
virescens
Spodoptera 
frugiperda;
Heliothis virescens
Orf 27 
(RNase III) Degradation of dsRNA
Birnaviridae Drosophila X virus D. melanogaster D. melanogaster VP3
Long dsRNA binding 
prevents Dicer-2 
cleavage;
siRNA binding 
Culex Y virus Culex pipiens Culex tarsalis VP3
Long dsRNA binding 
prevents Dicer-2 
cleavage;
siRNA binding 
Dicistroviridae Drosophila C virus (DCV) D. melanogaster D. melanogaster 1A 
Long dsRNA binding 
prevents Dicer-2 
cleavage;
interferes with RISC 
assembly
Cricket 
paralysis virus Teleogryllus sp. D. melanogaster 1A 
Inhibition of AGO2 
endonuclease activity
Flaviviridae Dengue virus Ae. aegypti; Ae. albopictus
Spodoptera 
frugiperda NS4B 
Inhibition of (human) 
Dicer processing activity
West Nile virus Culex spp. Ae. Albopictus;D. melanogaster sfRNA
Inhibition of (human) 
Dicer processing activity 
Dengue virus Ae. aegypti;Ae. albopictus Ae. albopictus sfRNA -
Nodaviridae Flock House virus (FHV)
Costelytra 
zealandica
D. melanogaster;
Spodoptera 
frugiperda;
Ae. aegypti;
Ae. albopictus
B2
Long dsRNA binding 
prevents Dicer-2 
cleavage;
siRNA binding prevents 
RISC incorporation;
Dicer-2 binding
Nodamuravirus 
(NoV)
Culex 
tritaeniorhynchus
D. melanogaster;
An. gambiae;
Ae. albopictus
B2
Binding of long dsRNA 
and siRNA;
inhibition of (human) 
Dicer processing activity
Wuhan 
Nodavirus 
(WhNV)
Pieris rapae Pieris rapae;D. melanogaster B2
Long dsRNA binding 
prevents Dicer-2 
cleavage;
siRNA binding prevents 
RISC incorporation;
Dicer-2 binding
Unassigned Nora virus D. melanogaster D. melanogaster VP1 Inhibition of AGO2 endonuclease activity
Dimm Nora-
like virus D. immigrans D. immigrans VP1
Inhibition of AGO2 
endonuclease activity
Table 2. Viral RNAi suppressors in insect viruses and arboviruses
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Replication 
defect of VSR 
mutant virusd
Rescue of 
FHV ΔB2 
replicon e
Increased 
replication of 
recombinant 
Alphavirus f
References
yesg n.t. n.t. (118)
n.a. yes n.t.
(133)
Unp. obs.
n.a. yes n.t. Unp. obs.
n.a. yes yes (72, 88, 134)
n.a. yes yes (74, 88, 89)
n.t. n.t. n.t. (120)
n.t. n.t. yes (121)
n.t. n.t. n.t. (121)
yes yes yes 
(74, 78, 79, 
87, 91-93, 
108, 112, 115, 
122, 134)
yes yes yes (78, 86, 87, 108, 112, 114)
n.t. n.t. n.t. (113, 116)
n.t. yes yes (89)Unp. obs.
n.a. n.t. yes Unp. obs. U
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that were persistently infected with this (+) RNA virus, we showed that Nora virus-
derived vsiRNAs could be detected in adult flies. Using a combination of functional and 
biochemical assays, we identified the VP1 protein of Nora virus as the viral suppressor 
that antagonizes the RNAi response by inhibiting the catalytic activity of AGO2. In 
chapter 3 we investigated whether RNAi mediates antiviral defense against DNA 
viruses. We first show that RNAi mutant flies are more susceptible to infection with 
the dsDNA virus IIV-6. Subsequently, we identified Dcr-2-dependent vsiRNAs in IIV-
6-infected flies. In addition, we demonstrate that sense and antisense transcripts are 
generated during IIV-6 replication, supporting a model in which base pairing between 
convergent overlapping transcripts generate the viral dsRNA substrate for vsiRNA 
production by Dcr-2. In chapter 4 we further discuss our findings in relation to other 
publications that analyzed vsiRNA profiles in DNA virus infections. Together, these 
studies demonstrate that an antiviral RNAi response is mounted against distinct DNA 
viruses in different invertebrate hosts. However, it remained unknown whether DNA 
viruses antagonize this small RNA-based antiviral response. In chapter 5 we therefore 
studied whether IIV-6 encodes an RNAi antagonist. We show that RNAi is suppressed 
in IIV-6-infected cells and we mapped RNAi suppressive activity to the viral protein 
340R. Using biochemical assays we reveal that 340R suppresses RNA silencing through 
binding of RNA duplexes, thereby inhibiting Dcr-2 processing activity and blocking 
RISC loading. We propose that, in analogy to RNA viruses, DNA viruses antagonize the 
Drosophila antiviral RNAi response to establish a productive infection. In chapter 6 we 
analyzed small RNA profiles of mosquito cells that were infected with different classes 
of RNA viruses, and report the de novo production of viral piRNAs. Chapter 7 provides 
a general discussion of the results in this thesis, as well as directions for future research.
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Abstract
RNA interference (RNAi) is a major antiviral pathway that shapes evolution of RNA viruses. We show here that Nora virus, a natural Drosophila pathogen, is both a target and suppressor of RNAi. We detected viral small 
RNAs with a signature of Dicer-2-dependent small interfering RNAs in Nora virus-
infected Drosophila. Furthermore, we demonstrate that the Nora virus VP1 protein 
contains RNAi suppressive activity in vitro and in vivo that enhances pathogenicity 
of recombinant Sindbis virus in an RNAi-dependent manner. Nora virus VP1 
and the viral suppressor of RNAi of Cricket paralysis virus (1A) antagonized 
Argonaute-2 (AGO2) Slicer activity of RNA induced silencing complexes pre-
loaded with a methylated single-stranded guide strand. The convergent evolution of 
AGO2 suppression in two unrelated insect RNA viruses highlights the importance 
of AGO2 in antiviral defense. 
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Introduction
An efficient antiviral immune response is essential for the control or elimination of 
virus infection and for survival of the infected host. The immune system exerts a strong 
evolutionary pressure that shapes the genetic makeup of viral pathogens. Indeed, viruses 
evolved counter-defense mechanisms to evade, suppress or inactivate host immunity. 
Studying these mechanisms provides important insight in the critical steps of antiviral 
responses and may uncover novel components and regulators of immune pathways. 
Plants, fungi, and invertebrate animals rely on the RNA interference (RNAi) pathway 
for antiviral defense (1, 2). The initial trigger of an antiviral RNAi response is the 
recognition and cleavage of viral double-stranded RNA (dsRNA) into viral small 
interfering RNAs (vsiRNAs), in insects by the ribonuclease Dicer-2 (Dcr-2). These 
vsiRNAs act as specificity determinants of the Argonaute-2 (AGO2) containing effector 
nuclease complex RISC (RNA induced silencing complex). RISC maturation involves a 
number of sequential steps: loading of the vsiRNA into AGO2, cleavage and elimination 
of the passenger RNA strand, and 2’-O-methylation of the 3’-terminal nucleotide of the 
retained guide strand. It is thought that vsiRNA-loaded RISC subsequently cleaves viral 
target RNA (Slicer activity). The hypersensitivity to viral infections of AGO2 mutant 
flies and of AGO2 knockdown mosquitoes provides genetic support for this hypothesis 
(3-7). Nevertheless, direct evidence supporting this model, for example by the detection 
of viral Slicer products, is lacking. 
The evolution of viral suppressors of RNAi (VSRs) is a testament to the antiviral potential 
of the RNAi pathway in plants and insects. Given the central role of dsRNA and siRNAs 
as initiators and specificity determinants of the RNAi pathway, it is not surprising 
that many VSRs sequester dsRNA. For instance, the Drosophila C virus (DCV) 1A 
protein binds long dsRNA and shields it from processing by Dcr-2 (6). Flock House 
virus (FHV) B2 displays a dual RNA binding activity: it binds long dsRNA as well 
as siRNAs, thereby preventing their incorporation into RISC (8-10). Similarly, many 
plant VSRs display dsRNA binding activities, leading to the hypothesis that dsRNA or 
siRNA binding is a general mechanism for RNAi suppression (11, 12). Nevertheless, 
other mechanisms have been reported (1). The RNAi suppressive activity of the Cricket 
paralysis virus (CrPV) 1A protein, for example, relies on a direct interaction with AGO2 
(13).
VSRs have been identified in dozens of plant viruses from all major virus families 
(1). In contrast, VSRs have thus far been identified in only three insect RNA viruses 
(FHV, CrPV, and DCV). These VSRs were characterized using genetic and biochemical 
approaches in the model organism Drosophila melanogaster. While these viruses indeed 
efficiently infect Drosophila laboratory stocks and cell lines, DCV is the only natural 
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Drosophila pathogen among these three viruses (14, 15). Although FHV and CrPV 
have a remarkable broad host range in the laboratory, they were originally isolated from 
non-Drosophilid host species: the New Zealand grass grub (Costelytra zealandica) and 
field crickets (Teleogryllus oceanicus and T. commodus), respectively (16-19).
Since viral counter-defense mechanisms co-evolve with the antiviral immune responses 
of the host species, it is essential to characterize a VSR within the correct evolutionary 
context. We therefore set out to identify an RNAi suppressor in Nora virus, a positive 
sense (+) RNA virus that persistently infects Drosophila laboratory stocks as well as 
Drosophila in the wild (20) (D.J. Obbard, personal communication). The genome 
organization and phylogeny suggest that Nora virus is the type member of a novel virus 
family within the order of Picornavirales (20). Here we show that Nora virus VP1, the 
protein product of open reading frame 1 (ORF1), suppresses RNAi in cell culture as 
well as in flies. In accordance, VP1 is an RNAi-dependent viral pathogenicity factor. In 
a series of biochemical assays, we show that both Nora virus VP1 as well as CrPV 1A 
inhibit Slicer activity of a pre-assembled RISC loaded with a methylated guide strand. 
The lack of amino acid sequence similarity between CrPV 1A and Nora virus VP1 
suggests that their Slicer antagonistic activities resulted from convergent evolution, 
providing direct support for the critical role of AGO2 Slicer activity in antiviral defense.
Results
Nora virus is a target of RNAi in vivo
Nora virus is an enteric (+) RNA virus that successfully establishes a persistent infection 
in flies (20). The mechanism by which this virus establishes persistent infections is 
unknown. To determine whether Nora virus is a target for Dcr-2, we analyzed the 
presence of Nora virus small RNAs in the w1118 Drosophila strain that is widely used 
as a recipient strain for transgenesis. We isolated and sequenced 19-29 nt small RNAs 
from body (abdomen and thorax), thorax and head of adult w1118 flies. Sequence reads 
that perfectly matched the Drosophila genome were annotated and discarded. Of the 
remaining reads, 396,646 (7,8%, body), 237,265 (10.6%, thorax), and 1,099,496 
(7.7%, head) matched the published Nora virus sequence (NC_007919.3), indicating 
that the w1118 strain was infected by Nora virus (Table 1). As RNA viruses rapidly evolve, 
viral small RNA sequences may have been missed in this initial matching step. We 
therefore reconstituted the Nora virus genome through an iterative alignment/consensus 
treatment of the viral small RNA sequences in our libraries (21). The reconstituted 
Nora virus genome (rNora virus) differed at only 3.2% of the nucleotides from the 
published genome sequence. Aligning small RNAs to the rNora virus genome instead 
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of the published Nora virus sequence resulted in an increased number of viral reads in 
the three libraries (~121%, Table 1). We therefore used the reconstituted genome as a 
reference genome in further analyses. 
In all three libraries, Nora virus-derived small RNAs were predominantly 21-nt long, 
the typical size of Dcr-2 products. The size distribution of small RNAs derived from the 
(+) RNA strand, however, were noticeably wider than those derived from the (-) RNA 
strand (Figure 1A). For 21-nt viral RNA reads, there was only a slight bias towards (+) 
small RNAs (ratio (+) RNA / total RNA ~0.58), whereas small RNAs of other sizes 
were predominantly derived from the (+) strand (Figure 1B). In all three libraries, the 
21-nt Nora virus-derived RNAs are distributed across the genome, covering both the (+) 
and (-) viral RNA strands with approximately equal numbers (Figure 1C). These data 
suggest that dsRNA replication intermediates of Nora virus are processed into 21-nt 
long siRNAs. The origin of the other size classes of viral small RNAs remains unclear. 
However, as the predominance of (+) over (–) small RNA reads is reminiscent of the 
excess of (+) over (-) viral (full-length) RNA that is typically observed in (+) RNA virus 
infection, they may be due to non-specific RNA degradation.
Drosophila Dcr-2 generates 21-nt duplex siRNAs in which 19 nucleotides are base paired 
leaving a 2-nt 3’ overhang at each end. For each library, we collected the 21-nt RNA 
reads whose 5’ ends overlapped with another 21-nt RNA read on the opposite strand of 
the Nora virus genome. Then, for each possible overlap of 1 to 21-nt, the numbers of 
read pairs were counted and converted into Z-scores (Figure 1D). This analysis revealed 
that 21-nt Nora virus-derived RNAs in body and thorax libraries tend to overlap by 19-
nt, which is a typical feature of siRNA duplex precursors. This siRNA duplex signature 
was observed to a lesser extent in head libraries. Very little Nora virus RNA can be 
detected in the head (22), yet vsiRNA levels were similar in head, thorax, and body 
Table 1. Annotation of small RNA sequences in libraries from body (abdomen and thorax), 
thorax, and head of Nora virus-infected w1118 adult flies
* The number of reads matching the Drosophila genome, reads that fail to map to the Drosophila 
genome (unmatched), and reads mapping to the Nora virus genome (isolate Umea 2007) and the 
reconstituted Nora virus genome are indicated for each library.
Body Thorax Head
Total library 18,296,275 17,280,520 49,633,458
Match to D. melanogaster* 13,184,119 15,033,831 35,435,546
Unmatched* 5,112,156 2,246,689 14,197,912
Nora virus (NC_007919.3)* 396,646 237,265 1,099,496
Nora virus (reconstituted)* 479,572 291,045 1,329,336
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(Table 1). The origin of the vsiRNAs in the head and the reason for the less pronounced 
vsiRNA signature of those small RNAs remain unclear. Altogether, our results strongly 
suggest that Nora virus double-stranded replication intermediates are processed by Dcr-
2 into vsiRNAs that trigger an RNAi response in infected flies.
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Figure 1. Nora virus is targeted by RNAi in adult flies. (A) Size distribution of Nora virus-
derived small RNAs in libraries from thoraxes, bodies and heads of w1118 flies. Read counts of 
small RNAs matching the (+) and (-) viral RNA strands are in gray and black, respectively. (B) 
Proportion of (+) Nora virus small RNA reads of total viral reads. Frequencies were computed 
from the distributions in panel A for each size class. (C) Viral siRNA distribution across the viral 
genome. The abundance of 21-nt small RNAs matching the (+) and (-) viral RNA strands of the 
reconstituted Nora virus (rNora) reference genome is shown in gray and black, respectively. (D) 
Z-scores for the number of overlapping pairs of sense and antisense 21-nt Nora virus small RNAs 
matching the rNora virus reference genome. For each possible overlap of 1 to 21-nt, the number 
of read pairs was counted and converted into a Z-score.
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Nora virus VP1 suppresses RNAi in vitro
Our small RNA profiles indicate that Nora virus is targeted by Dcr-2. Nevertheless, 
the virus efficiently establishes a persistent infection, suggesting that it is able to 
evade or suppress the antiviral RNAi response. The Nora virus genome contains four 
open reading frames (ORFs) (Figure 2A). Nora virus ORF2 is predicted to encode 
the helicase, protease, and polymerase domains that together form a picornavirus-like 
replication cassette. ORF4 encodes three proteins that make up the Nora virus capsid 
(VP4A, VP4B, and VP4C) (23). To determine whether the Nora virus genome encodes 
an RNAi suppressor, we analyzed the four ORFs in an RNAi sensor assay in Drosophila 
cell culture (Figure 2B-2D). 
In this assay, S2 cells are transfected with firefly (Fluc) and Renilla luciferase (Rluc) 
reporter plasmids and a plasmid that expresses one of the four viral ORFs. Subsequently, 
Fluc expression is silenced using specific dsRNA, and Fluc and Rluc activity is monitored. 
As expected, DCV 1A, a well characterized VSR that binds long dsRNA, efficiently 
suppressed RNAi, whereas the inactive DCV 1A K73A mutant was unable to do so 
(Figure 2C and (6)). Cotransfection of the ORF1 expression plasmid also resulted in 
de-repression of Fluc, suggesting that VP1, the protein product of ORF1, is a suppressor 
of RNAi. Expression of ORF3 and ORF4 did not affect Fluc activity (Figure 2C). 
However, since expression of ORF2 and the production of mature capsid proteins from 
ORF4 were not detectable on Western blot, we cannot exclude the possibility that these 
protein products are able to suppress RNAi as well (Figure 2B). 
Next, we tested whether VP1 inhibits the production of siRNAs by Dcr-2 or a 
subsequent step in the RNAi pathway. To this end, we repeated the RNAi sensor 
assay using a synthetic siRNA that does not require Dcr-2 cleavage for its silencing 
activity. Also under these conditions, Nora virus VP1 suppressed silencing of the Fluc 
reporter. Furthermore, VP1 suppressed RNAi to a similar extent as CrPV 1A, which 
was previously shown to suppress the effector stage of the RNAi machinery (13) (Figure 
2D).
In Drosophila, the microRNA (miRNA) and siRNA pathways are separate processes, 
with Dcr-1 and AGO1 dedicated to the miRNA pathway and Dcr-2 and AGO2 to 
the siRNA pathway. Nevertheless, crosstalk between the miRNA and RNAi pathways 
occurs. Using miRNA sensor assays in S2 cells, in which Fluc expression is silenced by 
endogenous miRNAs or co-expressed primary miRNAs, we observed that VP1 does not 
suppress miRNA activity (Text S1 and Figure S1). Together, these data indicate that 
VP1 is able to suppress the RNAi, but not the miRNA pathway, at a step after dsRNA 
processing by Dcr-2.
Chapter 2
2
44
The C-terminus of VP1 is essential for its suppressor activity
VP1 is highly conserved among different Nora virus isolates (Figure S2). We were unable 
to predict a protein domain in VP1 suggestive of a mechanism of action. Furthermore, 
we did not obtain a significant alignment to any other protein from the non-redundant 
protein sequence database. To map the VSR region of VP1, we generated a series of N- 
and C-terminal (ΔN and ΔC) truncations and tested them in the RNAi reporter assay in 
S2 cells (Figures 3A and S3). With the exception of the VP1ΔN390 and VP1ΔN418 mutants, 
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Figure 2. Nora virus VP1 suppresses RNAi in vitro. (A) Schematic representation of the Nora 
virus genome with its four predicted ORFs in three different reading frames. There is a 7-nt 
overlap between ORF1 and ORF2 and a 26-nt overlap between ORF2 with ORF3. An intergenic 
region of 85-nt separates ORF3 and ORF4. (B) Western blot analysis of V5-epitope tagged Nora 
virus expression constructs. Two days after transfection of the indicated plasmids into S2 cells, 
expression of the constructs was analyzed by Western blot using the V5 antibody (α-V5). Asterisks 
(*) indicate additional bands that do not correspond to the expected size of the full-length protein 
product. (C) RNAi reporter assay in Drosophila S2 cells. Copper-inducible plasmids encoding 
Fluc and Rluc were transfected into S2 cells together with a construct expressing Nora virus 
ORF1, 3, and 4, encoding viral protein 1 (VP1), VP3, and VP4, respectively. Two days after 
transfection, dsRNA targeting Fluc or GFP (Ctrl) was added to the medium. Seven hours later, 
expression of Fluc and Rluc was induced and luciferase activity was measured the next day. Fluc 
counts were normalized to Rluc counts and presented as fold silencing relative to the control 
GFP dsRNA. Plasmids encoding DCV 1A and the K73A mutant (DCV 1A mut) were used as 
controls. (D) siRNA-based RNAi reporter assay. The experiment was performed as described in 
panel C, but 21-nt Fluc siRNAs were cotransfected with the reporter plasmids to silence gene 
expression. An siRNA targeting the human MDA5 gene was used as a non-silencing control 
(Ctrl). Bars in panel C represent averages and standard deviations of five independent samples; 
bars in panel D represent averages and standard deviations of three independent samples. Panel 
C and D are representative for two and three independent experiments, respectively.
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in which no protein could be detected on Western blot, all VP1ΔN and VP1ΔC constructs 
produced proteins of the expected size (Figure 3B). Deletion of 74 amino acids (aa) or 
more from the C-terminus of VP1 resulted in loss of suppressor activity (Figure 3C). 
This suggests that the active domain of VP1 resides in its C-terminal region. Indeed, 
deleting up to 351-aa from the N-terminus (VP1ΔN351), out of a total of 475-aa, did not 
affect VSR activity. These results show that the RNAi suppressor activity of VP1 maps 
to the C-terminal 124-aa.
VP1 is an RNAi suppressor in vivo 
We next evaluated the VSR activity of Nora virus VP1 in vivo using transgenic flies 
in which thread (th), also known as Drosophila inhibitor of apoptosis 1, can be silenced 
by expression of dsRNA targeting this gene (thRNAi (24, 25)) (Figure 4). Eye-specific 
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Figure 3. The C-terminus of Nora virus VP1 is essential for RNAi suppressor activity. (A) 
Schematic presentation of full-length (FL) and N- and C-terminal deletion mutants (DN and 
DC) of VP1. (B, C) Western blot analysis of VP1 expression constructs. V5 epitope tagged 
expression constructs were transfected into Drosophila S2 cells and expression of VP1FL and the 
deletion mutants was analyzed by Western blot using a V5 antibody (α-V5). (D) RNAi reporter 
assay in S2 cells. The experiment was performed as described in the legend to Figure 2D, using 
plasmids encoding either CrPV 1A, VP1FL or the VP1 deletion mutants. Bars represent averages 
and standard deviations of three independent samples. The graph is representative for two 
independent experiments. 
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expression of thRNAi using the GMR-Gal4 driver leads to severe apoptosis in the 
developing eye. As a consequence, thRNAi flies display a reduced eye size, loss of eye 
pigmentation, and roughening of the eye surface (Figure 4A, results are shown for 
AGO2321 heterozygotes; thRNAi in a wildtype background shows the same phenotype, 
data not shown and ref. 24). Silencing of th in the eye of thRNAi flies is fully dependent 
on the RNAi pathway, since the phenotype is lost in an AGO2 null mutant background 
(Figure 4B). These results indicate that the thRNAi sensor fly is a robust system to monitor 
RNAi activity in vivo.
VP1 FLC
VP1∆C74D
GFPE
CrPV 1AF
AGO2321/321B
AGO2321/+A
thRNAi
Figure 4. VP1 suppresses RNAi in vivo. (A-F) RNAi of Drosophila Inhibitor of Apoptosis1 / 
thread (th) in the eye of adult flies in the indicated genetic background or in the presence of 
several transgene constructs. RNAi-mediated knockdown of th results in a reduced size and 
pigmentation of the eye and roughening of the eye surface in AGO2321 heterozygotes (A), but not 
in AGO2321 homozygotes (B). Eye phenotype of transgenic flies co-expressing the thRNAi construct 
and Nora virus full-length VP1 (VP1 FL, C), a C-terminal deletion mutant of VP1 (VP1DC74, D), 
GFP (E) or CrPV 1A (F). Maximum silencing of th was examined in the presence of the GFP 
control transgene (E). For each line, five representative pictures of eyes of two- to four-day-old 
male flies are presented. Pictures are representative for three independent experiments.
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Consistent with its RNAi suppressive activity in cell culture, expression of full-length 
VP1 (VP1FL) in thRNAi flies resulted in eyes with a normal size and a rescue of the rough 
eye phenotype (Figure 4C). The phenotype of thRNAi flies expressing the VP1ΔC74 mutant 
was similar to that of flies expressing GFP as a negative control, confirming that this 
mutant is functionally inactive (Figure 4D, E). Notably, while VP1 only partially rescued 
the RNAi-dependent phenotype, CrPV 1A fully reverted the thRNAi induced phenotype 
(Figure 4F). Whether this difference is due to a more robust RNAi suppressive activity 
of CrPV 1A or to a difference in expression level remains to be established.
VP1 enhances viral pathogenicity in vivo 
Having established that VP1 displays RNAi suppressive activity in vitro and in vivo, 
we next analyzed the effect of VP1 on viral pathogenicity in adult flies. To this end, we 
generated recombinant Sindbis virus (SINV) expressing the functional VP1ΔN351 (SINV-
VP1) or GFP (SINV-GFP) from a second subgenomic promoter (Figure 5A). Although 
arboviruses are a target of the RNAi pathway during infection in insects (3, 5, 26), we 
and others have not detected VSR activity in infections with SINV and the related 
alphavirus Semliki Forest virus (27, 28) (data not shown). 
Figure 5. VP1 enhances viral pathogenicity via its RNAi suppressive activity.(A) Schematic 
representation of Sindbis virus (SINV) and SINV recombinant containing a duplicated 
subgenomic promoter (sg1 and sg2) driving expression of a viral suppressor of RNAi (VSR). 
(B and C) Survival curves of w1118 wildtype flies (B) and Dcr-2L811fsX mutants (C) infected with 
SINV recombinants expressing either GFP (black diamond) or VP1ΔN351 (gray triangle), or 
mock-infected (black square). Survival curves are representative of two independent experiments.
Wildtype 
A
B
non-structural structural
sg1
SINV
non-structural structural VSR
sg1 sg2
Recombinant SINV
w1118
0 10 20 30 40
0
20
40
60
80
100
Time (days)
S
ur
vi
va
l (
%
)
Mock
Sindbis-V5-P1 N351
Sindbis-GFP
Dcr-2L811fsX
C
0 10 20 30 40
0
20
40
60
80
100
Time (days)
S
ur
vi
va
l (
%
)
Chapter 2
2
48
Indeed, SINV recombinants expressing the viral RNAi suppressors FHV B2 and CrPV 
1A were significantly more pathogenic than their controls in mosquitoes and Drosophila, 
respectively (13, 27). 
We injected wildtype w1118 flies with the SINV recombinants and monitored survival 
over time. SINV-GFP (and the parental SINV virus, data not shown) induced only 
modest mortality in these flies with a fully functional RNAi response. After 36 days 
of infection, 73% of the SINV-GFP-infected flies and all mock-infected flies were still 
alive. In contrast, SINV-VP1 infection resulted in more severe mortality. SINV-VP1 
infected flies died faster and only 9% of the flies survived the 36-days follow up period 
(Figure 5B). Although these results indicate that VP1 enhances viral pathogenicity, 
they fail to show that this effect depends on its VSR activity. Viral proteins are often 
multifunctional and the effect of VP1 on the course of infection might be attributed 
to another, as yet unknown, activity of VP1. We therefore performed recombinant 
SINV infections in RNAi deficient Dcr-2 mutant flies. In this genetic background, an 
RNAi suppressor is not expected to enhance pathogenicity of the virus. Upon infection 
with SINV-GFP, the Dcr-2 mutants died much faster than wildtype flies, confirming 
that SINV is indeed a target of the RNAi pathway. In contrast to infections in RNAi 
competent flies, the course of infection of SINV-VP1 and SINV-GFP was remarkably 
similar in Dcr-2 mutants, with 100% mortality at 22 days after infection in both cases 
(Figure 5C). We therefore conclude that VP1 enhances virulence of an RNA virus in 
vivo through its RNAi suppressive activity. 
Nora virus VP1 interferes with the effector phase of RNAi
To further characterize the VSR activity of Nora virus VP1, we next analyzed the activity 
of VP1 in a series of biochemical assays that monitor individual steps of the RNAi 
pathway. To this end, we fused the active VP1ΔN284 mutant to the maltose binding 
protein (MBP-VP1) and purified it from Escherichia coli. We verified that MBP-VP1 
fusion proteins are fully functional in VSR assays in S2 cells to exclude the possibility 
that MBP interferes with VP1 VSR activity (data not shown). 
The ability of VP1 to suppress siRNA-initiated RNAi in S2 cells (Figure 2D) suggests 
that VP1 inhibits a step downstream of siRNA production by Dcr-2. In accordance, 
recombinant VP1 was unable to bind long dsRNA in gel mobility shift assays and could 
not interfere with Dcr-2-mediated processing of long dsRNA into siRNAs in S2 cell 
extract (Figure S4A, B). We next analyzed whether VP1 is able to bind siRNAs in a gel 
mobility shift assay. As a positive control, we used a fusion protein of MBP and the Rice 
hoja blanca virus non-structural protein 3 (NS3), which binds duplex siRNAs with high 
affinity (29). Whereas NS3 efficiently bound siRNAs in our assays, we were unable to 
observe a shift in mobility of siRNAs after incubation with VP1, even at the highest 
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concentrations used (Figure 6A). 
Since VP1 is incapable of interfering with the initiator phase of the RNAi pathway, we 
next examined the effect of VP1 on the effector phase of RNAi. For this purpose, we 
used an in vitro RNA cleavage assay (Slicer assay) in Drosophila embryo extract (30), 
in which a sequence-specific siRNA triggers cleavage of a target RNA. Since the 5’ cap 
of the target RNA is radioactively labeled, the 5’ cleavage product can be visualized by 
autoradiography after separation on a denaturing polyacrylamide gel. Indeed, a cleavage 
product of the expected size was detected if embryo extract was incubated with a target 
RNA and a specific siRNA. Specific cleavage products were not generated in the presence 
of a non-specific control siRNA (Figure 6B, lanes 1 and 2). Recombinant VP1 protein, 
but not control MBP protein, efficiently inhibited the production of cleavage product 
(Figure 6B, lanes 3 and 4). We note, however, that a minor fraction of the target RNA 
is still cleaved in the presence of VP1 (Figure 6B, lane 3). Together, these experiments 
show that VP1 does not affect the initiator phase of the RNAi pathway, but interferes 
with RISC activity.
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Figure 6. VP1 interferes with the effector phase of the RNAi pathway. (A) Mobility shift 
assays for binding of viral RNAi suppressor proteins to siRNAs. Radiolabeled siRNAs were 
incubated in buffer (lane 1) or with decreasing amounts of recombinant MBP-VP1ΔN284 (lanes 
2-5), MBP (lanes 6-9), and MBP-NS3 (lane 10-13). Ten-fold dilutions were used, starting at 2 
µM for MBP-VP1ΔN284 (lane 2) and 2.6 µM for MBP (lane 6). MBP-NS3 was tested in two-
fold dilutions (highest concentration of 8 µM, lane 10). RNA mobility shifts were analyzed on 
an 8% native polyacrylamide gel. (B) RISC Slicer assay in Drosophila embryo lysate. Lysates 
were incubated with non-targeting control siRNA (Ctrl, lane 1) or with Fluc siRNA (lanes 2-4) 
in the absence (lane 2) or presence of recombinant MBP-VP1ΔN284 (lane 3) or MBP (lane 4). 
RISC cleavage products were analyzed on an 8 % denaturing polyacrylamide gel. Slicer assay is 
representative for two independent experiments.
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Nora virus VP1 inhibits RISC activity of pre-assembled mature RISC
To discriminate between RISC assembly and target RNA cleavage by a pre-assembled 
RISC complex, we performed Slicer assays under two experimental conditions (Figure 
7A). In the first approach, a purified suppressor protein is added 30 minutes before the 
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siRNA, which allows us to analyze the effect of the VSR on both RISC loading and 
target cleavage. In the second approach, the embryo extract is incubated with siRNAs 
for 30 minutes before addition of recombinant protein. This second protocol allows a 
mature RISC to form prior to the addition of a VSR, thereby allowing us to assess the 
effect of the VSR on slicing only. As CrPV 1A was previously shown to affect the effector 
phase of the RNAi pathway (13), we generated recombinant GST-CrPV 1A as well as 
control GST. These proteins were included in our assays. 
Using the first protocol, cleavage of the target RNA was suppressed by VP1 (Figure 7B, 
lane 3). Strikingly, VP1 was also able to inhibit target cleavage when added to an embryo 
lysate containing pre-loaded RISC (Figure 7B, lane 7). The observed suppression of 
slicing was VP1 specific, since MBP alone did not inhibit RNA cleavage (Figure 7B, 
lane 4 and 8). Recombinant CrPV 1A also suppressed slicing in both experimental 
procedures (Figure 7B, lanes 5 and 9). 
To determine if VP1 affects the protein stability of AGO2, we incubated the recombinant 
proteins in Drosophila embryo extract and analyzed endogenous AGO2 protein levels 
by Western blot. Neither VP1 nor CrPV 1A affected AGO2 protein levels in embryo 
lysate, indicating that these two proteins do not mediate RNAi suppression through 
degradation of AGO2 (Figure 7C).
To further confirm the inhibitory effect of VP1 on Slicer activity rather than RISC 
assembly, we performed Slicer assays using different siRNA guides. During RISC 
maturation, guide strands in AGO2 are 2’-O-methylated at their 3’ terminal nucleotide 
by the Drosophila methyltransferase Hen1 (31). This modification protects AGO2 
associated siRNAs from degradation by trimming and tailing events that occur when 
there is extensive base pairing of the guide RNA with a target RNA (32). To overcome 
Figure 7. VP1 inhibits Slicer activity of pre-assembled mature RISC. (A) Schematic overview of 
the two experimental conditions of the Slicer assay designed to monitor the effect of recombinant 
(rec.) proteins on RISC assembly and Slicer activity (top) or on Slicer activity of pre-assembled 
RISC (bottom) (B) Slicer assays in Drosophila embryo lysates. RISC activity was analyzed in 
the presence of a non-targeting control siRNA (lane 1) or a specific Fluc siRNA (lane 2-10). 
Recombinant proteins were added before (lanes 3-6) or after (lanes 7-10) assembly of RISC as 
indicated. As a control for possible buffer effects, recombinant protein was substituted by protein 
storage buffer (lanes 1 and 2). (C) Western blot showing the endogenous AGO2 protein levels in 
embryo lysate after incubation for 2 hours with the indicated recombinant proteins. The blot was 
developed with AGO2 antibody 4D2. (D) Slicer assay using an siRNA with a 2’-O-methylated 
guide strand. A non-modified control siRNA (lane 1) or a Fluc siRNA duplex containing a 
2’-O-methyl group at the 3’ terminal nucleotide of the guide strand (lanes 2-6) was added to 
embryo lysate 30 minutes prior to the addition of the indicated recombinant proteins. (E) Slicer 
assay using a 2’-O-methylated simplex guide RNA. A control siRNA duplex (lane 1) or a single-
stranded Fluc specific guide strand with a 2’-O-methyl group at the 3’ terminal nucleotide (lane 
2-6) was added prior to the addition of the indicated recombinant proteins. (F) Slicer assays in 
the presence or absence of ATP. Embryo lysate was incubated with a control siRNA (lanes 1 and 
6) or a specific Fluc siRNA (lanes 2-5 and 7-10). ATP was then depleted (lanes 1-5) or depleted 
and subsequently regenerated (lanes 6-10) and Slicer activity was monitored. An asterisk (*) 
indicates a non-specific band appearing in RISC assays under ATP depleted conditions.
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a requirement for Hen1, an siRNA bearing a 2’-O-methylated 3’-terminal nucleotide 
on the guide strand was used in Slicer assays. Similar to the non-methylated siRNA, the 
methylated siRNA produced a specific cleavage product of the expected size (Figure 7D, 
lane 2). Both Nora virus VP1 and CrPV 1A inhibited the cleavage activity of RISC that 
was pre-loaded with the methylated siRNA (Figure 7D, lane 3 and 5). Again, the GST 
and MBP control proteins were unable to affect Slicer activity (Figure 7D, lane 4 and 6).
After loading of the siRNA as a duplex, AGO2 cleaves the passenger strand which is 
then degraded by the C3PO nuclease complex (33). To circumvent canonical loading 
of RISC, we induced RISC formation with a single-stranded methylated guide RNA. 
Although less efficient, loading of single-stranded guide strands into AGO2 is possible 
via a bypass mechanism (34, 35). Indeed, at high concentrations, methylated single-
stranded guide RNA induced specific cleavage of cap-labeled target RNA (Figure 7E, 
lane 2). Interestingly, single-stranded guide RNA-induced target cleavage was specifically 
inhibited both by Nora virus VP1 and by CrPV 1A (Figure 7E, lanes 3 and 5). These 
results indicate that both CrPV 1A and Nora virus VP1 inhibit Slicer activity of mature 
RISC rather than RISC assembly. 
Following maturation, RISC binds, cleaves, and releases complementary target RNA, 
and returns to a Slicer-competent state. Drosophila RISC is a multiple turnover complex, 
in which release of the cleaved target RNA is a rate-limiting step that is greatly enhanced 
by ATP (36). We therefore analyzed suppression of Slicer activity under ATP-limiting 
conditions with a 20-fold molar excess of siRNA over target RNA. RISC was loaded in 
the presence of ATP, after which creatine kinase was inactivated by NEM, and ATP was 
depleted (-ATP) by addition of hexokinase and glucose (Figure S5). In parallel, ATP 
levels were restored (+ATP) after NEM treatment by adding back creatine kinase, and 
omitting hexokinase treatment. As expected, RISC shows a lower cleavage rate in –ATP 
conditions than in +ATP conditions (Figure 7F, compare lanes 3 and 5 with lanes 8 and 
10). Even under –ATP conditions, Nora virus VP1 and CrPV 1A were able to inhibit 
Slicer activity (Figure 7F, lanes 2 and 4), suggesting that these two VSRs inhibit the 
catalytic target cleavage by AGO2.
Discussion
The mechanisms by which RNA viruses evade sterilizing immunity and establish 
chronic persistent infections remain poorly understood (37). Nora virus successfully 
establishes a persistent infection in Drosophila, providing an excellent model to study 
mechanisms of persistence. We show here that Nora virus is a target of the antiviral 
RNAi machinery and that it encodes a potent suppressor of RNAi. Of note, Nora virus 
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RNA levels are unaffected by mutations in the RNAi pathway (38). These observations 
therefore suggest that dynamic interactions between the antiviral RNAi response and 
viral counter-defense mechanisms determine viral persistence. 
The production of viral siRNAs is a hallmark of an antiviral RNAi response. By detection 
of Nora virus-derived vsiRNAs in infected fly stocks, we provide direct evidence that 
Nora virus is a target of Dcr-2. Nora virus vsiRNAs are distributed across the viral 
genome, with similar amounts derived from the (+) and (-) RNA strands. During (+) 
RNA virus infection, (+) viral RNA accumulates in large excess over (-) viral RNA 
(~50-100 fold). Cleavage of structured RNA elements by Dcr-2 is therefore expected 
to produce viral small RNAs that mirror this asymmetric distribution. Thus, similar to 
other RNA viruses, our results imply that Dcr-2 targets the dsRNA intermediates in 
Nora virus replication (2, 4, 39-41). 
The current model proposes that the antiviral RNAi response relies on dicing of viral 
dsRNA and on slicing of viral target RNAs using vsiRNAs as a guide. Genetic analyses 
support the role of AGO2 in antiviral defense: AGO2 mutants are hypersensitive to a 
number of RNA virus infections (3-7, 42). Yet, interpretation of this AGO2 phenotype 
is complicated by other cellular functions of AGO2, such as regulation of cellular gene 
transcription and control of transposon activity (43-45). An alternative model proposes 
that dicing of double-stranded replication intermediates plays an important role in latent 
virus infection (46). Dicing of an essential replication intermediate by Dcr-2 should 
theoretically be sufficient to abort a productive virus replication cycle. The convergent 
evolution of VSRs that suppress the catalytic activity of AGO2 in two distantly related 
RNA viruses, Nora virus and CrPV, underlines the essential role of AGO2 Slicer activity 
in antiviral defense, also in persistent infections in vivo. Importantly, these two viruses 
display a strikingly different course of infection – CrPV causes a lethal infection, whereas 
Nora virus establishes a non-lethal, persistent infection – suggesting that the interaction 
between a VSR and the host RNAi machinery is not the main determinant for viral 
pathogenicity.
Materials and Methods
Small RNA sequencing and analysis
Total RNA was extracted from dissected heads, bodies (abdomens and thoraxes) and 
thoraxes from w1118 male flies using Trizol reagent (Invitrogen), and RNA quality was 
verified on a Bioanalyzer (Agilent). Small RNAs were then cloned using the DGE-Small 
RNA Sample Prep Kit and the Small RNA v1.5 Sample Preparation Kit (Illumina) 
following the manufacturer’s instructions. Libraries were sequenced on the Illumina 
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HiSeq platform. 
Sequence reads were clipped from 3’ adapters using fastx_clipper (http://
hannonlab.cshl.edu/fastx_toolkit/). Reads in which the adapter sequence 
(CTGTAGGCACCATCAATCGT) could not be detected were discarded. Only the 
clipped 19-30 nt reads were retained. Sequence reads were first matched against the 
Drosophila genome (v5.37) using Bowtie (http://bowtie-bio.sourceforge.net/index.
shtml). Reads not matching the Drosophila genome were then matched against the 
published Nora virus sequence (NC_007919.3, isolate Umeå 2007), allowing one 
mismatch during alignment. Viral small RNAs were then used to reconstitute a small 
RNA-based consensus genome sequence (rNora virus, JX220408) using Paparazzi 
(21) with NC_007919.3 as a starting viral reference genome. Distributions of Nora 
virus small RNA sizes were computed by parsing the Bowtie outputs with a python 
script (available upon request). Small RNA profiles were generated by collecting the 
21-nt reads that matched the rNora virus sequence allowing one mismatch, and their 
frequency relative to their 5’ position in the rNora virus (+) or (-) genomic strand 
was plotted in R. siRNA duplex signatures were calculated according to an algorithm 
developed to calculate overlap in piRNA sequence reads (47, 48). The distribution of 
siRNA overlaps was computed by collecting the 21-nt rNora virus RNA reads whose 
5’ ends overlapped with another 21-nt read on the opposite strand. For each possible 
overlap of 1 to 21-nt (i), the number of read pairs (O) was counted and converted to a 
Z-score with the formula Z(i) = (O(i)-mean(O))/standard deviation (O). Small RNA 
sequences were deposited to the Sequence Read Archive (SRA) at the National Center 
for Biotechnology Information (NCBI) under accession number SRA054241.
Cell culture and viruses
Drosophila S2 cells were cultured at 25 °C in Schneider’s medium (Invitrogen) 
supplemented with 10% heat inactivated fetal calf serum, 50 U/mL penicillin, and 50 
µg/mL streptomycin (Invitrogen). DCV was cultured and titered on S2 cells as described 
previously (6). For the production of recombinant SINV, the coding sequence of either 
GFP or the N-terminal V5 epitope tagged VP1ΔN351 was cloned into the XbaI site of 
the double subgenomic pTE3’2J vector (49). The resulting plasmids were linearized 
by XhoI restriction, purified and used as template for in vitro transcription using the 
mMESSAGE mMACHINE SP6 High Yield Capped RNA Transcription kit (Ambion). 
In vitro transcribed RNA was purified using the RNeasy kit (Qiagen) and transfected 
into BHK cells. Viral titers in the supernatant were determined by plaque assay on BHK 
cells.
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RNAi reporter assay in S2 cells
RNAi reporter assays were performed as described previously using 25 ng pMT-GL3, 6 
ng pMT-Ren, and 25 ng suppressor plasmid per well of a 96-well plate (50). Plasmids 
encoding Nora virus cDNA constructs were generated as described in Protocol S1.
Flies and fly injections
Flies were maintained on standard medium at 25 °C with a light/dark cycle of 12 
hours/12 hours. Fly stocks that were used for Sindbis virus infection and for preparation 
of embryo lysate were cleared of Wolbachia and endogenous virus infection (see Protocol 
S1). We used the following fly stocks and alleles: UAS-CrPV 1A (13, 51), AGO2321 
(52), Dcr-2L811fsX (53), thRNAi (24, 25). The coding sequences of the full-length VP1 and 
the inactive VP1ΔC74 mutant with an N-terminal V5 epitope tag were cloned into the 
pUAST vector using the SacII and XbaI restriction sites (54). The resulting plasmids were 
microinjected into Drosophila w1118 embryos to generate transgenic fly lines (Bestgene 
Inc). Virus infections of adult female flies were performed as described previously using 
5,000 PFU of recombinant SINV (6). Survival was monitored daily. In vivo RNAi 
experiments were performed by crossing GMR-Gal4, UAS-thRNAi/CyO virgins (24) with 
UAS-VSR/TM3 Sb flies. The eye phenotype was monitored in two- to four-day-old male 
F1 offspring lacking the CyO and TM3 Sb balancers.
Production of recombinant proteins in E. coli
The GST and MBP fusion proteins were purified from E. coli as described in Protocol 
S1. Purified recombinant proteins were dialyzed against dialysis buffer (20 mM Tris-
HCl, 0.5 mM EDTA, 5 mM MgCl2, 1 mM DTT, 140 mM NaCl, 2.7 mM KCl) 
Recombinant proteins were stored as aliquots at -80 °C in dialysis buffer containing 
30% glycerol.
Gel mobility shift, Dicer and Slicer assays
Gel mobility shift assays were performed as described (6). Briefly, uniformly radio-
labeled 113-nt long dsRNA (50 cps/reaction) or end-labeled siRNAs (200 cps/reaction) 
were incubated with purified recombinant protein for 30 minutes at room temperature. 
Samples were then separated on an 8% native polyacrylamide gel and exposed to a 
Kodak Biomax XAR film.
Dicer and Slicer assays were performed according to the protocol of Haley and colleagues 
with minor modifications, described in Protocol S1 (30). For Slicer assays with the 
methylated duplex, Fluc guide strand 5’- UCG AAG UAC UCA GCG UAA GU[mU] 
and passenger strand 5’- CUU ACG CUG AGU ACU UCG AUU were annealed 
by incubating 20 µM of each siRNA strand in annealing buffer (100 mM potassium 
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acetate, 30 mM HEPES-KOH at pH 7.4, 2 mM magnesium acetate) for 1 min at 90 
°C, followed by incubation for 1 hour at 37 °C. For guide strand loading of RISC, 
embryo lysates were incubated with Fluc single-stranded guide strand RNA at a final 
concentration of 10 µM. Radiolabeled probes and target RNA for gel shift and Slicer 
assays are described in Protocol S1. 
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Supporting Information
Text S1.
Nora virus VP1 is unable to suppress the miRNA pathway
Several plant virus RNAi suppressors influence the miRNA pathway, thereby inducing 
strong developmental defects in transgenic plants that express RNAi suppressors during 
development (55, 56). This effect may be due to convergence of the antiviral RNAi 
and miRNA pathways on Argonaute-1 (AGO1) in plants. In Drosophila, the miRNA 
and siRNA pathways are parallel pathways. Nevertheless, there is crosstalk between 
these pathways with miRNA and miRNA-star sequences being loaded into AGO2 and, 
conversely, with siRNAs being loaded into AGO1 (57, 58). To determine whether VP1 
suppresses the miRNA pathway, we used a miRNA sensor assay in S2 cells (Protocol 
S1). In this assay, an Fluc reporter containing the 3’UTR of the Drosophila par6 gene 
(Fluc-par6), a target for miRNA1, is co-transfected with a plasmid expressing the 
primary miRNA1 (pri-miR1), or a control plasmid expressing pri-miR12 (59, 60). Co-
transfection of pri-miR1 led to specific silencing of the Fluc-par6 gene (Figure S1). 
We verified whether the reporter was suppressed in an AGO1-dependent manner, by 
cotransfection of dsRNA targeting AGO1 or, as a control, AGO2. As expected, the 
miRNA reporter assay monitors the canonical miRNA pathway, since knock-down of 
the AGO1 gene by dsRNA led to de-repression of Fluc-par6 expression (although this did 
not reach statistical significance, p=0.09). In contrast, co-transfection of AGO2 dsRNA 
did not lead to de-repression, but even enhanced silencing of the miRNA reporter, 
perhaps reflecting more efficient AGO1 loading under conditions in which AGO2 is 
depleted. Expression of Nora virus VP1 did not de-repress the Fluc-par6 construct, 
indicating that VP1 does not suppress the miRNA pathway. Similarly, VP1 did not affect 
silencing of a miRNA sensor consisting of a luciferase construct containing two perfect 
complementary target sites for the endogenous miR2 in its 3’UTR (data not shown) 
(6). In addition, transgenic flies expressing VP1 driven by a strong ubiquitous promoter 
(Tubulin-Gal4) are viable and fertile, lending further support to the conclusion that 
VP1 does not inhibit miRNA biogenesis and function (data not shown).
Protocol S1.
Extended Experimental Procedures and Supplemental Methods
Molecular cloning
To construct plasmids encoding C-terminal V5 epitope tagged proteins of Nora virus, 
cDNA prepared from Nora virus-infected flies was amplified using primers 5’-AGT 
GGT ACC AAC ATG ATT AAC AAT CAA ACA AAC and 5’-GGT GGG CCC TTG 
ACA TTG TTG TTT CTG CG for ORF1, primers 5’-AGT GGT ACC AAC ATG 
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TTA ATT GAA GCT TTC ATC and 5’-GGT GGG CCC TCC AAG ATC TCC TCT 
TTT AAT G for ORF2, primers 5’-AGT GGT ACC AAC ATG GCA TTA AAA GAG 
GAG ATC and 5’-GGT GGG CCC TTG CAT AGA GTC ATA AAT TAC for ORF3, 
and primers 5’-AGT GGT ACC AAC ATG CAG AAT CCA ACA CAA ACC and 
5’-GGT GGG CCC CTG CTG CCT CAC GGA AGG GAA for ORF4. Amplified 
products were cloned as KpnI and ApaI fragments into pAc5.1-V5-His-A (Invitrogen).
For the expression of VP1 mutants tagged at the N-terminus with the V5-His epitopes, 
the pAc5.1-V5-His-Ntag plasmid was constructed. This plasmid was created by 
annealing and cloning the oligonucleotides 5’-CAA CAT GGG TAA GCC TAT CCC 
TAA CCC TCT CCT AGG TCT CGA TTC TAC GCG TAC CGG TCA TCA TCA 
CCA TCA CCA TG and 5’-AAT TCA TGG TGA TGG TGA TGA TGA CCG GTA 
CGC GTA GAA TCG AGA CCT AGG AGA GGG TTA GGG ATA GGC TTA CCC 
ATG TTG GTA C into the EcoRI and KpnI restriction sites of pAc5.1-V5-His-A. The 
sequences of all VP1 deletion mutants were cloned into pAc5.1-V5-His-Ntag using the 
EcoRI and SacI restriction sites. For mutant sequences see supplemental Figure S3.
miRNA sensor assay
The miRNA sensor assay and its plasmids were described previously (59, 60). Briefly, 
5 × 104 S2 cells were seeded per well in a 96-well plate one day before transfection. 
Subsequently, the cells were transfected with 54.5 ng suppressor plasmid, 6.8 ng 
pMT-Fluc-par6, 1.6 ng pMT-Ren, and 2.7 ng pMT-miR1 or pMT-miR12 using the 
Effectene transfection reagent (Qiagen) according to the manufacturer’s protocol. To 
knockdown AGO1 or AGO2 expression, 5.4 ng of dsRNA was cotransfected with the 
plasmids. Expression of the reporter constructs was induced with CuSO4 at 48 hrs post- 
transfection and luciferase activities were measured at 72 hrs post-transfection.
Clearance of Wolbachia and endogenous viruses from fly stocks
Fly stocks used for Sindbis virus infection and preparation of embryo lysates were cleared 
from endogenous viruses by collecting eggs on apple-juice agar plates, followed by a 
treatment with 50% household bleach for 5 minutes. Subsequently, the bleached eggs 
were washed three times in a large volume of water, after which they were transferred to 
clean vials containing standard fly food. After culturing the fly stocks for two generations 
we confirmed the absence of Nora virus and Drosophila C virus (DCV) by RT-PCR. Fly 
stocks were then cleared from Wolbachia infection by raising the flies for two generations 
on standard fly food supplemented with 0.05 mg/mL tetracycline hydrochloride (Sigma). 
To verify the clearance of Wolbachia infection, PCR amplification was performed with 
Wolbachia specific primers on DNA extracts of adult flies, as described earlier (61).
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Production of recombinant proteins in E. coli
To fuse the VP1ΔN284 protein to the C-terminus of maltose binding protein (MBP), 
the coding sequence of the VP1NΔ284 mutant was cloned as an EcoRI-SalI fragment 
into the pMal-C2X vector (New England Biolabs). The resulting pMal-C2X-VP1NΔ284 
and parental pMal-C2X plasmids were transformed into the E.coli BL21 (DE3) strain. 
Expression of the recombinant fusion proteins was induced at 1.0 OD600 by adding 
0.2 mM IPTG followed by incubation at 37 °C for 3 hours. MBP and MBP-VP1NΔ284 
fusion proteins were purified using amylose resin (New England Biolabs) according to 
the manufacturer’s protocol.
The coding sequence of CrPV 1A (amino acids 1-148) was amplified using primers 
5’- CGG GAA TTC ATG TCT TTT CAA CAA ACA AAC AAC and 5’- AGA GTC 
GAC TTA GAA GGC TCT GCA TT and cloned into the pGEX-4T-1 plasmid (GE 
healthcare) as an EcoRI-SalI fragment. After transformation of the E. coli BL21 (DE3) 
strain with the resulting pGEX-CrPV 1A plasmid, expression was induced at 1.0 OD600 
using 0.2 mM IPTG. Protein production was allowed to continue overnight at 20 °C. 
The GST-CrPV 1A fusion protein was purified using glutathione sepharose 4 fast flow 
(GE healthcare) according to the manufacturer’s protocol. GST (pGEX-4T-1) and 
GST-DCV 1A (pGEX-DCV 1A) fusion proteins were purified using the same method, 
after induction of protein expression at 37 °C for 3 hours (6).
Radioactively labeled probes and target RNA
Uniformly radio-labeled 113-bp long dsRNA was generated by in vitro transcription in 
the presence of α-[32P]-UTP using a T7 promoter flanked firefly luciferase (GL3) PCR 
product as a template. T7 promoter flanked PCR products were generated with primers 
5’-TAA TAC GAC TCA CTA TAG GGA GAT ATG AAG AGA TAC GCC CTG GTT 
and 5’-TAA TAC GAC TCA CTA TAG GGA GAA TAG CTT CTG CCA ACC GAA 
C. Unincorporated nucleotides were removed using a G-25 sephadex column (Roche) 
followed by purification of the dsRNA from an 8% polyacrylamide gel. Gl3 siRNAs 
(Dharmacon) were 32P end-labeled using T4 polynucleotide kinase (Roche) after which 
unincorporated nucleotides were removed using a G-25 sephadex column (Roche).
To generate target RNA for the Slicer assay, a 492-bp region of the GL3 luciferase gene 
was PCR amplified using the primers 5’-TAA TAGAC TCA CTA TAG GGA GAA TGG 
AAG ACG CCA AAA ACA T and 5’-CAT CGA CTG AAA TCC CTG GT. The GL3 
PCR product was used as a template for in vitro transcription using the Ampliscribe T7 
flash transcription kit (Epicentre). After purification from an 8% urea-polyacrylamide 
gel, the RNA was cap-radiolabeled with the Scriptcap m7G capping system (Epicentre) 
according to the manufacturer’s protocol. The capped RNA was purified from an 8% 
Urea-polyacrylamide gel before use in the Slicer assay. 
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Dicer assay
Dicer assays were performed in a final volume of 12 µL containing 4µL S2 cell 
extract, 3 µL dicer buffer, 1 µL uniformly labeled dsRNA (200 cps), and 4 µL purified 
recombinant protein. Dicer buffer contained 0.175 µg/µL creatine kinase (Roche), 16.7 
mM DTT, 0.02 mg/µL creatine monophosphate (Roche), 3.3 mM MgAc, 50 mM 
Hepes-KOH, 33.3% glycerol, 0.67 U/µL RNasin (Roche), and 3.3 mM ATP. Reactions 
were incubated for 3 hrs at 27 °C after which they were deproteinized by proteinase 
K and phenol extracted (30). After precipitation, the RNA was dissolved in Ambion 
loading buffer II and loaded on a 12% denaturing polyacrylamide gel. Dicer products 
were visualized by exposing the polyacrylamide gel to a Kodak Biomax XAR film.
Slicer assay
Drosophila embryo lysates were produced from w1118 flies as described (30). Slicer 
reactions contained 5 µL embryo lysate, 3 µL cleavage buffer, 100 nM siRNA, 0.3 µM 
recombinant protein, and 1 µL capped target RNA (~1000 cps) in a final volume of 11 
µL. The GL3 siRNA (Dharmacon) was used to induce cleavage of the firefly luciferase 
target RNA, whereas the control siRNA (Qiagen) was used as a negative control. After 
assembly of the reaction, samples were incubated for 2 hours at 25 °C. Samples were 
then treated with proteinase K, extracted with phenol, and precipitated as described 
(30). Precipitated RNA was dissolved in Loading buffer II (Ambion) and analyzed on an 
8% urea-polyacrylamide gel. Slicer products in ATP depleting conditions were analyzed 
on a 6% urea-polyacrylamide gel. Kodak Biomax XAR films were used to visualize the 
radioactive Slicer products.
Supplemental Figures
Figure S1. VP1 is unable to suppress the 
miRNA pathway. A firefly luciferase (Fluc) 
construct containing the par6 3’UTR, a target 
for miRNA1 (Fluc-par6), was co-transfected 
with plasmids encoding Renilla luciferase (Rluc) 
and either Nora virus VP1 or the inactive 
VP1ΔC74 mutant. Fluc-par6 expression was 
silenced by co-transfecting a plasmid encoding 
pri-miRNA1, whereas a pri-miRNA12 
expressing construct was used as a negative 
control. AGO1 or AGO2 gene expression was 
knocked down by co-transfection of dsRNA 
targeting these genes (dsAGO1 and dsAGO2, 
respectively). Expression of Fluc and Rluc was induced 2 days after transfection, and reporter 
activities were measured 3 days after transfection. Rluc activity was used to normalize Fluc 
activity within each sample, and data were normalized to the pri-miR12 treated sample. Bars 
represent averages and standard deviations of biological triplicates. A representative graph of two 
independent experiments is shown. The numbers represent p-values relative to pri-miR1 treated 
vector control samples in a two-tailed Student’s t-test assuming equal variances.
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NoraV Umea 2007          MINNQTNKKGPQLERVHFGSTQVVGKSTKRRQRGTKLDIEYTVRRNDAPKEQKFLISEIF 60 
NoraV NL1                MINNQTNKKGPQLERVHFGSTQVVGKSTKRRQRGTKLDIEYTVRRNDAPKEQKFLISEIF 60 
NoraV NL2                MINNQTNKKGPQLERVHFGSAQVVGKSTKRRQRGTKLDIEYTVKRNDAPKEQKFLVSEIF 60 
NoraV reconstituted FR1  MINNQTNKKGPQLERVHFGSAQVVGKSTKRRQRGTKFDIEYTVKRNDAPKEQKFLVSEIF 60 
                         ********************:***************:******:***********:**** 
 
NoraV Umea 2007          DEKLDKQIKYEKKQNHTFIKPKLNLVIKEEQHITKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV NL1                DEKLDKQIKYEKKQNHTFIKPKLNLVIKEEQHIIKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV NL2                DEKLDKQIKYEKKQNHTFIKPKLNLVTREEQHMTKKVLRGKERAATHAFMKEMVESNKIQ 120 
NoraV reconstituted FR1  DEKLDKQIKYEKKQNHTFIKPKLNLVTREEQHVTKKVLRGKERAATHAFMKEMVESNKIQ 120 
                         ************************** :****: ************************** 
 
NoraV Umea 2007          PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSIDEIV 180 
NoraV NL1                PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSIDEIV 180 
NoraV NL2                PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSINEIV 180 
NoraV reconstituted FR1  PSWNVEYEKEIDEVDLFFMKKKTKPFSGFSIKELRDSLIVQSDDKNMAQPTVMSSTNEIV 180 
                         ******************************************************* :*** 
 
NoraV Umea 2007          TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEAKKIKQE 240 
NoraV NL1                TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEVKKIKQE 240 
NoraV NL2                TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIESVKKEAKRTKQE 240 
NoraV reconstituted FR1  TPREEISVSAISEQLASLMERVDKLEKMNAALEEENKQLKKEREATIKSVKKEAKRTKQE 240 
                         ***********************************************:*****.*: *** 
 
NoraV Umea 2007          KPQIVKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPLKVSKKMTEHQL 300 
NoraV NL1                KPQIVKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPLKVSKKMTEHQL 300 
NoraV NL2                KPQIAKKTQHKSLGVNLKITKIKVVGQEQCLEIENTQHKKFVEKPSMPSKVSKKMKGQQL 300 
NoraV reconstituted FR1  KPQIAKKTQHKSLGVNLKITKTKVVGQEQCLEIENTQHKKFVEKPSMPSKVSKKMKGQQL 300 
                         ****.**************** ************************** ******. :** 
 
NoraV Umea 2007          KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYVAKPPAEEKRSI 360 
NoraV NL1                KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYIAKPPAEEKRSI 360 
NoraV NL2                KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYTAKPPAEEKRSI 360 
NoraV reconstituted FR1  KKTIRTWYEFDPSKLVQHQKEVLNSVVTNTTFADKVRETGIPKQKIRYTAKPPAEEKRSI 360 
                         ************************************************ *********** 
 
NoraV Umea 2007          HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMIYRNKWVKFSKEFNPY 420 
NoraV NL1                HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMIYRNKWVKFSKEFNPY 420 
NoraV NL2                HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADRYLYHQFKREMMVYRNKWVKFSKEFNPY 420 
NoraV reconstituted FR1  HFYGYKPKGIPNKVWWNWVTTGTAMDAYEKADHYLYHQFKREMMVYRNKWVKFSKEFNPY 420 
                         ********************************:***********:*************** 
 
NoraV Umea 2007          LSKPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV NL1                LSKPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV NL2                LSEPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
NoraV reconstituted FR1  LSEPKMVWEENTWEYEYKTDVPYNFILKWRQLVQTYKPNTPIQADWYKISQKQQC 475 
                         **:**************************************************** 
 
Figure S2. Alignment of VP1 sequences from different Nora virus isolates. Alignment of 
VP1 sequences of Nora virus isolate Umeå 2007 (accession number GQ257737) and Nora virus 
sequences from infected fly stocks from our own laboratory (isolates NL1 and NL2, GenBank 
accession number JQ288019 and JQ288020). We analyzed VP1 sequences in a total of eight 
Nora virus-infected fly stocks. Five VP1 sequences were identical to NL1, one was the NL2 
sequence, and two stocks contained a mixed population of Nora virus sequences. These eight 
stocks were obtained from five different laboratories or stock centers. However, they have been 
maintained in our laboratory before we tested them for Nora virus infection, and we cannot 
exclude the possibility that they became infected in our laboratory. Although we therefore cannot 
infer overall virus diversity from these data, they do indicate that VP1 is a conserved protein. The 
FR1 isolate is the Nora virus genome that was reconstituted from small RNA sequences from 
wildtype w1118 flies from a laboratory based in France (GenBank accession number JX220408).
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Figure S4. Nora virus VP1 is unable to bind long dsRNA or to interfere with Dcr-2 activity. 
(A) Mobility shift assay of suppressor proteins with long dsRNA. Uniformly radiolabeled long 
dsRNA was incubated for 30 minutes with buffer (lane 1) or recombinant MBP-VP1ΔN284 (lanes 
2-4), MBP (lanes 5-7), GST-DCV 1A (lanes 8-10) or GST (lanes 11-13). Ten-fold dilutions of 
recombinant protein were used starting from the following concentrations: MBP-VP1ΔN284 (2 
µM, lane 2), MBP (2.6 µM, lane 5), GST-DCV 1A (1 µM, lane 8), and GST (2.24 µM, lane 
11). RNA mobility shifts were analyzed on an 8 % native polyacrylamide gel. (B) Dicer activity 
in S2 cell extract in the presence of viral suppressors. Uniformly radiolabeled long dsRNA 
was incubated in S2 cell extract for 3 hours with buffer (lane 3) or the indicated recombinant 
proteins. Two-fold dilutions were used for MBP-VP1ΔN284 (lanes 4-7, highest concentration 1.1 
µM) and MBP (lanes 8-11, highest concentration 4.2 µM). Two independent preparations of 
GST-DCV 1A were used (lane 12, concentration of 0.54 µM and lane 13, concentration of 
0.03 µM). GST was used at a concentration of 1.2 µM (lane 14). As size markers, dsRNA input 
(lane 1) and end-labelled siRNAs (lane 2) were used. Dicer products were analyzed on a 12% 
denaturing polyacrylamide gel.
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Figure S5. ATP depletion during Slicer assay. (A) Schematic representation of the protocol 
used to deplete (-ATP) or to regenerate ATP after initial depletion (+ATP) for Slicer assays 
of Figure 7F. For RISC loading, Drosophila embryo lysate was incubated with an siRNA for 
30 minutes under standard conditions. Subsequently, N-ethylmaleimide (NEM) was added in 
both conditions to inhibit the ATP regenerating activity of creatine kinase. After incubating 
the reactions for 10 minutes on ice, DTT was added to quench the NEM in both conditions. 
Hexokinase, glucose, and milliQ water (MQ) were added in the –ATP protocol to deplete the 
pool of ATP. For the +ATP condition, Hexokinase was substituted by hexokinase buffer, and 
MQ was substituted for Creatine kinase to restore the ATP regenerating activity. Subsequently, 
the reactions were incubated for 30 minutes after which recombinant protein (rec. protein) was 
added. Following another 30 minutes incubation period, the 32P-cap-labelled RNA was added 
to the reaction, after which the incubation was continued for another 2 hours. Subsequently, 
reactions were analyzed on a polyacrylamide gel. (B) ATP concentrations before and after the 
Slicer assay under –ATP and +ATP conditions. ATP levels were measured at the moment of target 
RNA addition (0 hrs) or after 2 hours of incubation with target RNA. For ATP concentration 
measurements, recombinant protein was substituted for protein storage buffer, and target RNA 
was substituted for MQ. ATP levels were measured using the Celltiter-Glo Luminescent Cell 
Viability Assay (Promega) according to the manufacturer’s protocol.
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Abstract
RNA viruses in insects are targets of an RNA interference (RNAi)-based antiviral immune response, in which viral replication intermediates or viral dsRNA genomes are processed by Dicer-2 (Dcr-2) into viral small 
interfering RNAs (vsiRNAs). Whether dsDNA virus infections are controlled by 
the RNAi pathway remains to be determined. Here, we analyzed the role of RNAi 
in DNA virus infection using Drosophila melanogaster infected with Invertebrate 
iridescent virus 6 (IIV-6) as a model. We show that Dcr-2 and Argonaute-2 mutant 
flies are more sensitive to virus infection, suggesting that vsiRNAs contribute to the 
control of DNA virus infection. Indeed, small RNA sequencing of IIV-6-infected 
WT and RNAi mutant flies identified abundant vsiRNAs that were produced in a 
Dcr-2-dependent manner. We observed a highly uneven distribution with strong 
clustering of vsiRNAs to small defined regions (hotspots) and modest coverage 
at other regions (coldspots). vsiRNAs mapped in similar proportions to both 
strands of the viral genome, suggesting that long dsRNA derived from convergent 
overlapping transcripts serves as a substrate for Dcr-2. In agreement, strand-
specific RT-PCR and Northern blot analyses indicated that antisense transcripts 
are produced during infection. Moreover, we show that vsiRNAs are functional in 
silencing reporter constructs carrying fragments of the IIV-6 genome. Together, 
our data indicate that RNAi provides antiviral defense against dsDNA viruses in 
animals. Thus, RNAi is the predominant antiviral defense mechanism in insects 
that provides protection against all major classes of viruses.
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Introduction
Double-stranded RNA (dsRNA) is a danger signal: It cannot be detected in healthy, non-
infected cells, but it is produced during infection by many RNA and DNA viruses (1). 
It is thus not surprising that dsRNA is a central trigger of innate immune responses. In 
vertebrates, recognition of dsRNA by the cytosolic sensors RIG-I and MDA-5 initiates 
a cascade of events culminating in the production of type I IFN and the subsequent 
induction of an antiviral state (2). Likewise, dsRNA triggers a sequence-independent 
antiviral response in penaeid shrimp that is distinct from the vertebrate IFN pathway 
(3). In plants, fungi, and arthropods, viral dsRNA triggers an antiviral RNAi response 
(4, 5).
Studies in insects like Drosophila melanogaster and mosquitoes support a model in which 
viral dsRNA is processed by Dicer-2 (Dcr-2) into viral small interfering RNAs (vsiRNAs). 
These vsiRNAs are then incorporated into Argonaute-2 (AGO2) in the RNA induced 
silencing complex (RISC), where they guide the recognition and endonucleic cleavage 
of viral target RNAs (6-8). Indeed, early seminal work in mosquitoes and Drosophila 
cells directly detected viral small RNAs by Northern blot analysis and demonstrated 
that knockdown of core RNAi genes resulted in an increase in virus replication (8-10). 
In accordance, in the genetic model organism D. melanogaster, flies with defects in Dcr-
2, R2D2, or AGO2 are unable to control RNA virus replication and, consequently, are 
hypersensitive to virus infection and succumb more rapidly than their wildtype (WT) 
controls (11-14). 
Small RNA cloning and next-generation sequencing provides detailed insights into 
vsiRNA biogenesis. In several studies in insects, the polarity of the vsiRNA population 
deviates strongly from the highly skewed distribution of positive strand (+) over negative 
(-) viral RNAs that is generally observed in (+) RNA virus infection. Indeed, vsiRNAs 
mapped in similar proportions to (+) and (-) viral RNA strands in Aedes aegypti, A. 
albopictus and Culex pipiens mosquitoes infected with a number of arthropod-borne 
viruses including Sindbis virus, Semliki Forest virus, West Nile virus, Dengue virus 
and Chikungunya virus, as well as in Drosophila infected with (+) RNA viruses from 
different families (5, 15-24). In addition, in infections of Drosophila with the negative 
strand RNA virus vesicular stomatitis virus similar numbers of (+) over (-) vsiRNAs 
were recovered (14). These results, together with the distribution of vsiRNAs all along 
the viral genome, imply that viral replication intermediates of RNA viruses are the main 
targets for Dcr-2. Also in dsRNA virus infections, similar amounts of vsiRNAs of both 
polarities were generated, most likely by Dcr-2-dependent processing of viral genomic 
dsRNA (18). Thus, different classes of viruses seem to be processed by a similar vsiRNA 
biogenesis pathway. These studies have focused on RNA viruses, because all well-
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established model viruses of Drosophila and all known mosquito-transmitted viruses 
are RNA viruses. More recently, a next-generation sequencing approach identified small 
RNAs derived from a novel densovirus, a single-stranded (ss) DNA virus, in wild-caught 
C. pipiens molestus (25). These observations suggest that ssDNA viruses are a target for 
Dicer in mosquitoes, although the biogenesis and function of the viral small RNAs 
remain unclear.
dsDNA viruses produce dsRNA during their replication, presumably due to base pairing 
of convergent overlapping transcripts from both strands of the DNA genome (26-28). 
Whether such dsRNA is a bona fide target for Dcr-2 remains to be established. Although 
a dsDNA virus has recently been identified in wild-caught Drosophila innubila (29), a 
dsDNA virus that naturally infects D. melanogaster has yet to be discovered. Invertebrate 
iridescent virus 6 (IIV-6), a member of the Iridovirus genus within the Iridoviridae 
family, has a broad host range; under experimental conditions it replicates in a number 
of Dipteran species, including D. melanogaster (30-32). We therefore used IIV-6, also 
known as Chilo iridescent virus, as a model to analyze the RNAi response against 
dsDNA viruses in Drosophila. IIV-6 is a large, complex virus with a dsDNA genome of 
212,482-bp that encodes 211 putative open reading frames (ORFs) distributed along 
the two strands of the viral genome (33, 34). Here, we report that IIV-6 is a target of the 
RNAi machinery. We demonstrate that Dcr-2 and AGO2 mutant flies are more sensitive 
to IIV-6 infection. Moreover, we identified Dcr-2-dependent vsiRNAs that map to both 
strands of the viral genome, show an uneven distribution across the viral genome, but 
are remarkably conserved between independent libraries. In accordance, we showed that 
both sense and antisense transcripts are generated in vivo and in vitro during IIV-6 
replication, supporting a model in which viral dsRNA that is produced by bidirectional 
overlapping transcription is a target for Dcr-2. Together, our results indicate that RNAi 
provides antiviral defense against DNA viruses in Drosophila.
Results
IIV-6 as a model to study antiviral immunity against DNA viruses in 
Drosophila
We investigated the replication kinetics of IIV-6 in w1118 and Oregon-R (OR) WT flies. 
We inoculated adult flies intra-abdominally with IIV-6 and monitored survival and 
viral titers over time. IIV-6 established a productive infection as revealed by iridescence 
in eyes, thorax and abdomen, which is the result of light reflection by assemblies of 
paracrystalline arrays of IIV-6 particles (35) (Figure 1A). Accordingly, IIV-6 virion 
coat proteins were detected by Western blot analysis in total lysates of IIV-6-infected 
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flies (Figure 1B, lanes 2 and 4). The specificity of the IIV-6 antibody was verified by 
lack of signal in mock-infected flies (lanes 1 and 3). IIV-6 replicated efficiently with a 
rapid 6- to 7-log increase in viral titer over the first 6 days, and a relatively stable titer 
thereafter (Figure 1C). However, despite these high and stable titers, virus infection did 
not efficiently kill WT flies over the course of 31 days (Figure 1D, over 60% survival 
after follow-up). These results establish IIV-6 as a model to study DNA virus infection 
in Drosophila.
RNAi mutant flies are more susceptible to IIV-6 infection
To examine the role of the antiviral RNAi machinery on IIV-6 replication in vivo, we 
analyzed the outcome of IIV-6 infection in flies that lack core RNAi components. First, 
we analyzed whether Dcr-2 mutant flies were more sensitive to IIV-6 infection. After an 
initial stable survival, Dcr-2 mutants died from 18 days post-infection onwards, with 
100% mortality at 29 days after infection. In contrast, over 85% of y1w1 controls survived 
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Figure 1. IIV-6 as a model to study antiviral 
immunity against DNA viruses in D. 
melanogaster. (A) IIV-6 infection of w1118 and 
Oregon-R (OR) WT flies results in iridescence 
in eyes, thorax and abdomen. Female flies were 
inoculated in the abdomen with 14,000 TCID50 
units of IIV-6 or with Tris buffer as a control 
(mock). Representative images of flies at 30 days 
post-infection are shown. Iridescence becomes 
apparent as of day 9. (B) Western blot analysis 
of viral proteins in IIV-6 or mock-infected w1118 
and y1w1 WT flies. Female flies were harvested 
at 12 days post-infection. Polyclonal anti-IIV-6 
antibodies were used to visualize virion coat 
proteins. A polyclonal anti-α-tubulin (α-Tub) 
antibody was used as loading control. Molecular 
mass (kDa) is indicated to the right of the 
autoradiograph. (C) Viral titers in w1118 (black) 
and OR (gray) female flies after infection with 
IIV-6. Three pools of four flies were collected and 
homogenized at each indicated time point and 
viral titer in the homogenate was determined by 
end-point dilution. Titers represent averages and 
SEMs of three independent pools of four flies. 
The dashed line represents the detection limit of 
the assay. (D) Survival curve of D. melanogaster 
WT flies after IIV-6 infection. Survival rate of 
w1118 (circles) and y1w1 (diamonds) female flies 
was monitored daily after virus infection (fileld 
symbols) or mock infection (open symbols). A 
representative of three independent experiments 
is shown.
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over the same time course (Figure 2A). Survival after inoculation with UV-inactivated 
IIV-6 was similar to that of mock-infected flies (about 85% survival after follow-up), 
indicating that mortality is the result of active virus replication (Figure 2B). To further 
analyze whether RNAi controls IIV-6 infection in vivo, we monitored survival rates of 
AGO2 mutant flies. AGO2 homozygous mutants (AGO2414/414) and their heterozygous 
controls (AGO2414/+) were challenged with IIV-6. Although heterozygous controls were 
resistant to IIV-6 infection, AGO2 homozygotes were more sensitive to virus infection 
with 35% mortality after follow-up for 31 days (Figure 2C). To exclude the possibility that 
the susceptibility of AGO2 homozygous mutant flies was due to second-site mutations 
in the genome of AGO2414 flies, we analyzed survival of flies that carried a combination 
of two different AGO2 null alleles and thus do not express AGO2 (AGO2414/454, 
AGO2414/321 and AGO2321/454 transheterozygotes) and their AGO2 heterozygous controls 
(AGO2414/+ and AGO2321/+). Because AGO2321 and AGO2454 were reported to be true 
null alleles (36), we first analyzed survival of these AGO2 transheterozygous mutants in 
the well-studied Drosophila C virus (DCV) and Cricket paralysis virus (CrPV) models 
of infection. AGO2 transheterozygous flies are equally sensitive to DCV challenge as 
AGO2414 homozygous mutant flies, whereas their heterozygous controls displayed a 
slower mortality rate (Figure S1A). Similar results were obtained upon CrPV challenge 
(Figure S1B). These results establish AGO2 transheterozygous mutant flies as a reliable 
genetic model to analyze survival following virus infection. We observed that AGO2 
transheterozygous mutants died more rapidly after IIV-6 challenge (40-65% survival 
after follow-up) compared to their heterozygous controls (over 85% survival) (Figure 
2D) and with their mock-infected controls (over 88% survival). To analyze whether the 
increased lethality correlates with an increase in viral titers, we analyzed the viral load 
in RNAi mutant and WT flies. We observed a modest increase in viral titers in RNAi 
mutant flies compared to WT controls at 3 days post-infection (Figure 2E). However, 
viral titers were similar at 12 days after infection. Our results thus imply that RNAi 
controls IIV-6 infection in Drosophila, but that it only modestly affects viral titers.
IIV-6 infection triggers the production of Dcr-2-dependent viral siRNAs
dsDNA viruses are known to produce dsRNA during infection (1), presumably as a 
result of convergent overlapping transcription from both strands of the viral genome. 
The IIV-6 genome is predicted to encode 211 ORFs, of which 45% and 55% derive 
from the upper and lower strands, respectively (34). We refer to the viral strand that is 
transcribed from left to right on the conventional map as the R (upper) strand and to its 
complement as the L (lower) strand.
To investigate whether viral dsRNA is processed into vsiRNAs, we sequenced the small 
RNAs from WT and RNAi mutant flies at 12 days after infection with IIV-6. Small 
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RNAs ranging in size from 19 to 30-nt were cloned and deep-sequenced on an Illumina 
Genome Analyzer. Two independent libraries of IIV-6-infected WT and AGO2 mutant 
flies were analyzed (datasets 1 and 2). Small RNAs were first mapped to the Drosophila 
genome; nonmapping small RNAs were then mapped to the IIV-6 genome (Table 1). 
The vast majority of IIV-6-derived small RNAs in WT and AGO2 mutant flies was 
21-nt long (Figure 3). These small RNAs were Dcr-2-dependent vsiRNAs, because the 
normalized levels of vsiRNAs decreased >875-fold in Dcr-2 mutant flies compared with 
WT flies (Table 1).
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Figure 2. D. melanogaster RNAi mutant flies are susceptible to IIV-6 infection. (A) Survival 
of Dcr-2 mutant flies after IIV-6 challenge. The survival rate of female Dcr-2L811fsX (squares) and 
y1w1 control (triangles) flies was monitored daily after IIV-6 (filled symbols) or mock infection 
(open symbols). A representative of three independent experiments is shown. (B) Survival assay 
of Dcr-2L811fsX female flies injected with UV-inactivated IIV-6 (IIV-6UV, gray squares), IIV-6 
(black squares) or Tris buffer (white squares). (C) Survival of AGO2414 homozygous (diamonds) 
and AGO2414/+ heterozygous controls (squares) infected with IIV-6 (filled symbols) or Tris buffer 
(open symbols). A representative of two independent experiments is shown. (D) Survival of 
IIV-6-infected AGO2-null mutant flies. AGO2414/454 (gray squares), AGO2414/321 (black squares), 
and AGO2321/454 (black circles) transheterozygous flies, as well as AGO2414/+ (white squares) 
and AGO2321/+ (white circles) heterozygous controls were infected with IIV-6, and survival was 
monitored daily. A representative of two independent experiments is shown. The experiments 
in C and D were run in parallel; the survival curve of IIV-6-infected AGO2414/+ flies is depicted 
in both panels. (E) Viral load in RNAi mutant and WT flies after IIV-6 infection. Dcr-2L811fsX, 
AGO2414 and their WT controls y1w1 and w1118, respectively, were infected with IIV-6, and virus 
production in the flies was monitored over time. At each time point, three pools of four flies 
were homogenized, and the viral titer in the homogenate was determined by end-point dilution. 
Bars represent averages and SEMs of three independent pools of four flies. The horizontal line 
represents the detection limit of the titration.
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Dcr-2 generates 21-nt duplex siRNAs in which 19 nucleotides are base paired, leaving 
2-nt 3’overhangs at each end. We thus analyzed 21-nt viral small RNAs for the presence 
of this Dcr-2 signature, as previously described (37). In contrast to our observations 
in infections with Nora virus, a (+) RNA virus (37), we did not observe enrichment 
for a 19-nt overlap among viral small RNAs mapping to opposite strands of the IIV-6 
genome (Figure S2A). Asymmetric RISC loading preferentially retains one of the two 
strands of an siRNA duplex (38). Our results thus suggest that the majority of IIV-6-
derived vsiRNAs do not exist as siRNA duplexes, but that they are associated with RISC.
Although the size distribution of viral small RNAs was similar between AGO2 mutant 
and WT flies, the size distribution of the viral small RNAs in Dcr-2 mutants was 
vastly different. In contrast to the sharp 21-nt peak in WT flies and AGO2 mutants, 
small RNAs in Dcr-2 mutants showed a broader size distribution, with only a minor 
enrichment at 21-nt. A similar shift toward small RNAs with sizes other than 21-nt 
was noted before in Dcr-2 mutant flies infected with vesicular stomatitis virus (14). 
Recombinant and immunoprecipitated Dicer-1 (Dcr-1) is able to process long dsRNA 
into siRNA in in vitro assays, albeit with low efficiency (39-41). Moreover, small RNAs 
derived from an inverted repeat transgene could be detected by Northern blot analysis 
in Dcr-2 null mutants (42). We thus hypothesize that in the absence of Dcr-2, another 
nuclease, presumably Dcr-1, processes low levels of viral dsRNA to generate viral small 
RNAs. The lack of a prominent 22-nt viral RNA peak in Dcr-2 mutants (Figure 3) 
suggests that IIV-6 does not produce viral microRNAs (miRNAs). Together, our data 
indicate that IIV-6 infection results in the production of vsiRNAs in a Dcr-2-dependent 
manner.
w1118 AGO2414 Dcr-2L811fsx
Dataset 1 Dataset 2 Dataset 1 Dataset 2 Dataset 1
Drosophila genome, reads 1,647,783 10,588,690 7,664,970 14,758,882 5,371,641
rRNA, %* 49.0 49.9 27.7 32.1 21.5
miRNA, %* 44.7 38.4 65.5 55.9 67.5
IIV-6: 0 mismatch, %* 8.3 8.2 2.8 10.1 0.03
IIV-6: 1 mismatch, %* 0.4 0.3 0.2 0.5 0.001
IIV-6, % to miRNAs† 17.4 20.0 3.5 17.5 0.02
*Descriptions of small RNAs in the size range of 19-25 nt; percentage relative to reads mapping 
to the Drosophila genome.
†Normalized 21-nt viral reads mapping to the IIV-6 genome, allowing 0 or 1 mismatch during 
alignment; percentage viral reads relative to total cellular miRNA reads.
Table 1. Descriptions of small RNA libraries
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Uneven distribution of viral siRNA profiles across the IIV-6 genome
We next analyzed the distribution of vsiRNAs across the viral genome in WT and AGO2 
mutant flies (Figure 4A and B). A global presentation of vsiRNA coverage over the 
viral genome indicates that vsiRNAs are derived from both strands of the viral genome. 
In Dcr-2 mutants (Figure 4C), the low number of viral small RNAs also mapped to 
both strand of the viral genome, which is in line with our hypothesis that low level 
of viral dsRNA processing may occur in a Dcr-2-independent manner. Although 
vsiRNAs mapped along the entire viral genome in WT and AGO2 mutant flies, a 
highly uneven distribution of vsiRNAs with strong clustering in small defined genomic 
regions (hotspots) and only modest coverage in other regions (coldspots) was observed 
(Figure 4 A and B, Figure S2B). The uneven coverage of vsiRNAs across the genome was 
highly reproducible between experiments, with a strong correlation between vsiRNA 
densities in the two independent datasets of WT and AGO2 mutant flies (r =0.975, P 
<0.001 and r =0.967, P <0.001, respectively, Figure S3). Furthermore, the distribution 
of vsiRNAs across the genome was highly similar between WT and AGO2 mutant 
flies (Figure 4A and B). Indeed, a remarkable congruence of vsiRNA profiles in both 
genetic backgrounds was apparent in more detailed views of highly covered regions of 
the genome (representative examples are shown in Figure 4D and E). To substantiate 
the congruence between small RNA profiles in WT and AGO2 mutant flies further, we 
divided the viral genome into 500-bp bins and compared the number of small RNAs in 
each bin between these genotypes (Figure 4F). Indeed, we observed a strong correlation 
between vsiRNA densities in WT and AGO2 mutant libraries in both independent 
datasets (r =0.939, P <0.001 and r =0.959, P <0.001 for dataset 1 and 2 respectively). 
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Figure 3. Production of Dcr-2-dependent viral siRNAs in IIV-6 infection. Size profiles of 
viral small RNAs mapping to the IIV-6 genome, allowing one mismatch during alignment, in 
w1118 WT (Left), Dcr-2L811fsX, (Center) and AGO2414 (Right) flies are shown. Small RNA libraries 
were generated from a pool of 15 female flies at 12 days post-infection. Two independent libraries 
of IIV-6-infected WT flies and AGO2 mutants were analyzed (datasets 1 and 2; dark gray and 
light gray, respectively).
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The concordance of vsiRNA profiles in flies with different genetic backgrounds suggests 
that the uneven distribution of vsiRNAs and the presence of vsiRNA hotspots in the 
genome are caused by factors intrinsic to the virus, such as the relative expression of viral 
transcripts.
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Figure 4. Uneven distribution of viral siRNA profiles across the IIV-6 genome. (A-C) Profile 
of IIV-6-derived vsiRNAs across the IIV-6 genome. Viral siRNAs were aligned to the IIV-6 
genome allowing one mismatch during alignment. The genome coordinates of the 5’ end of each 
vsiRNA in w1118 WT (A), AGO2414 (B), and Dcr-2L811fsX (C) flies were plotted. (D-E) Profile of 
IIV-6-derived vsiRNAs in w1118 WT (D) and AGO2414 (E) flies mapping to genome coordinates 
91,000-92,000 (Left) and 116,000-120,000 (Right) that contain regions with a high density of 
vsiRNAs are shown. ORFs located in the genome region are depicted above the plot, drawn to 
scale. Viral siRNAs that mapped to the R and L strand of the IIV-6 genome are shown in red 
and blue, respectively. Small RNA libraries were generated from a pool of 15 female flies at 12 
days post-infection. Profiles from dataset 1 are presented; profiles from dataset 2 are provided in 
Figure S3. (F) The IIV-6 genome was divided into 500-bp bins and the number of vsiRNAs per 
bin in w1118 WT and AGO2414 mutant flies was analyzed in a scatter plot (log-transformed data, 
dataset 1; r = 0.939, P <0.001, Pearson’s correlation test).
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Convergent transcripts as a source of viral double-stranded RNA in 
IIV-6 infection
To identify the dsRNA substrate for vsiRNA biogenesis, we analyzed the distribution 
of the vsiRNAs corresponding to the L and R strands of IIV-6. We found that 47% 
and 43% of the vsiRNAs mapped to the R strand in WT and AGO2 mutant flies, 
respectively (Figure 5A), closely mimicking the distribution of the ORFs over the viral 
genome strands (45% R strand ORFs). When restricting our analyses to individual 
ORFs, we also observed that vsiRNAs are derived from both the L and R strands. 
Moreover, the density of vsiRNAs that map to the L strand strongly correlated with 
the density of reads mapping to the R strand of individual ORFs (Figure 5B, r =0.78, 
P <0.001). Thus, individual ORFs produced vsiRNAs that map to both strands of the 
genome, irrespective of the L or R orientation of the ORF. These results suggest that 
vsiRNAs predominantly derive from overlapping sense and antisense transcripts, rather 
than from intramolecular stem-loop structures in single-stranded viral transcripts. 
To analyze the occurrence of antisense transcription during IIV-6 infection, we performed 
strand-specific RT-PCRs on infected w1118 WT flies. To avoid possible false-positive 
Figure 5. Convergent transcripts are a source of dsRNA during IIV-6 infection. (A) Percentage 
of the total vsiRNAs that map to the viral R strand in w1118 WT (wt) and AGO2414 mutant flies. 
(B) Scatter plot of the vsiRNAs from individual ORFs that map to the viral L and R strand in 
w1118 WT flies. For each ORF, the total number of vsiRNAs derived from each strand was divided 
by the length of the ORF. The data were log transformed and presented in a scatter plot. Circles 
and triangles indicate ORFs on the viral L and R strand, respectively. Correlation between both 
read densities was evaluated with a Pearson’s correlation test. (C) Ethidium bromide-stained gels 
of strand-specific RT-PCR assays for the detection of sense and antisense transcripts from the 
indicated IIV-6 ORFs in infected w1118 WT flies. RT-PCR assays were performed in either the 
presence (+RT) or absence (-RT) of reverse transcriptase. H2O was included as nontemplate 
control during PCR amplification. 85L, 206R, 249R, 251L and 441R represent ORFs with a 
high coverage of vsiRNA reads per base pair (bp), whereas 357R represents an ORF with a low 
coverage of vsiRNAs per bp.
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results due to mispriming during cDNA synthesis, we used strand-specific primers 
containing a nonviral tag sequence (T7 promoter) at the 5’ end, thereby generating 
tagged cDNA that can be PCR-amplified using a combination of a virus-specific primer 
with a T7 primer (43-46). We selected five ORFs with a high density of vsiRNA reads 
(85L, 206R, 249R, 251L and 441R) and one ORF with a low vsiRNA density (357R). 
For five out of six selected ORFs, we readily detected sense and antisense transcripts; 
for ORF 249R we could not detect antisense transcripts using this method (Figure 5C). 
All gene-specific primers efficiently amplified fragments of the selected ORFs in control 
PCR reactions using viral DNA as a template (Figure S4), excluding inefficient primer 
binding as an explanation for our inability to detect antisense ORF 249R transcripts. 
These results further support the existence of bidirectional overlapping transcription in 
the IIV-6 genome. Because antisense transcription also occurs in genomic regions with 
low vsiRNA coverage (ORF 357R), these results suggest that other factors, such as the 
relative amounts of viral sense and antisense transcripts, may contribute to differences 
in vsiRNA coverage across the genome.
To confirm the presence of sense and antisense transcripts, we performed Northern blot 
analysis on mock and IIV-6-infected Drosophila S2 cells using oligonucleotide probes 
that specifically recognize either viral RNA strand (Figure S5). For all tested ORFs 
(85L, 206R, and 441R), sense transcripts that matched the predicted size of the selected 
ORFs were readily detected. Northern blot analyses using probes that detect antisense 
transcripts revealed the presence of high molecular weight (>9 kb) antisense transcripts 
for all three ORFs as well as a small antisense transcript for ORF 441R. The origin and 
biogenesis of these antisense transcripts awaits further investigation.
Together, the small RNA profiles, strand-specific RT-PCR, and Northern blot analyses 
indicate that both sense and antisense transcripts are generated during IIV-6 infection. 
We propose that these viral transcripts form dsRNA that activates the RNAi pathway, 
resulting in the production of Dcr-2-dependent vsiRNAs.
IIV-6 derived vsiRNAs mediate gene silencing
To analyze whether IIV-6 derived vsiRNAs are functional in mediating target gene 
silencing, we designed luciferase reporter plasmids. To this end, the IIV-6 genome was 
divided into 500-bp bins, from which we selected 10 hotspot regions that produced 
the highest number of vsiRNAs (Figure S2B). These fragments, as well as a non-specific 
GFP control sequence, were cloned in the 3’ UTR of a firefly luciferase (Fluc) reporter 
plasmid (Figure 6A). Drosophila S2 cells were transfected with these reporter plasmids 
together with a plasmid encoding Renilla luciferase (Rluc) as a normalization control. 
We then infected these cells with IIV-6 and monitored luciferase activity. If vsiRNAs 
are incorporated in a functional RISC complex, it is expected that IIV-6 infection 
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will induce specific silencing of the IIV-6 reporters, but not the GFP control plasmid. 
Indeed, we observed significant silencing of six IIV-6 reporters (Figure 6B). The extent 
of silencing did not seem to correlate with vsiRNA density. For example, the reporter 
for hotspot 8 was silenced most efficiently, whereas the reporter for the hotspot with 
the highest density (hotspot 1) was silenced to a lesser extent. These results are in line 
with observations in Nicotiana benthamiana, in which no clear correlation was observed 
between vsiRNA density and efficiency of silencing of a sensor construct (47). Strikingly, 
in mosquito cells, hotspot vsiRNAs were found to be less efficient at mediating antiviral 
RNAi than coldspot vsiRNA, which was hypothesized to reflect a decoy strategy to 
evade the antiviral RNAi response (22). Whether a similar mechanism plays a role in 
IIV-6 infection remains to be established.
Having established that IIV-6-derived vsiRNAs are incorporated into a functional RISC 
complex, we analyzed their effect on viral gene expression. To this end, we compared 
viral transcript levels in IIV-6-infected w1118 WT and AGO2414 mutant flies. We selected 
5 ORFs with a high coverage of vsiRNA reads per base pair and analyzed expression 
levels using strand-specific quantitative RT-PCR (qRT-PCR). Although we observed 
a modest, but not statistically significant, 1.6-1.8 fold increase in antisense and sense 
transcripts for one ORF (227L), we were unable to detect a general increase in viral 
transcripts levels in AGO2 mutant flies (Figure S6). Becuase we analyzed viral transcript 
levels at a single time point and viral gene expression is likely to be under tight temporal 
control, we cannot exclude the possibility that the pathology in RNAi mutant flies is due 
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Figure 6. IIV-6 derived vsiRNAs mediate 
gene silencing. (A) Schematic representation 
of reporter plasmids. Sequences (500-bp) of 
IIV-6 genome or GFP (control) were cloned 
into the 3’ UTR of a copper-inducible firefly 
luciferase (Fluc) plasmid to generate IIV-6 and 
GFP reporter plasmids. (B) RNAi reporter 
assay in Drosophila S2 cells. IIV-6 or control 
reporter plasmids were transfected together 
with a Renilla luciferase (Rluc) plasmid 1 day 
before mock or IIV-6 infection. Two days 
after transfection, expression of Fluc and 
Rluc was induced and luciferase activity was 
measured the day thereafter. Fluc expression was 
normalized to Rluc expression and presented 
as ratio of infected over noninfected cells 
relative to the values for GFP control plasmid 
(set at 1). Bars represent averages and SEMs of 
three independent experiments. P values were 
calculated using Student’s t test; * P < 0.05; ** P 
< 0.01; *** P < 0.001; ns, not significant.
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to an early disequilibrium of transcripts levels (i.e. high levels of specific viral transcripts 
in AGO2 mutants at a specific time in infection). Future genome-wide transcriptome 
analyses will be required to analyze the dynamics of viral gene expression and the role of 
the RNAi machinery in post-transcriptional regulation thereof.
Discussion
RNA viruses in insects are targets of an RNAi-based antiviral immune response, in 
which viral replication intermediates or viral dsRNA genomes are processed by Dcr-2 
into vsiRNAs. In this study, we established IIV-6 as a model to study the role of RNAi 
in a productive but nonlethal infection by a dsDNA virus. Our results demonstrate that 
RNAi targets dsDNA viruses in vivo, further extending the role of RNAi as an antiviral 
defense mechanism.
The production of vsiRNAs upon RNA virus infection is a key feature of an antiviral 
RNAi response. The detection of Dcr-2-dependent vsiRNAs in infected flies provides 
direct evidence that IIV-6 is a target of the Drosophila RNAi machinery. We observed a 
highly uneven distribution of vsiRNAs across the IIV-6 genome, with similar levels of 
vsiRNAs mapping to both strands of the viral genome. Accordingly, analysis of individual 
ORFs revealed a strong correlation in vsiRNA reads derived from the R and L strands 
of the viral genome. Furthermore, using strand-specific (q)RT-PCR and Northern blot 
analysis, we demonstrate the presence of sense and antisense viral transcripts derived 
from different regions in the IIV-6 genome. Finally, we show that IIV-6-derived vsiRNAs 
mediate gene silencing in reporter assays in S2 cells. These results support a model in 
which dsRNA that is generated by bidirectional overlapping transcription is the major 
substrate for vsiRNA biogenesis during dsDNA virus infection.
Antisense transcription is prevalent among different families of DNA viruses, and has 
been suggested to affect viral gene expression (48-52). Antisense transcripts have the 
potential to form dsRNA by base pairing with sense transcripts. Indeed dsRNA can 
readily be detected in infections by DNA viruses in mammalian cells (1). However, 
although mammalian DNA viruses encode microRNAs, they do not seem to produce 
Dicer-dependent vsiRNAs (53, 54). For example, a recent report detected widespread 
antisense transcription in lytic Kaposi’s sarcoma-associated herpesvirus infection, but 
failed to identify abundant vsiRNAs (51). Similarly, antisense transcription is very 
abundant throughout the genome of human cytomegalovirus (50). However, deep 
sequencing of the small RNAs in infected cells readily identified viral miRNAs, but 
detected only a limited number of other viral small RNAs. These small RNAs mapped 
to a restricted number of defined genomic loci and whether they are bona fide Dicer 
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products remains unclear (55). In plants (Arabidopsis), the pararetrovirus Cauliflower 
mosaic virus (CaMV) also produces long antisense transcripts (56, 57). Furthermore, 
CaMV vsiRNAs mapped to both strands of the genome, indicating that antisense 
transcripts base pair with sense transcripts to produce dsRNA substrates for members 
of the Dicer-like protein family. Formation of dsRNA by convergent transcription in 
Cassava mosaic virus, a single-stranded DNA virus of the Geminiviridae family, was also 
postulated to be the source of vsiRNA production in tobacco (N. benthamiana) and 
cassava (Manihot esculenta) plants (58, 59).
Thus, DNA viruses in plants, insects and mammals have an enormous potential to 
form dsRNA, but only in plants and insects this dsRNA is processed into vsiRNAs. 
The reason for this discrepancy is not obvious because in vitro and in vivo studies imply 
that mammalian Dicer is capable of processing long stretches of dsRNA into siRNAs 
(60-63). Strikingly, humans only encode a single Dicer protein, whereas plants and 
Drosophila encode multiple Dicer family members (two and four in Drosophila and 
Arabidopsis, respectively). Perhaps, the diversification of the Dicer gene family in plants 
and insects allowed the functional specialization and more efficient processing of viral 
dsRNA for antiviral defense.
Another remarkable difference between vertebrate DNA viruses and IIV-6 is the notable 
absence of viral miRNAs in IIV-6. Mammalian DNA viruses, including herpesviruses 
and polyomaviruses, produce viral miRNAs that are capable of modulating viral or 
host gene expression (64). Individual herpesviruses may encode multiple miRNAs; for 
example, human cytomegalovirus encodes 22 miRNAs in its 230-kb genome (55). In 
Drosophila, miRNA biogenesis involves the sequential processing of primary miRNA 
transcripts into pre-miRNAs by Drosha and its cofactor Pasha (together known as the 
Microprocessor complex) in the nucleus and the cleavage of pre-miRNA into mature 
miRNAs by cytoplasmic Dcr-1. Mature miRNAs are then incorporated into an 
Argonaute-1-containing RISC, where they trigger translational repression or degradation 
of the target mRNA (65). Iridoviruses are nucleocytoplasmic viruses with an initial stage 
of replication in the nucleus, where early viral transcripts are generated from the input 
virion DNA template by host RNA Polymerase II (30). These viral transcripts may 
follow the canonical miRNA processing pathway of cellular miRNAs. Indeed, 11 viral 
miRNAs were identified in Singapore grouper iridovirus, a member of the Iridoviridae 
family (Ranavirus genus) that infects fish (66). Analysis of our deep sequencing data 
revealed the lack of a prominent 22-nt RNA peak in Dcr-2 mutants. Furthermore, we 
were unable to computationally predict pre-miRNA-like stem-loop structures in regions 
of the viral genome that gives rise to the most abundant viral small RNAs. Together, 
these results suggest that IIV-6 does not produce viral miRNAs. However, the lack of 
viral miRNAs is not a general attribute to insect DNA viruses, because miRNAs have 
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been identified in other large invertebrate DNA viruses, Heliothis virescens ascovirus and 
Bombix mori nucleopolyhedrosis virus (67, 68).
Our model postulates that base pairing of overlapping converging transcripts generates 
the viral dsRNA substrates for vsiRNA production by Dcr-2. Consequently, vsiRNAs 
are 100% complementary to viral transcripts and should be able to target them for 
degradation. Indeed, we observed an enhanced susceptibility of RNAi mutant flies to 
IIV-6 infection and observed that vsiRNAs mediate silencing of reporter constructs. 
Nevertheless, we only observed a modest increase in viral load at early time points 
in RNAi mutant flies. Several hypotheses could explain this apparent paradox. First, 
vsiRNAs may target viral genes that are involved in viral pathogenesis, but not viral 
replication per se. Consequently, in the absence of a functional RNAi response, 
expression of these putative pathogenicity factors will be increased, resulting in a more 
rapid onset of disease. Second, the observed IIV-6-associated mortality may be due to 
invasion or high-level replication in specific critical tissues. Perhaps RNAi-pathway 
components have tissue-specific functions during IIV-6 replication that could explain 
the observed mild differences in viral titers in whole flies. Third, the susceptibility of 
RNAi mutant flies could also be attributed to additional (direct or indirect) functions 
of Dcr-2 and AGO2, other than controlling viral RNA levels. For example, the putative 
antiviral effector Vago is induced upon RNA virus infection in a Dcr-2-dependent, but 
AGO2-independent manner (69). We note that Dcr-2 mutants seem to be more severely 
affected by IIV-6 infection than AGO2 mutants, which would fit a Dcr-2-dependent 
induction of a disease modifying activity.
It is well established that the RNAi machinery targets endogenous retroviruses, dsRNA 
viruses as well as viruses with (+) or (-) RNA genomes. We now show that dsDNA virus-
derived siRNAs are produced by Dcr-2 and that these vsiRNAs provide defense against 
infection. Thus RNAi in insects is the predominant antiviral defense mechanism that 
provides protection against all major classes of viruses.
Materials and Methods
Virus titration
IIV-6 was kindly supplied by C. Joel Funk (US Department of Agriculture-Agricultural 
Research Service Western Cotton Research Laboratory, Phoenix, Arizona) and was 
propagated in Galleria mellonella (greater wax moth) larvae and purified by 25-65% 
(wt/vol) sucrose density gradient centrifugation as described previously (70, 71). IIV-6 
UV-inactivated virus was produced by exposing the virus stock to a total of 12,000 mJ 
UV light in four intervals of 3 min (72).
3IIV-6 induces an antiviral RNAi response in Drosophila
87
Viral titers were determined by end-point dilution. Drosophila S2 cells (Invitrogen) 
were seeded in 96-well plates at a density of 2.5 × 104 cells per well. Subsequently, 
cells were infected with 10-fold serial dilutions of fly homogenate or virus suspension. 
Each infection was performed in quadruplicate. IIV-6 infection was scored by a lack 
of proliferation of cells and by the presence of cell debris and large cells, presumably 
syncytia. Viral titers were calculated according to the method of Reed and Muench (73).
For titration of infectious virus in adult flies, three pools of four flies were harvested and 
stored at -70 ˚C until further processing. Each pool of flies was homogenized in 150 µL 
of PBS, and fly debris was removed by centrifugation for 10 min at 16,000 × g at 4 ˚C. 
The supernatant was transferred to a fresh tube and, prior to titration, centrifuged again 
for 5 min at 16,000 × g at room temperature.
Clearance of Wolbachia- and virus-infected flies and validation by PCR 
To clean fly stocks from persistent viruses, eggs were collected on apple-juice agar 
plates and treated with 50% (vol/vol) household bleach for 5 min. After three extensive 
washes with water, eggs were transferred to fresh vials containing standard fly food. After 
culturing for two subsequent generations, we verified the absence of Nora virus and 
DCV by RT-PCR assay.
For RT-PCR assays, total RNA was extracted from pools of 15 flies using Isol-RNA Lysis 
Reagent (5 Prime) according to manufacturer’s recommendations. cDNA synthesis was 
performed on 1 µg of DNase-I (Invitrogen)-treated total RNA using random hexamers 
and Taqman reverse transcriptase (Roche). Primers used for PCR amplification of 
Nora virus were NoV 1370F (5’-ATGGCGCCAGTTAGTGCAGACCT-3’) and NoV 
1780R (5’-CCTGTTGTTCCAGTTGGGTTCGA-3’). DCV primers were DCV 
1947F (5’-TTGATCTAGATACTGAAACCGCAAATCGTG-3’) and DCV 2528R 
(5’-TCGCCCATACGATTAAAGAAA-3’). As positive control for RNA extraction, 
we used Act42A 19F (5’-GCGTCGGTCAATTCAATCTT-3’) and Act42A 386R 
(5’-CTTCTCCATGTCGTCCCAGT-3’). The PCR program used was: 94 ˚C for 5 
min; 35 cycles of 94 ˚C for 30 s, 57 ˚C for 30 s, and 72 ˚C for 50 s; 72 ˚C for 10 min.
To clear fly stocks from Wolbachia infection, flies were raised for two generations in 
standard fly food containing 0.05 mg/ml of tetracycline hydrochloride (Sigma). 
Clearance of Wolbachia infection was validated by PCR amplification of Wolbachia-
specific genes from DNA extracts of adult flies, as described previously (32).
Fly stocks and virus infections
Virus- and Wolbachia-cleared flies were reared on standard medium at 25 ˚C with a 
light/dark cycle of 12 h/12 h. We used the following alleles: AGO2414 (74), AGO2321, 
AGO2454 (36), and Dcr-2L811fsX (42). We used w1118 and y1w1 flies were used as WT 
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controls for AGO2 and Dcr-2 mutant flies, respectively. For generation of AGO2 
transheterozygous mutant flies, AGO2414 homozygous flies were crossed with AGO2454/
TM3Sb or AGO2321/TM3Sb flies, and the F1 progeny was selected based on the 
absence of the balancer. Likewise, for generation of AGO2321/454 transheterozygous flies, 
AGO2321/TM3Sb flies were crossed with AGO2454/TM3Sb flies. Heterozygous controls 
were generated by crossing AGO2 flies with w1118 flies.
Female flies (2-4 days of age) were injected with 50 nL of the appropriate virus dilution 
[containing 14,000 median (50%) tissue culture infectious dose (TCID50) units of 
IIV-6, 500 TCID50 units of DCV or 2,500 TCID50 units of CrPV] in 10 mM Tris-
HCl (pH 7.5) or with 10 mM Tris-HCl (pH 7.5) as a mock infection, as described 
previously (13). Flies were injected in the anterior ventral abdomen near the dorsal-
ventral boundary while anesthetized with CO2 (75). Flies were cultured at 25 ˚C, and 
mortality was monitored daily. Every 3 to 4 days, the flies were transferred to fresh food. 
Fly mortality at day 1 was attributed to damage invoked by the injection procedure and 
was excluded from survival analysis. In all survival experiments, 20-30 female flies per 
genotype were injected.
Western blots
Pools of five IIV-6-infected or mock-infected female flies were homogenized in lysis 
buffer [50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA, 1% (vol/vol) Nonidet P-40, 
0.05% (wt/vol) SDS, 1 mM DTT, 0.5 mM PMSF and complete protease inhibitor 
mixture (Roche)] for 30 min at 4 ˚ C. Fly lysates were centrifuged for 10 min at 16,000 × 
g at 4 ˚ C. The supernatant was transferred to a fresh tube and centrifuged again for 5 min 
at 16,000 × g at room temperature. For Western blot analysis, SDS-solubilized proteins 
were separated on a 10% (wt/vol) denaturing polyacrylamide gel and transferred to 
a nitrocellulose membrane for detection. For the detection of virus-specific proteins, 
polyclonal rabbit antibodies raised against IIV-6 virion coat proteins were diluted 
(1:2,000) in blocking buffer [5% (wt/vol) skimmed milk, 0.1% (vol/vol) Tween 20 in 
PBS]. The blot was incubated for 1 h at room temperature with the primary antibody. 
Subsequently, the blot was incubated with a secondary antibody, HRP-conjugated 
polyclonal goat anti-rabbit IgG (Dako), for 1 h in blocking buffer (1:5,000 dilution). 
Bound antibodies were detected using chemiluminescence (Roche). As a loading control, 
the same blot was probed with a rat anti-α-tubulin antibody (1:1,000 dilution; AbD 
Serotec) as a primary antibody. Goat anti-rat-IRdye680 antibody (1:15,000 dilution; 
Invitrogen) was used as a secondary antibody. Bound antibodies were visualized on an 
Odyssey infrared imager (LI-COR Biosciences).
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Small RNA library preparation and analysis
Total RNA was extracted from pools of 15 IIV-6-infected female flies harvested at 12 
days post-infection, using Isol-RNA Lysis reagent. Small RNA libraries were prepared 
as previously described (76) and sequenced on a Genome Analyzer IIx (Illumina). Small 
RNA libraries were analyzed as described previously (77). Briefly, small RNA reads were 
first mapped to the D. melanogaster genome allowing no mismatches during alignment. 
Nonmapping reads were then aligned to the IIV-6 reference genome (National Center 
for Biotechnology Information database, accession no. AF303741), allowing one 
mismatch. The IIV-6 genome annotation as proposed by Eaton et al. (34) was used to 
analyze read density per ORF. Correlations were evaluated using Pearson’s correlation test 
as implemented in the statistical package SPSS (IBM SPSS). Sequences were submitted 
to the Sequence Read Archive at the National Center for Biotechnology Information 
(accession no. SRA048623).
Strand-specific RT-PCR assays
For strand-specific RT-PCR assays, a pool of 10 IIV-6-infected w1118 flies (14,000 
TCID50 units) was harvested at 12 days post-infection. RNA was isolated from the flies 
using Isol-RNA Lysis Reagent and treated with DNase-I (Ambion). cDNA synthesis was 
performed on 400 ng of DNase-I-treated RNA using the TaqMan Reverse Transcription 
Reagents in a 20-µL reaction according to the manufacturer’s instructions (Applied 
Biosystems) utilizing strand-specific primers tagged with a 5’ T7 promoter sequence at a 
final concentration of 0.2 µM (Table S1). Following cDNA synthesis, PCR analysis was 
performed using a combination of an IIV-6-specific primer and a primer specific for the 
T7 promoter sequence (Table S1). One microliter of the cDNA product was used in a 
20-µL PCR assay containing 2.5 mM MgCl2, 1× reaction buffer, 0.2 mM dNTPs, 0.5 
µM of each primer and 0.625 U/µL Thermoperfect DNA polymerase (Integro). The 
PCR program was as follows: 95 ˚C for 5 min; 40 cycles of 95 ˚C for 30 s, 55 ˚C for 30 
s, and 72 ˚C for 30 s; 72 ˚C for 10 min. RT-PCR products were analyzed on 2% (wt/
vol) agarose gels. Several control reactions were run in parallel for each sample. cDNA 
synthesis without reverse transcriptase and PCR amplification without cDNA template 
were performed to verify the absence of contaminating DNA in RNA preparations 
and PCR reagents, respectively. A control PCR assay was performed on proteinase K 
(Qiagen)-treated virus stock to verify primer efficiency (Figure S4).
For strand-specific qRT-PCR assays, RNA was isolated from three pools of 25 IIV-6-
infected w1118 and AGO2414 flies at 12 days post-infection. RNA isolation, DNase-I 
treatment and cDNA synthesis with T7 promoter-tagged primers were performed as 
described above. qPCR analysis using a combination of T7 promoter and IIV-6-specific 
primers were performed on a LightCycler 480 using LightCycler 480 SYBR Green I 
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Master (Roche). The PCR program was as follows: 95 ˚C for 5 min; 45 cycles of 95 ˚C 
for 5 s, 60 ˚C for 10 s, and 72 ˚C for 20 s. The data were normalized to Rp49, for which 
qRT-PCR assays were run in parallel. The entire experiment was performed three times.
Northern blots
S2 cells were either mock-infected or infected with 4.23 × 106 TCID50 units of 
IIV-6. At 3 days post-infection, RNA was isolated from the cells using Isol-RNA 
Lysis Reagent. The RNA (10 µg per lane) was separated on 1.5% (wt/vol) agarose/
formaldehyde gel and transferred onto Nytran SuPerCharge nylon membranes 
(Whatman). Blots were hybridized with 32P end-labeled oligonucleotide DNA 
probes for specific detection of sense and antisense transcripts of selected ORFs. 
Probes for ORF 85L were 85L antisense (5’-tggcttgcgggatatttggatgcagatggctgcgtc-3’) 
and 85L sense (5’- gacgcagccatctgcatccaaatatcccgcaagcca-3’). ORF 206R probes 
were 206R antisense (5’-gggaaactcagaagaaaaaggaaagtggcgagtacg-3’) and 206R 
sense (5’- cgtactcgccactttcctttttcttctgagtttccc-3’). Probes for ORF 441R were 
441 antisense (5’- cctcttatagagacttggcaaagtttgccgatcctg-3’) and 441R sense (5’- 
caggatcggcaaactttgccaagtctctataagagg-3’). Blots were hybridized in ULTRAhyb-Oligo 
hybridization buffer (Ambion) according to the manufacturer’s instructions and 
visualized by autoradiography. Blots of gels with in vitro transcribed RNA (25 ng per 
lane) were run in parallel as positive controls (Table S2).
IIV-6 sensor assay in S2 cells
To generate IIV-6 sensor plasmids, we amplified ten 500-bp regions of the IIV-6 genome 
from proteinase K-treated virus stock by PCR assay using the primers from Table S3. 
PCR fragments were cloned in the 3’ UTR of the Fluc gene in the pMT-GL3 plasmid 
(13) using the PspOMI and PmeI restriction sites. As a nonspecific control, a 500-bp 
fragment of GFP (nucleotides 192-691) was amplified from the pEGFP-N1 plasmid 
(Clontech) and cloned in a similar manner. The pMT-Ren plasmid (13) was used as a 
transfection control.
For the RNAi reporter assay, 1.5 × 105 S2 cells were seeded in a 24-well plate. Twenty-
four hours post-seeding, cells were transfected with 12 ng pMT-Ren and 50 ng of 
an IIV-6 sensor or GFP control plasmid, as described (78). Twenty-four hours after 
transfection cells were mock-infected or infected with 21,000 TCID50 units of IIV-6. 
Expression of the Fluc and Rluc reporters was induced at 24 h after infection by adding 
CuSO4 at a final concentration of 500 µM to the culture supernatant. After incubation 
for an additional 18 h, luciferase activities were measured using the Dual Luciferase 
reporter system (Promega).
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Figure S1. Enhanced susceptibility of Argonaute-2 (AGO2) transheterozygous mutant 
flies to RNA virus infection. AGO2414/414 homozygous flies (black squares), AGO2414/454 
transheterozygous flies (gray squares), AGO2321/454 transheterozygous flies (black circles), and 
AGO2321/414 transheterozygous flies (gray circles), as well as AGO2414/+ (white squares) and 
AGO2321/+ (white circles) heterozygous controls were infected with 500 median (50%) tissue 
culture infectious dose (TCID50) units of Drosophila C virus (A) or with 2,500 TCID50 units of 
Cricket paralysis virus (CrPV) (B), and survival was monitored daily.
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Figure S2. Profile of Invertebrate iridescent virus 6 (IIV-6)-derived viral small interfering 
RNAs (vsiRNAs). (A) Relative (Rel.) frequencies of 5’overlap between 21-nt small RNAs that 
map to opposite strands of the viral genome in IIV-6-infected w1118 (Left), Dcr-2L811fsX (Center), 
and AGO2414 (Right) flies. For each possible overlap of 1-21 nt, the number of read pairs was 
quantified and converted into a Z-score. (B) Viral siRNAs in w1118 WT flies were aligned to the 
IIV-6 genome allowing one mismatch during alignment, and genome coordinates of the 5’ end 
of vsiRNAs are plotted in 10,000-bp regions. vsiRNAs that mapped to the upper (R) and lower 
(L) strands of the IIV-6 genome are shown in red and blue, respectively. Note that the scale of the 
y axes differs between the individual plots. The ten 500-bp bins [hotspots, (hs)] that contained 
the highest density of vsiRNA reads and were used in the sensor assay of Figure 6B are presented 
above the plots. ORFs that were analyzed for the presence of sense and antisense are depicted 
above the plots, drawn to scale. Small RNA profiles are from dataset 1.
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Figure S3. Small RNA profiles from two independent libraries from Invertebrate iridescent 
virus 6 (IIV-6)-infected flies. Profile of IIV-6-derived viral small interfering RNAs (vsiRNAs) 
across the IIV-6 genome from dataset 1 (A) and dataset 2 (B). Viral siRNAs were aligned to the 
IIV-6 genome, allowing one mismatch during alignment. The genome coordinates of the 5’ end 
of vsiRNAs in w1118 WT (Left) and Argonaute-2 (AGO2)414 (Right) flies were plotted. vsiRNAs 
that mapped to the upper (R) and lower (L) strands of the IIV-6 genome are shown in red and 
blue, respectively. Small RNA libraries were generated from a pool of 15 female flies at 12 days 
post-infection. Small RNA libraries of dataset 1 and dataset 2 were prepared at different times 
from independent batches of infected flies and analyzed on different runs on a Genome Analyzer 
(Illumina). Note the profiles from dataset 1 are also presented in Figure 4A and 4B; they are 
shown here to allow direct comparison of both datasets. (C) The IIV-6 genome was divided into 
500-bp bins, and the correlation between vsiRNA densities in the two datasets was analyzed in a 
scatter plot (log-transformed data) for w1118 WT (Left; r =0.975, P <0.001, Pearson’s correlation 
test) and AGO2414 mutant flies (Right; r =0.967, P <0.001).
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Figure S4. Control PCR assay on viral DNA. Ethidium bromide-stained gels of a PCR assay on 
proteinase K-treated Invertebrate iridescent virus 6 (IIV-6) virus stock are shown to demonstrate 
amplification efficiency of the primers used for Figure 5C. H2O was included as nontemplate 
control during PCR amplification. In strand-specific RT-PCR assays, a T7-tagged IIV-6-specific 
primer was used for cDNA synthesis, and a nontagged IIV-6-specific primer in combination 
with a T7 primer was used in PCR assays. Note that this primer combination cannot be tested 
on viral DNA. We therefore verified PCR efficiency of the non-tagged IIV-6 specific primer in 
PCR reactions with the T7-tagged IIV-6-specific primer in combination with the nontagged 
IIV-6 specific primer (Table S1).
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Figure S5. Northern blot analysis for the detection of sense and antisense Invertebrate 
iridescent virus 6 (IIV-6) transcripts. Northern blots for the detection of sense and antisense 
transcripts of the indicated IIV-6 ORFs in mock- or IIV-6-infected Drosophila S2 cells. The 
position and sizes of the RNA markers are indicated. The rRNA bands on the ethidium bromide-
stained gels before blotting are shown to indicate equal loading. Hybridization of the probes to 
in vitro transcribed (IVT) sense and antisense RNA was used as a positive control to verify the 
ability of the probes to detect the indicated transcripts. Equal exposures were used for detection 
of sense and antisense transcripts of 85L and 441R. Exposure times for 206R sense and antisense 
were 1 h and 16 days, respectively. The asterisk indicates cross-hybridization to Drosophila rRNA. 
Sizes of the predicted ORFs are: 85L, 2,880-nt; 206R, 459-nt; 441R, 351-nt. Transcription 
start and stop sites for IIV-6 genes remain unknown; thus, the size of the UTRs and the actual 
expected size of the viral transcript cannot be accurately predicted.
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Figure S6. Viral transcript levels in Invertebrate iridescent virus 6 (IIV-6)-infected w1118 WT 
and Argonaute-2 (AGO2)414 flies. Five ORFs that were among the 10 ORFs with the highest 
density of viral small interfering RNAs (vsiRNA) reads were selected, and sense (s) and antisense 
(as) transcript levels were analyzed using strand-specific qRT-PCR at 12 days post-infection. 
Transcript levels were normalized to Rp49 levels and are presented as the fold induction of AGO2 
mutant over WT flies. Values represent averages and SEMs of three independent experiments.
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ORF Orientation cDNA synthesis primer (5’-3’)* (quantitative) PCR primer (5’-3’)*
85L Antisense
taatacgactcactatagggaga
tgacgtacgaaccatgacaggact gcatccaaatatcccgcaagccat
85L Sense
taatacgactcactatagggaga
gcatccaaatatcccgcaagccat tgacgtacgaaccatgacaggact
206R Antisense
taatacgactcactatagggaga
gcaagtaaagcattgggtgatgatg gcaagtaaagcattgggtgatgatg
206R Sense
taatacgactcactatagggaga
gtttccctcttgtggaatgacagg gtttccctcttgtggaatgacagg
227L Antisense
taatacgactcactatagggaga
gagcctgaaattaaaacatttgc ccaatttctaccataaaaagttttcc
227L Sense
taatacgactcactatagggaga
ccaatttctaccataaaaagttttcc gagcctgaaattaaaacatttgc
244L Antisense
taatacgactcactatagggaga
acctcccggaagatttgtagaagc accttctgttgactctatcgcacc
244L Sense
taatacgactcactatagggaga
accttctgttgactctatcgcacc acctcccggaagatttgtagaagc
249R Antisense
taatacgactcactatagggaga
ggttgtttcttctaaacaaaccaagacct ccaattagttaatccacatcctccc
249R Sense
taatacgactcactatagggaga
ccaattagttaatccacatcctccc ggttgtttcttctaaacaaaccaagacct
251L Antisense
taatacgactcactatagggaga
aaacagtcgtttccactcctgg tttcctgtttgtgttgttctatttgga
251L Sense
taatacgactcactatagggaga
tttcctgtttgtgttgttctatttgga aaacagtcgtttccactcctgg
346R Antisense
taatacgactcactatagggaga
gatgaatcgtctatgagtcctcaagctaa tttcctcttcgcctagcatcac
346R Sense
taatacgactcactatagggaga
tttcctcttcgcctagcatcac gatgaatcgtctatgagtcctcaagctaa
357R Antisense
taatacgactcactatagggaga
tttaaattgcaaagaaggaactgg aattatgttctggaccaatcc
357R Sense
taatacgactcactatagggaga
aattatgttctggaccaatcc tttaaattgcaaagaaggaactgg
441R Antisense
taatacgactcactatagggaga
caaagtttgccgatcctgtatgt tgcagtatttgctagtgctgttct
441R Sense
taatacgactcactatagggaga
tgcagtatttgctagtgctgttct caaagtttgccgatcctgtatgt
RP49† Sense ctgcatgagcaggacctcca atgaccatccgcccagcatac
L, Left, lower strand; R, right, upper strand
*T7 promoter tag sequences are underlined; (quantitative) PCR primers were used in combination 
with a T7 primer (5’-taatacgactcactataggg-3’).
†For amplification of Rp49, the cDNA synthesis primer was also used as the reverse primer in 
qPCR assays.
Table S1. Primers used for strand-specific RT-PCR assays
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ORF Orientation Forward primer (5’-3’)* Reverse primer (5’-3’)*
85L Sense
taatacgactcactatagggaga
tatcatgcactcccg agtgggcccaaaatctaaatgtatacac
85L Antisense ggtgtttaaactatcatgcactcccg
taatacgactcactatagggaga
aaaatctaaatgtatacac
206R Sense
taatacgactcactatagggaga
tacaaatacatgtgaa ggtgtttaaactatagatttatagattttttaaattataatatt
206R Antisense agtgggccctacaaatacatgtgaa
taatacgactcactatagggaga
tatagatttatagattttttaaattataatatt
441R Sense
taatacgactcactatagggaga
taaaagcacttcatag ggtgtttaaacagatcctatggaaactgg
441R Antisense agtgggccctaaaagcacttcatag
taatacgactcactatagggaga
agatcctatggaaactgg
Table S2. Primers used to generate 500-bp PCR templates for in vitro transcription of RNA
L, left; R, right
*T7 promoter sequences are underlined. PspOMI and PmeI restriction sites are in italic.
Sensor plasmid Nucleotide 
positions
Forward primer (5’-3’)* Reverse primer (5’-3’)*
pMT-GL3_HS1 91,501–92,000 agtgggccctacaaatacatgtgaa
ggtgtttaaactatagatttatagattttt
taaattataatatt
pMT-GL3_HS2 92,001–92,500
agtgggcccaatctataaatatatt
ttttaaggtttcttaacacc
ggtgtttaaacggttgaatttttaatatat
ttttagccaac
pMT-GL3_HS3 118,001–118,500 agtgggccccatttattttgttc ggtgtttaaacatttgaagggtgtgataag
pMT-GL3_HS4 171,501–172,000 agtgggcccagttgaagatcg ggtgtttaaactacaccgcttttcaacc
pMT-GL3_HS5 196,501–197,000 agtgggccctaaaagcacttcatag ggtgtttaaacagatcctatggaaactgg
pMT-GL3_HS6 36,501–37,000 agtgggcccaaaatctaaatgtatacac ggtgtttaaactatcatgcactcccg
pMT-GL3_HS7 171,001–171,500 agtgggcccgcgacagtact ggtgtttaaacgcaatatctaatttttcac
pMT-GL3_HS8 118,501–119,000 agtgggcccactattaaaagaccac
ggtgtttaaactttattcacttctacattt
aaagaag
pMT-GL3_HS9 37,501–38,000 agtgggcccggatggttattatt ggtgtttaaacataaagaaagtaaacatgagc
pMT-GL3_HS10 117,001–117,500 agtgggcccttcaaaattatttaatac ggtgtttaaacaattgtaacaattgaagg
pMT-GL3_eGFP500 192-691 agtgggccccctgacctacg ggtgtttaaactgatcccggcg
 *PspOMI and PmeI restriction sites are in italic.
Table S3. Primers used for cloning of IIV-6 sensor plasmids
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Abstract
The antiviral RNA interference (RNAi) pathway processes viral double-stranded RNA (dsRNA) into viral small interfering RNAs (vsiRNA) that guide the recognition and cleavage of complementary viral target RNAs. 
In RNA virus infections, viral replication intermediates, dsRNA genomes or 
viral structured RNAs have been implicated as Dicer-2 substrates. In a recent 
publication, we demonstrated that a double-stranded DNA virus, Invertebrate 
iridescent virus 6, is a target of the Drosophila RNAi machinery, and we proposed 
that overlapping converging transcripts base pair to form the dsRNA substrates for 
vsiRNA biogenesis. Here, we discuss the role of RNAi in antiviral defense to DNA 
viruses in Drosophila and other invertebrate model systems.
4Antiviral RNAi against invertebrate DNA viruses
109
Introduction
Viruses can infect all living organisms and are a major cause of infectious diseases. 
Survival of an infected host depends on an effective immune response that limits viral 
replication and minimizes virus-induced damage (1). A critical attribute of the innate 
immune system is its ability to recognize ongoing virus infection and to distinguish 
non-self molecular patterns from those of the host (self ). An effective mechanism to 
sense virus infection is by the specific recognition of viral nucleic acids based on non-
self signatures or on their subcellular localization. Double-stranded RNA (dsRNA) is a 
strong non-self pattern; it is present at high levels in virus-infected cells, whereas healthy 
cells normally do not produce detectable amounts of dsRNA (2).
In mammals, viral nucleic acids are sensed by innate pattern recognition receptors, 
such as Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I)-like receptors 
(RLRs) and nucleotide oligomerization domain (NOD)-like receptors (NLRs). For 
example, the transmembrane receptors TLR3 and TLR7/8 mediate the recognition of 
double-stranded (ds) RNA and single-stranded (ss) RNA in endosomal and lysosomal 
compartments, whereas endolysosomal TLR9 detects virus derived DNA (3). The RLR 
family members RIG-I and melanoma differentiation-associated gene 5 (MDA5) sense 
replicating RNA viruses in the cytoplasm based on non-self RNA signatures. MDA5 
detects dsRNA replication intermediates that are generated during the viral life cycle 
of positive strand RNA viruses (4, 5), and the protein is also believed to mediate the 
recognition of viral genomic RNA of dsRNA viruses (6). RIG-I recognizes short dsRNA 
as well as RNAs with a 5’ triphosphate moiety that is present on RNAs of specific 
virus families, but absent from highly abundant cellular RNAs, such as mRNAs and 
tRNAs (6). Activation of intracellular signaling cascades by the TLR and RLR receptor 
families leads to the induction of the transcription factors nuclear factor-kB (NF-kB) 
and interferon-regulatory factor 3 (IRF3) and/or 7 (IRF7), which induce expression 
of type I interferon (IFN) and other inflammatory cytokines that in turn establish an 
antiviral state of the cell (3).
DNA viruses are also known to induce production of type I IFNs. Viral dsDNA can be 
sensed directly by a variety of cytosolic DNA-binding proteins that activate downstream 
signaling cascades (7, 8). Interestingly, two recent reports show that the cyclic guanosine 
monophosphate-adenosine monophosphate (cGAMP) synthase enzyme binds viral 
cytoplasmic DNA and induces the production of the second messenger molecule 
cGAMP, which subsequently triggers STING (stimulator of interferon genes)-dependent 
IFN signaling (9, 10). More indirect detection of cytoplasmic DNA may occur via host 
DNA-dependent RNA polymerase III that transcribes viral cytoplasmic AT-rich dsDNA 
into 5’ triphosphate containing dsRNA, which is subsequently detected by RIG-I (11).
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Lacking the adaptive and interferon-based innate responses of vertebrates, insects rely on 
other mechanisms for antiviral defense. Over the last few years it has become increasingly 
clear that RNA interference (RNAi) is a major mechanism for the defense against RNA 
viruses (12-14). This gene-silencing pathway is primed by dsRNA, thus providing a 
strong basis for self-nonself discrimination. However, it was not clear how insects defend 
themselves from infections by DNA viruses. In a recent publication, we demonstrated 
that RNAi is also involved in the defense against dsDNA virus infection in flies (15). 
Here, we discuss our results in light of other recent observations in Drosophila and other 
invertebrate model systems.
The antiviral RNA interference pathway in insects
In plants, fungi, nematodes, and arthropods, viral dsRNA triggers an antiviral RNAi 
response (Figure 1) (12, 13). Several studies in Drosophila melanogaster and mosquitoes 
demonstrated that viral small RNAs 
are produced during infections with 
different classes of RNA viruses (14, 16, 
17). These virus-derived small interfering 
RNAs (vsiRNAs) are RNA duplexes of 
21-nt with 2-nt 3’ overhangs that are 
generated by cleavage of viral dsRNA by 
the RNase III enzyme Dicer-2 (Dcr-2). 
After incorporation of vsiRNA duplexes 
into an Argonaute-2 (AGO2) containing 
RNA-induced silencing complex (RISC), 
one of the strands (the passenger strand) 
is excluded from RISC. The guide strand 
remains associated with the mature 
RISC and mediates recognition of 
complementary viral target RNAs. Upon 
recognition of a fully complementary 
sequence, AGO2 cleaves the viral target 
RNA. Thus, the RNAi pathway may exert 
its antiviral activity at two different levels: 
by Dicer-mediated cleavage of essential 
dsRNA replication intermediates or viral 
dsRNA genomes and by AGO2-mediated 
Argonaute-2
Viruses
Dicer-2
Viral dsRNA
Viral siRNA
Viral target
 cleavage
Figure 1. Virus infection triggers an antiviral 
RNA interference response in insects. The 
endoribonuclease Dicer-2 processes viral double-
stranded (dsRNA) substrates into viral small 
interfering RNAs (siRNA) of 21-nt in size. The 
guide strand that remains incorporated in RISC 
directs Argonaute-2 onto fully complementary 
RNA sequences to mediate viral target cleavage.
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cleavage (slicing) of viral genomes and transcripts (Figure 1).
Fly mutants with defects in the core RNAi genes Dcr-2 and AGO2 are highly susceptible 
to RNA virus infection (18-22). The inability of these RNAi-deficient flies to control 
RNA virus replication is also evident from higher viral RNA copy numbers and higher 
viral titers in RNAi mutants. The hypersensitivity to virus infection of R2D2 and AGO2 
mutants (19, 20, 22), which have defects in RISC loading and RISC activity but are 
fully competent in Dcr-2 activity, implies that slicing of viral target RNAs contributes 
to the antiviral potential of the RNAi machinery. This notion is further supported by 
the observation that 2 unrelated RNA viruses encode RNAi antagonists that inhibit the 
catalytic activity of the RISC complex (23, 24).
The antiviral RNAi pathway controls DNA virus infection in 
Drosophila
We used Invertebrate iridescent virus 6 (IIV-6), a member of the Iridoviridae family, 
as a model to study antiviral immunity against DNA viruses in Drosophila (15). 
Although IIV-6 is not a natural pathogen of Drosophila, it is known to experimentally 
infect a broad range of Dipteran species including Drosophila (25-27). IIV-6 replicated 
efficiently in wildtype flies, with a rapid increase in viral titers over the first 6 days 
after inoculation and stable titers thereafter. Despite the stable high titers, infected flies 
survived for prolonged periods of time (> 30 days), suggesting that IIV-6 establishes a 
productive non-lethal infection. To monitor whether the RNAi pathway controls DNA 
virus infection in vivo, we next analyzed survival of Dcr-2 and AGO2 mutants upon IIV-
6 infection. IIV-6 infection dramatically decreased survival of Dcr-2 null mutant flies 
compared with wildtype controls and mock-infected flies. Similarly, flies that do not 
encode a functional AGO2 protein were also more susceptible to IIV-6 infection. Dcr-2 
mutants seem to be more severely affected than AGO2 mutants. However, the reduced 
stress-resistance and shorter life span of non-infected Dcr-2 mutants (28) complicates 
the interpretation of this apparent difference. Our results were further supported by a 
recent study of Kemp et al. who show that Dcr-2, R2D2 and AGO2 null mutants die 
more rapidly upon IIV-6 challenge than wildtype controls (29). Moreover, Kemp et 
al. observed that the increased lethality in RNAi mutant flies correlates well with an 
increase in viral load at 10 days post-infection (29). We, however, only observed mild 
differences in viral titers in AGO2 and Dcr-2 mutant flies early in infection, whereas 
viral load was not affected at a later time point (12 days post-infection). The reason for 
this difference between the two studies remains unclear.
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Dcr-2-dependent vsiRNA are produced from overlapping 
transcripts
Having determined that the RNAi pathway controls DNA virus infection in vivo, 
we next analyzed whether vsiRNAs are produced during IIV-6 infection. Using small 
RNA cloning and next-generation sequencing technology, we readily detected viral 
small RNAs in wildtype and AGO2 mutant flies, the majority of which were 21-nt in 
size. A strong decrease in normalized levels of 21-nt viral small RNAs in Dcr-2 mutant 
flies indicates that these RNAs are indeed Dcr-2-dependent vsiRNAs. Using a similar 
approach, Kemp and colleagues also demonstrated Dcr-2-dependent vsiRNA biogenesis 
in IIV-6 infection (29).
Viral dsRNA replication intermediates or structured elements in single-stranded viral 
RNAs are potential targets for Dcr-2-dependent vsiRNA production. Several studies 
reported similar ratios of positive strand (+) over negative strand (-) vsiRNAs in 
invertebrate hosts infected with dsRNA viruses or positive strand RNA viruses (30, 
31). In addition, (+) and (-) vsiRNAs are present in approximately equal ratios in flies 
infected with the (-) RNA virus vesicular stomatitis virus (VSV) (22, 32). Moreover, 
viral siRNAs from these different classes of RNA viruses generally cover the entire viral 
genome. This is further exemplified by the finding that vsiRNAs can be used to deduce 
up to full-length genomes of known and novel (+) RNA and dsRNA viruses (24, 30, 
33). Together, these results imply that viral replication intermediates or viral dsRNA 
genomes serve as the Dcr-2 substrates for vsiRNA biogenesis in RNA virus infection 
(13, 31).
Nevertheless, for several RNA viruses structured RNA elements seem to be preferentially 
processed by Dcr-2, indicating that vsiRNA biogenesis may be more complex. For 
example, in small RNA profiles of 2 (+) RNA viruses, Drosophila C virus (DCV) and 
Flock House virus (FHV), there is an over-representation of (+) strand vsiRNAs (32, 
33). This bias reflects the higher abundance of viral genomic (+) RNA strands over 
antigenomic (-) RNA strands that is generally observed in (+) RNA virus infection. 
It was thus suggested that structured elements in viral genomic RNA become the 
predominant target for Dcr-2 when dsRNA replication intermediates are shielded from 
Dcr-2 cleavage by a viral RNAi suppressor (32, 34). This hypothesis was supported by 
the observation that vsiRNA reads are heavily biased toward the (+) strand in wildtype 
FHV infections, whereas similar numbers of (+) and (-) vsiRNAs were derived from 
infections with RNAi suppressor-deficient virus (34, 35). DCV encodes an RNAi 
antagonist that binds dsRNA (20) and may similarly skew vsiRNAs towards (+) viral 
strands (32).
DNA viruses do not replicate via a dsRNA replication intermediate and other dsRNA 
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sources must therefore be processed by Dcr-2 for vsiRNA biogenesis. In mammalian 
cells, dsRNA can be detected upon dsDNA virus infection, (2) which is probably 
generated by base pairing of convergent overlapping transcripts of both strands of the 
viral genome or derives from secondary structures in viral transcripts (36).
To identify the dsRNA substrate for vsiRNA biogenesis during IIV-6 replication, we 
analyzed the distribution of vsiRNAs across the IIV-6 genome. Viral open reading 
frames (ORFs) in IIV-6 are oriented in both directions in the viral genome. Nevertheless, 
irrespective of the orientation of the viral ORFs, vsiRNAs mapped in similar proportions 
to the upper and lower strand of the viral genome (Figure 2A). These data suggest that 
vsiRNAs are derived from overlapping sense and antisense transcripts. Indeed, sense and 
antisense transcripts that cover highly targeted ORFs (i.e. ORFs with high density of 
vsiRNA reads) could readily be detected by strand-specific RT-PCR assays and Northern 
blot analyses. These bidirectional transcripts have the potential to base pair and form 
long dsRNA molecules that trigger the antiviral RNAi machinery via Dcr-2-dependent 
vsiRNA biogenesis (Figure 3A).
Uneven distribution of vsiRNAs across the IIV-6 genome
IIV-6 derived vsiRNAs display a highly uneven distribution along the viral genome, 
with some regions in the genome producing high numbers of vsiRNAs (hotspots) and 
other regions only producing few vsiRNAs. The uneven coverage of vsiRNAs across 
the genome was very similar between wildtype and AGO2 mutant flies and between 2 
independent datasets from our study. Strikingly, the distribution of vsiRNAs along the 
viral genome in our study is highly similar to that of Kemp et al. (Figure 2A and B). To 
further substantiate this observation, we divided the IIV-6 genome in non-overlapping 
500-bp bins and counted the number of vsiRNAs mapping to individual bins in both 
datasets. Indeed, we observed a strong correlation between vsiRNA mapping between 
the two studies (Figure 2C, r = 0.894, P < 0.001). Nevertheless, when zooming in on 
highly targeted regions, it becomes apparent that vsiRNA profiles are not fully identical 
in the 2 studies, with some highly targeted sequences from one study being markedly 
less abundant in the other study (Figure 2B). It has been reported that vsiRNA cloning 
procedures may induce cloning biases. Such biases are introduced during the ligation 
steps that are used to link the small RNAs to 3’ end 5’ adaptor sequences, with small 
RNA sequences that more stably anneal to the adapters producing higher read numbers 
(37). As the 2 studies used different adaptor sequences, slight differences in vsiRNA 
profiles, such as observed in Figure 2B, may be due to cloning/sequencing biases.
How do the major vsiRNA hotspot regions in the viral genome arise? Since the 2 
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independent studies used different sequencing platforms and adaptor sequences but 
display highly similar profiles, we deem it unlikely that cloning biases explain the observed 
IIV-6 vsiRNA hotspots. Another putative source for biases could be differential stability 
of RISC-loaded small RNAs, as siRNAs that possess a cytidine at their 5’ termini seem 
to be preferentially loaded into AGO2 (38, 39). IIV-6 derived siRNA profiles are highly 
similar between wildtype and AGO2 mutant flies that lack a functional RISC (15). Thus 
the observed uneven distribution of vsiRNA profiles cannot be explained by differences 
in stability within RISC.
Viral siRNA hotspots often map to regions in the genome that correspond to predicted 
ORFs (Figure 2B). It is likely that vsiRNA hotspots derive from regions in the genome 
in which there is high bidirectional transcriptional activity. We thus propose a model 
in which highly abundant transcripts base pair with low-level antisense transcripts to 
generate dsRNA substrates for Dcr-2. Alternatively, there may be particularly high level 
of antisense transcription in hotspot regions. At this point, the transcriptional landscape 
of IIV-6 remains poorly defined; thus, the temporal regulation of transcription, 
transcription start and stop sites, as well as the extent of antisense transcription 
throughout the viral genome remains unclear. Future studies using strand-specific 
next generation cDNA sequencing (RNA-seq) may provide a high-resolution map of 
transcriptional activity across the IIV-6 genome. Once these data become available, our 
model can be more robustly tested.
DNA virus-derived vsiRNA profiles in other model systems
A number of recent publications have now analyzed vsiRNA profiles in DNA virus 
infections in different invertebrate model systems. These studies further underscore that 
DNA viruses are targets of an antiviral RNAi response, but that the mechanism for 
vsiRNA biogenesis may differ from that in IIV-6-infected flies. In a recent study, Dcr-
2-dependent vsiRNAs were recovered from a Drosophila cell line infected with Vaccinia 
virus (VACV), a dsDNA virus of the poxvirus family (32). Abundant vsiRNAs were 
particularly recovered from tandem repeats located at the covalently closed genomic 
termini. Computational predictions indicated that transcripts of these repetitive 
sequences have the ability to fold into hairpin RNA structures (Figure 3B). Indeed, 
knockdown experiments indicated that these RNA structures are targets of Dcr-2, and 
to a lesser extent of the microRNA processing enzyme Dcr-1. Base paired bidirectional 
transcripts or structured regions of single-stranded transcripts were proposed to be Dcr-
2 substrates in other regions of the VACV genome, but these hypotheses remain to be 
experimentally tested. Moreover, Drosophila cells do not support a full VACV replication 
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cycle, and the full extent of vsiRNA production in poxvirus infection remains to be 
established.
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Figure 2. Viral small RNA profiles from 2 independent studies of IIV-6-infected Drosophila. 
(A) Viral siRNAs (21-nt) were aligned to the IIV-6 genome, allowing one mismatch during 
alignment. The genome coordinates of the 5’ end of vsiRNAs in the study of Bronkhorst et al. 
(upper panel; w1118 control flies) and of Kemp et al. (lower panel; y1w1 control flies) were plotted. 
vsiRNAs that map to the upper and lower strands of the IIV-6 genome are shown in gray and 
black, respectively. Data from Bronkhorst et al. are the sum of 2 independent data sets of IIV-6-
infected w1118 flies. (B) Detailed profile of IIV-6 derived vsiRNAs (21-nt) mapping to genome 
coordinates 91,400 to 92,000 is shown for the 2 independent studies. ORF 206R, which is 
located in this region, is depicted above the plot (drawn to scale). (C) The IIV-6 genome was 
divided into non-overlapping 500-bp bins, and the correlation between vsiRNAs densities in the 
studies of Bronkhorst et al. and Kemp et al. was analyzed in a scatter plot (log-transformed data; 
r = 0.894, P < 0.001, Pearson’s correlation test).
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Structured RNA elements were also implied as Dcr-2 substrates in Culex tritaeniorhynchus 
densovirus, a novel, single-stranded DNA virus of the densovirus genus virus that was 
recently identified in wild-caught mosquitoes (40). Two inverted repeat sequences at 
the non-coding genomic termini, which were previously not known to be transcribed, 
gave rise to abundant viral small RNAs. This observation suggests that these termini are 
transcribed and fold into dsRNA structures that are processed into small RNAs. Indeed, 
in silico predictions suggest that putative transcripts of these regions have the potential to 
fold into Y-shaped RNA structures with extensive perfectly base paired stems of 35- and 
68-bp for the 5’ terminal inverted repeat 1 (IR1, Figure 3C) and the 3’ terminal inverted 
repeat 2 (IR2, not shown), respectively. To explore whether these structures are putative 
Dicer substrates, we analyzed the published small RNA sequences to determine the size 
profiles of the viral small RNAs. 74.3% and 79.8% of the small RNAs that map to IR1 
and IR2, respectively, were 21 or 22-nt in size. Moreover, these small RNAs mapped to 
the stem, but not to the two arms of the predicted Y-shaped RNA structures (data not 
shown). These results suggest that IR-derived small RNAs are bona fide Dicer products, 
but this remains to be experimentally demonstrated. Densoviral terminal stem-loop 
structures likely play a role in genome replication and/or packaging (41). It remains to 
be investigated how transcription of the inverted repeats and Dicer-mediated processing 
of the resulting transcripts affect these processes. Another source of viral small RNAs 
in this study were the protein coding transcripts of the viral genome (40). These small 
RNAs predominantly derive from the sense transcripts of the viral genome and have a 
broad distribution of sizes, ranging from 18 to 30-nt, with only a minor enrichment at 
21 or 22-nt (32.3%, data not shown). The majority of these small RNAs are therefore 
unlikely to be generated in a Dicer-dependent manner.
Like our observations in IIV-6-infected flies, convergent transcripts also seem to the 
source of vsiRNAs in other insect species infected with complex dsDNA viruses. In a 
recent study, the antiviral RNAi response to the baculovirus Helicoverpa armigera single 
nucleopolyhedrovirus (HaSNPV) was analyzed in larvae of the cotton bollworm moth 
(Helicoverpa armigera) (42). Similar to vsiRNAs in IIV-6-infected flies, small RNAs 
displayed an uneven distribution across the viral genome, with some hotspot regions 
generating abundant amounts of small RNAs, and other regions generating few small 
RNAs. Moreover, in most hotspots, vsiRNAs map to both strands of the viral genome, 
consistent with base paired overlapping transcripts as a Dicer substrate. For a number 
of highly targeted ORFs, small RNAs were enriched for those derived from only one 
strand of the viral genome. The substrates for the biogenesis of these small RNAs remain 
unclear. When Dcr-2 was depleted in Helicoverpa zea derived fat body cells, higher 
expression levels were detected for 2 highly targeted ORFS, but not for 2 ORFs that 
did not give rise to vsiRNAs. Moreover, a modest increase in viral DNA replication was 
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observed upon Dcr-2 knockdown. It was thus proposed that RNAi-mediated silencing 
of essential viral genes restricts virus replication (42).
The antiviral potential of RNAi to control DNA virus infection was recently also 
confirmed in another invertebrate system. Knockdown of Dcr-2 expression in white 
spot syndrome virus (WSSV)-infected shrimp resulted in an increase in virus replication, 
suggesting that this circular dsDNA virus is a target of the invertebrate RNAi machinery 
(43). Unfortunately, the authors only monitored the production of a single viral siRNA 
by Northern blot. This particular siRNA was indeed produced in a Dcr-2-dependent 
manner. Future studies using small RNA deep sequencing may provide more detailed 
insights into the Dcr-2 substrates in this virus and into the mechanism of vsiRNA 
biogenesis.
Seminal studies have established that RNA viruses are processed into vsiRNAs in 
plants (12, 44). Interestingly, DNA viruses are also targets of the RNAi machinery in 
plants. Like DNA viruses in insects, vsiRNA may arise from processing of structured 
RNA elements (45) or from dsRNA generated by base pairing of sense and antisense 
ORF ORF 1
ORF 2
Antisense transcription /
 overlapping transcripts
A
A
U
A
U
U
U
U
U
G
U
G
A
G
A
C
C
A
U
C
G
A
A
G
A
G
A
G
A
A
A
G
A
G A
U
A
A
A
A
C
U
U
U
U
U
U
A
C
G
A
C
U
C
C
A
U
C
A
G
A
A
A
G
A
G
G
U
U
G
U
A
U
U
A
U
U
C
G
U
G
A
U
A
C
G
G
A
U
A
C
U
G
U
A
A
G
A
U
A
C
A
G
A
U
G
U
A
A U
A
C
A
U
C G
U
U
U
C
U
A
A
U
A
G
A
A
A
C
U
G
U
A
U
C
U
U
A
C
A
G
U
A
U
C
C
G
U
A
U
C
A
C
G
G
A
A
U
A
A
U
A
C
U
U
CBA
Figure 3. Proposed substrates for vsiRNA biogenesis in DNA virus infection of insects. 
(A) Converging overlapping transcripts base pair to generate dsRNA substrates for Dicer-2 in 
iridovirus, Vaccinia virus, and baculovirus infection. (B) Transcripts of repeats at the genomic 
termini of vaccinia virus are predicted to fold into hairpin RNA structures that give rise to Dicer-
dependent small RNAs (in gray). (C) Putative transcripts of the 5’ terminal inverted repeat 
sequence (IR1) of Culex tritaeniorhynchus densovirus are predicted to fold into a Y-shaped RNA 
structure. Small RNAs of 21-22 nt in size map to the stem, but not the arms, of the structure 
(in gray). It is not possible to unambiguously map the small RNAs to either the 5’ or 3’ stem 
sequence, since the stem is a perfectly base paired sequence and the orientation in which the 
region is transcribed is unknown. Transcripts of the 3’ terminal inverted repeat sequence (IR2) 
are predicted to fold in a similarly Y-shaped shaped structure with a longer, 68-bp stem. IR2-
derived 21-22 nt small RNAs map along the dsRNA stem, without evidence for phasing.
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transcripts (46, 47). Indeed, vsiRNAs of both sense and antisense polarity are generated 
upon infection with Gemini viruses (ssDNA virus) and the pararetrovirus Cauliflower 
mosaic virus (circular dsDNA virus) (46-49).
Concluding remarks
Together, these studies demonstrate that an antiviral RNAi response is mounted against 
distinct DNA viruses in different invertebrate hosts. Our study implies that base paired, 
overlapping sense and antisense transcripts are the major Dcr-2 substrates in IIV-6 
infection; in other viruses (VACV and densovirus) structured RNA elements may be 
additional substrates for Dcr-2. Important questions remain. For example, are vsiRNAs 
incorporated in RISC and functional in directing target RNA cleavage? Using sensor 
assays, we demonstrated that some IIV-6-derived vsiRNAs are indeed functional, but 
that the efficiency of silencing is modest. Moreover, for 5 selected ORFs that contained 
a high density of vsiRNA reads, we did not observe a general increase in viral transcript 
levels in AGO2 mutant flies. Further genome-wide transcriptome analyses are required 
to establish if and to what extent RNAi regulates IIV-6 viral gene expression. Strikingly, 
in HaSNPV infection an increase in transcript levels upon Dcr-2 knockdown was 
observed, suggesting that vsiRNAs are RISC-associated and functional in silencing viral 
gene expression (42).
Other questions pertain to the function of vsiRNAs in DNA virus infection. Is dsRNA 
produced as an inevitable by-product of a densely packed genome that is transcribed 
in 2 directions? Does the RNAi machinery exploit this feature for antiviral defense? 
Alternatively, the virus may exploit the antiviral RNAi machinery to regulate expression 
of viral genes. RNAi-mediated regulation of expression of essential viral genes may 
contribute to the fine-tuning of viral replication and pathogenesis. In this respect, it 
would be of interest to see whether antisense transcription (and thus the potential 
for dsRNA formation) is dynamically regulated. For some ORFs of HaSNPV, sense 
transcripts seem to be the major origin of small RNAs (42). These small RNAs by 
definition cannot target coding transcripts as they have the same orientation. Perhaps 
these highly abundant transcripts are decoy Dcr-2 substrates that saturate the RNAi 
machinery, thereby preventing other essential viral genes from being targeted. Dedicated 
non-coding transcripts may have a similar function in large complex DNA viruses. 
Finally, as was reported for the plant DNA virus cauliflower mosaic virus, (45) viral 
small RNAs may regulate the expression of cellular genes, in functional analogy to virus-
encoded miRNAs (50). A striking similarity between VACV and Culex tritaeniorhynchus 
densovirus is that both viruses produce small RNAs from putative RNA structures 
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encoded by non-coding genomic termini. How these small RNAs affect the viral life 
cycle is an open question for future investigation.
In several organisms, small RNAs mediate gene silencing at the transcriptional level. For 
example, small RNAs guide RNA-mediated DNA methylation in plants (Arabidopsis 
thaliana) or induce heterochromatin formation by guiding the deposition of repressive 
marks on histone proteins in yeast (S. pombe) and in D. melanogaster (51, 52). During 
nuclear replication of geminiviruses in plants, viral dsDNA intermediates associate with 
cellular histone proteins, thus forming viral minichromosomes. Interestingly, it was 
proposed that viral small RNAs guide de novo cytosine methylation of the geminivirus 
genome as an antiviral defense strategy (53). DNA viruses in mammals also form 
chromatin-like structures that are subject to epigenetic regulation (54, 55). Whether 
vsiRNAs guide transcriptional silencing of DNA viruses in insects remains an open 
question.
A final important question is whether there are alternative mechanisms for antiviral 
defense against DNA viruses. Several cytoplasmic DNA sensors have been identified in 
mammals over the last few years. While insects lack the interferon response of mammals 
that are induced by these sensors, direct cytoplasmic DNA sensing could also play a role 
in activating immune or stress responses in insects. Altogether, recent studies reveal that 
DNA viruses produce bona fide Dcr-2 substrates that elicit antiviral RNAi responses 
in invertebrates; nevertheless, the identification of several atypical Dcr-2 substrates 
suggests that the interaction between DNA viruses and the host RNAi machinery may 
be highly complex.
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Abstract
Invertebrate RNA viruses are targets of the host RNA interference (RNAi) pathway, which limits virus infection by degrading viral RNA substrates. Several insect RNA viruses encode suppressor proteins to counteract this 
antiviral response. We recently demonstrated that the dsDNA virus Invertebrate 
iridescent virus 6 (IIV-6) induces an RNAi response in Drosophila. Here, we show 
that RNAi is suppressed in IIV-6-infected cells and we mapped RNAi suppressor 
activity to the viral protein 340R. Using biochemical assays, we reveal that 340R 
binds long dsRNA and prevents Dicer-2-mediated processing of long dsRNA into 
small interfering RNAs (siRNAs). We demonstrate that 340R additionally binds 
siRNAs and inhibits siRNA loading into the RNA-induced silencing complex. 
Finally, we show that 340R is able to rescue a Flock House virus replicon that lacks 
its viral suppressor of RNAi. Together, our findings indicate that, in analogy to 
RNA viruses, DNA viruses antagonize the antiviral RNAi response.
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Introduction
Recognition of double-stranded (ds) RNA is critical for many cellular processes, including 
gene regulation, RNA transport, and RNA editing. Most dsRNA-protein interactions 
are established by proteins that contain a canonical dsRNA-binding domain (dsRBD), 
which binds dsRNA in a sequence-independent manner (1,2). RNA interference 
(RNAi) is a dsRNA-initiated mechanism for post-transcriptional gene silencing that is 
guided by small interfering RNAs (siRNAs) and requires dsRBD-containing proteins at 
several stages (3,4).
The RNAi pathway serves as a cellular defense mechanism that destroys viral RNA 
in diverse eukaryotes, including plants, fungi, nematodes, insects, and mammals 
(5-8). In Drosophila, cytoplasmic Dicer-2 (Dcr-2), which contains two RNase III 
motifs and a single dsRBD, recognizes viral dsRNA as non-self and processes it into 
viral small interfering RNAs (vsiRNAs), RNA duplexes of 21-nt that contain 2-nt 3’ 
overhangs (5,9). A heterodimer composed of the dsRBD adaptor protein R2D2 and 
Dcr-2 subsequently binds vsiRNA duplexes to mediate their loading into Argonaute-2 
(AGO2) in the RNA-induced silencing complex (RISC). Within RISC, vsiRNAs guide 
the recognition and cleavage of fully complementary viral target RNA by AGO2 (9,10).
Several insect RNA viruses have evolved viral suppressors of RNAi (VSRs) to antagonize 
the initiation phase of the antiviral RNAi pathway (9). For example, the 1A protein of 
Drosophila C virus (DCV) contains a canonical dsRBD that binds long dsRNA and 
prevents Dcr-2-mediated vsiRNA biogenesis (11). The B2 protein of Flock House virus 
(FHV) and the VP3 proteins of Drosophila X virus and the mosquito-specific Culex 
Y virus interfere with the insect RNAi pathway by sequestering long dsRNA as well as 
siRNAs (12-16). These VSRs may thus inhibit the production of vsiRNAs and prevent 
their incorporation into RISC.
In RNA virus-infected plants, viral dsRNA is processed by the Dicer-like (DCL) proteins 
DCL2, DCL3, and DCL4, which generate viral small RNAs of 22, 24, and 21-nt in 
size, respectively (5). The P19 protein of tombusviruses is one of the best-characterized 
VSRs in plants. P19 specifically binds 21-nt sized siRNAs (17-20) and thereby prevents 
siRNA incorporation into RISC (21). A similar strategy is used by several other plant 
RNA viruses (22,23). Sweet potato chlorotic stunt virus prevents siRNA loading into 
RISC via an alternative mechanism. This single-stranded RNA virus encodes a viral 
RNase III protein that processes siRNAs into 14-bp small RNA duplexes, which are 
non-functional in RNAi (24). Likewise, the RNase III of the dsDNA virus Heliothis 
virescens ascovirus-3e cleaves long dsRNA in the tobacco budworm (Heliothis virescens) 
(25). Thus, the RNase III proteins of two unrelated viruses interfere with RNAi, either by 
inhibiting vsiRNA production through destruction of Dcr-2 substrates or by preventing 
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the incorporation of functional vsiRNAs into RISC.
Importantly, some insect and plant RNA viruses inhibit the RNAi pathway at the effector 
phase (9,23). For example, the Cricket paralysis virus (CrPV) 1A and Nora virus VP1 
proteins antagonize the enzymatic activity of AGO2 in Drosophila (26,27). Similarly, 
the Cucumber mosaic virus 2b protein inhibits the endonuclease activity of AGO1 
in plants (28). Plant AGO1 function is also suppressed by the P0 and P38 proteins of 
Beet western yellows virus and Turnip crinkle virus, respectively (29-32). These studies 
indicate that unrelated viruses have evolved VSRs that inhibit the catalytic activity of 
RISC and thus highlight the critical role of Argonaute proteins in antiviral defense.
Over the last years, several studies revealed that different classes of RNA viruses are 
both targets and suppressors of RNAi in Drosophila (11,13,33,34). Recently, we and 
others showed that RNAi also provides antiviral defense against DNA viruses in vivo 
(35,36). Indeed, Dcr-2-dependent vsiRNAs were generated in Invertebrate iridescent 
virus 6 (IIV-6)-infected flies and, accordingly, AGO2 and Dcr-2 mutant flies were more 
susceptible to IIV-6 infection than wildtype flies. However, it remained unknown 
whether DNA viruses antagonize the Drosophila antiviral RNAi response.
In the present study, we investigated whether IIV-6 suppresses RNAi. We demonstrate 
that the IIV-6 340R protein inhibits RNA silencing when RNAi is induced by long 
dsRNA as well as by siRNA duplexes. In a series of biochemical assays, we further 
demonstrate that 340R binds RNA duplexes to prevent siRNA biogenesis and to inhibit 
RISC loading. Our findings indicate that DNA viruses are targets and suppressors of the 
antiviral RNAi response.
Results
RNAi is suppressed in IIV-6-infected cells
We and others recently reported that the dsDNA virus IIV-6 triggers an antiviral RNAi 
response in Drosophila (35,36). To investigate whether IIV-6 antagonizes the host RNAi 
response, we performed RNAi reporter assays in Drosophila S2 cells. In these well-
established assays, RNAi-mediated silencing of a Fluc reporter gene is induced by Fluc-
specific long dsRNA or siRNAs (11,38).
We first tested whether RNAi is suppressed in IIV-6-infected S2 cells. As a positive 
control, we included the positive-sense RNA virus DCV, which encodes a VSR and 
inhibits RNAi in infection (11). Co-transfection of reporter plasmids along with Fluc-
specific long dsRNA resulted in efficient silencing of the Fluc reporter in mock-infected 
cells (240-fold, Figure 1A). In contrast, in IIV-6-infected cells, silencing of the Fluc 
reporter was suppressed in an MOI (multiplicity of infection)-dependent manner, to 
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118-fold at an MOI of 0.01 and to 28-fold at an MOI of 0.1 (Figure 1A; P = 0.061 
and P = 0.004, respectively). As observed before (11), DCV also suppressed RNAi in 
an MOI-dependent manner (Figure 1A). Together, these results indicate that the RNAi 
pathway is suppressed in IIV-6-infected cells.
The IIV-6 340R protein is a suppressor of RNAi
IIV-6 is a large, complex virus with a 212-kb genome that contains 211 predicted open 
reading frames (ORFs) (45,46). We therefore browsed the IIV-6 genome for ORFs that 
encode proteins with predicted domains or motifs that might account for the observed 
RNAi suppressor activity. A candidate is ORF 142R, which encodes a putative RNase 
III that might degrade siRNAs or long dsRNA substrates for Dcr-2, as was observed 
for RNase III proteins of other viruses (24,25). Another candidate VSR is 340R, which 
contains a predicted canonical dsRBD. Such domains have also been observed in other 
VSRs (11,47). The 142R and 340R proteins are conserved in different genera within 
the Iridoviridae family (46,48), suggesting that these proteins have important functions 
in the viral life cycle.
To analyze whether 142R and 340R inhibit the RNAi pathway, we cloned the individual 
ORFs into expression plasmids for RNAi reporter assays. S2 cells were transfected with 
the expression plasmids along with the reporter plasmids. Two days after transfection, 
dsRNA was added to the culture supernatant to induce RNAi, thus allowing expression 
of viral proteins before induction of RNAi. The CrPV 1A protein, which suppresses the 
RNAi pathway by antagonizing RISC enzymatic activity, served as a positive control 
(26). The dsRBD protein 340R suppressed RNAi to background levels (compared with 
12-fold silencing for the empty control vector, P ≤ 0.001), similar to CrPV 1A (Figure 
1B, P ≤ 0.001). In contrast, we did not observe VSR activity for the predicted RNase III 
142R (Figure 1B). Although we readily detected protein expression of 142R and 340R 
in transfected S2 cells by Western blot analysis (Figure 1C), 142R was expressed at lower 
levels than 340R. Increasing the amount of transfected 142R expression plasmid led to 
a mild increase in protein levels. However, also under these conditions, we could not 
detect VSR activity for 142R (Figure S1A). To confirm these results, we performed an 
RNAi reporter assay in which a Renilla luciferase (Rluc) reporter is silenced by an Rluc-
specific hairpin RNA expressed from a copper-inducible promoter. Also in this assay, 
340R efficiently suppressed RNAi (Figure 1D, P = 0.003), whereas 142R was unable 
to do so.
To investigate whether 340R inhibits the RNAi pathway downstream of siRNA 
production, we performed an assay in which we induced RNAi with siRNAs instead of 
long dsRNA. We found that 340R efficiently inhibited siRNA-induced RNAi (Figure 
1E; 7.7-fold silencing compared with 27-fold for the empty control plasmid, P ≤ 
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0.001), indicating that this VSR is capable of suppressing the RNAi pathway at a stage 
downstream of Dcr-2-dependent siRNA production.
Figure 1. IIV-6 encodes a suppressor of RNAi. (A) dsRNA-induced RNAi reporter assay in 
virus-infected Drosophila S2 cells. S2 cells were mock-infected (-) or infected with either IIV-6 or 
DCV at the indicated MOI. Fluc and Renilla luciferase (Rluc) reporter plasmids were transfected 
along with dsRNA targeting Fluc (dsFluc) or a non-specific control sequence (dsCtrl) and 3 
days after transfection, luciferase activities were measured. (B) RNAi reporter assay in S2R+ cells 
expressing individual viral proteins. Cells were transfected with luciferase reporter plasmids along 
with control plasmid (empty) or expression plasmids encoding the indicated viral proteins. CrPV 
1A was included as a positive control. Two days post-transfection, RNAi was induced by adding 
long dsRNA to the culture supernatant. (C) Western blot analysis of V5 epitope-tagged 340R 
and 142R in transfected S2 cells. Viral proteins were detected using anti-V5 antibodies (α-V5); 
polyclonal anti-α-tubulin (α-Tub) antibody was used as a loading control. Molecular mass (in 
kDa) is indicated on the left of the image. The predicted molecular weights for 340R and 142R 
are 23 kDa and 37 kDa, respectively. The asterisk (*) indicates a 340R-specific processing or 
degradation product. (D) Renilla hairpin-induced RNAi reporter assay. S2 cells were transfected 
with luciferase reporter plasmids, expression plasmids for the indicated viral proteins, and either 
a plasmid that encodes a Renilla hairpin RNA (hairpin-Renilla) or an empty plasmid control 
(Ctrl). (E) siRNA-induced RNAi reporter assay in S2 cells. Cells were transfected with plasmids 
encoding the indicated viral proteins followed by transfection of luciferase reporter plasmids 
along with siRNAs that target the Fluc reporter (siFluc) or non-silencing control siRNAs (siCtrl). 
For all reporter assays in which Fluc expression was silenced, Fluc counts were normalized to 
Rluc counts and expressed as fold silencing relative to control treatment, and vice versa when 
Rluc expression was silenced. Fold silencing in the non-silencing controls (dsCtrl or siCtrl) was 
set to one for all panels. Bars in all panels represent the means and standard deviations of three 
independent samples. Difference in RNAi efficiency compared to controls (dark gray bars) was 
analyzed by one-way ANOVA followed by a post-hoc Dunnett’s test. *P ≤ 0.05; **P ≤ 0.01; ***P 
≤ 0.001; ns, not significant.
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The dsRBD of 340R is required for RNAi suppression 
The IIV-6 340R gene encodes a 23-kDa protein that contains a 70-aa dsRBD flanked 
by a 30-aa N-terminal sequence and a 73-aa C-terminal sequence. Alignment of the 
the dsRBD of 340R to the dsRBDs of DCV 1A and cellular proteins from different 
model organisms shows that conserved amino acids are present throughout the motif 
(Figure 2A). Homology modeling suggests that the dsRBD of 340R adopts the expected 
abbba topology, in which two a helices are packed along a three-stranded antiparallel b 
sheet, and that the dsRBD is preceded by an N-terminal helical structure (Figure 2B). 
Based on these analyses, we selected for site-directed mutagenesis four highly conserved 
residues (L35Y, F63A and AA92LL) and two residues within a region expected to 
interact with dsRNA (K86A and K89A) (Figure 2A and 2B and S2). In addition, we 
generated a C-terminally truncated version of 340R, consisting of the N-terminal 100-
aa that contains the complete dsRBD (dsRBD100).
Western blot analysis verified that all mutant proteins were expressed in transfected 
S2 cells, albeit at different levels relative to the wildtype (WT) protein (Figure 2C). 
We subsequently analyzed VSR activity of WT and mutant 340R in reporter assays in 
which RNAi was induced by feeding of long dsRNA. In these assays, WT 340R almost 
completely blocked RNAi (Figure 2D; 1.4-fold silencing compared with 11-fold for the 
empty control vector, P ≤ 0.001). All tested mutants lost VSR activity relative to WT 
340R (Figure 2D). Mutation of residues predicted to be involved in dsRNA binding 
reduced silencing to 3.6-fold (K86A, P ≤ 0.001) and 8.2-fold (K89A, P = 0.074) (Figure 
2D). Loss of VSR activity of the conserved residue mutants AA92LL and L35Y might 
result from reduced expression levels (Figure 2C), perhaps due to destabilizing effects of 
the substitutions on the local protein structure (Figure S2). 
To increase VSR protein levels in our RNAi reporter assays, we increased the amount of 
transfected L35Y and AA92LL expression plasmids (Figure S2B and S2C, respectively). 
L35Y expression was increased to WT 340R levels under several conditions, but this did 
not result in detectable VSR activity (Figure S2B). For the AA92LL mutant, we only 
observed a slight increase in protein levels, which was not sufficient for suppression of 
RNAi (Figure S2C). Similar to the 340R point mutants, dsRBD100 did not suppress 
RNAi (Figure 2D). Since this construct was expressed at lower levels than WT 340R, 
we repeated the assay with increasing amounts of plasmid. However, although dsRBD100 
reached similar protein levels as WT 340R under these conditions, dsRBD100 did not 
inhibit silencing of the reporter, indicating that the dsRBD by itself is insufficient to 
exert VSR activity (Figure S1D).
We next performed an RNAi reporter assay in which RNAi is induced by siRNA 
transfection and included dsRBD100 as well as the K89A mutant (Figure 2E). As observed 
before (Figure 1E), WT 340R, as well as the positive control CrPV 1A, efficiently 
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Figure 2. Viral protein 340R requires a functional dsRBD to suppress RNAi. (A) Alignment 
of the dsRBD of 340R (aa 30-100) to the dsRBDs of proteins from different model organisms 
and to the dsRBD of DCV 1A. Red boxes indicate residues that interact with dsRNA in 
structural analyses of the second dsRBD of Xenopus laevis RNA-binding protein A (Xl RBPA2) 
(56). Residues predicted to be involved in RNA binding or conserved amino acids were selected 
for site-directed mutagenesis. Position of secondary structures are indicated above the alignment. 
(B) Homology model of 340R in complex with dsRNA. The protein is shown in cartoon-view 
with the WT residue K89 shown in red (left panel) or with the WT residue shown in green and 
the mutant residue (Alanine) shown in red (right panel). The RNA is shown in ball-and-stick 
view, without atomic details (left) and with all atoms (right). The side-chain of residue K89 is 
positioned towards the phosphate backbone of the RNA and likely binds dsRNA through an 
electrostatic interaction of the positively charged Lysine with the negatively charged phosphates. 
The substitution of this Lysine into the small and hydrophobic Alanine is likely to abolish the 
interaction. See Figure S2 for other residues selected for site-directed mutagenesis. (C) Western 
blot analysis of V5 epitope-tagged WT and mutant 340R from transfected S2 cells. Proteins were 
detected using anti-V5 antibodies (α-V5) or, as a loading control, using anti-α-tubulin (α-Tub) 
antibodies. Molecular mass (in kDa) is indicated on the left of the image. The predicted molecular 
weight for dsRBD100 is 14.7 kDa. FL, full-length. The asterisk (*) indicates a 340R-specific 
processing or degradation product. (D) dsRNA-induced RNAi reporter assay. The experiment 
was performed as described in the legend to Figure 1B, using expression plasmids for WT and 
mutant 340R. (E) siRNA-induced RNAi reporter assay. Sequential transfection was performed 
as described in the legend to Figure 1E, using expression plasmids for WT and mutant 340R and 
CrPV 1A. Difference in RNAi efficiency compared to controls (dark gray bars) was analyzed by 
one-way ANOVA followed by a post-hoc Dunnett’s test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001; ns, 
not significant.
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suppressed siRNA-induced RNAi (11-fold and 1.2-fold silencing, respectively, compared 
with 44-fold for the empty vector). The K89A and dsRBD100 mutants completely lost 
VSR activity (47-fold and 43-fold silencing, respectively), suggesting that suppression of 
siRNA-induced RNAi requires the dsRNA-binding activity of 340R as well as its 73-aa 
C-terminal domain.
340R binds long dsRNA and siRNA duplexes
To directly analyze dsRNA binding by 340R, we performed electrophoretic mobility 
shift assays (EMSAs) using different dsRNA substrates. Full-length WT 340R and the 
VSR-defective mutants K89A and dsRBD100 were fused to maltose-binding protein 
(MBP) and affinity-purified from E. coli. We first tested whether these recombinant 
proteins can bind radioactively-labeled, 126-bp long dsRNA. As positive control, we 
included recombinant MBP-DCV 1A. As expected, no shift in mobility of long dsRNA 
on native polyacrylamide gels was observed with increasing concentrations of MBP 
(Figure 3A, compare lanes 2-4 with lane 1). By contrast, addition of DCV 1A resulted 
in protein-dsRNA complex formation (Figure 3A, lane 5), which is in line with previous 
observations (11,27). Similarly, WT 340R bound dsRNA in a dose-dependent manner 
(Figure 3A, lanes 6-10). Interestingly, the K89A mutant could still bind long dsRNA, 
although 8-fold higher protein concentrations were required for a complete dsRNA 
shift (Figure 3A, lanes 11-15). Indeed, WT 340R had a ~12-fold higher affinity for 
long dsRNA than the K89A mutant (dissociation constants of 138.8 ± 34.0 nM and 
1626 ± 412.2 nM, respectively, Figure 3B). No dsRNA-binding activity was detected 
for dsRBD100, even when a 25-fold higher protein concentration was tested (Figure 3A, 
lanes 16-18). These results are in line with the results from the RNAi reporter assay, in 
which we observed slight VSR activity for the K89A mutant and a lack of VSR activity 
for dsRBD100 (Figure 2D).
We next used EMSAs to analyze whether 340R has binding affinity for siRNA duplexes. 
Synthetic 21-nt siRNA duplexes that contain 2-nt 3’ overhangs shifted after incubation 
with increasing amounts of WT 340R (Figure 3C, lanes 3-8) and the K89A mutant 
(Figure 3C, lanes 9-13), indicating that these proteins are able to bind siRNAs. No 
protein-siRNA complexes were formed with either MBP (Figure 3C, lane 2) or dsRBD100 
(Figure 3C, lanes 14-18). Similar to the long dsRNA binding assay, higher concentrations 
of the K89A mutant were required to observe an siRNA shift. Accordingly, WT 340R 
had higher affinity for siRNA duplexes than the K89A mutant (dissociation constants 
of 717.7 ± 97.8 nM and 6353 ± 699.5 nM, respectively, Figure 3D).
To analyze whether the 3’ overhangs are required for efficient siRNA binding, we used 
a 19-nt blunt dsRNA probe in EMSAs (Figure 3E). These experiments revealed that 
both WT and K89A mutant 340R bind 19-nt blunt dsRNA in a dose-dependent 
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Figure 3. 340R binds long dsRNA and duplex siRNAs. (A) EMSA of 126-nt blunt dsRNA 
with WT 340R and the K89A and dsRBD100 mutants. Buffer only (-, lane 1) and decreasing 
concentrations of MBP were included as negative controls (lanes 2-4; 10 µM, 3.2 µM and 0.4 
µM). An MBP-DCV 1A fusion protein was included as positive control (lane 5; 0.1 µM). WT 
and K89A 340R were tested in 2-fold serial dilutions starting at 0.4 µM (WT, lanes 6-10) and 
3.2 µM (K89A, lanes 11-15). dsRBD100 340R protein was tested in 10-fold dilutions starting 
at 10 µM (lanes 16-18). (B) Quantification of the fraction bound probe at different protein 
concentrations for WT 340R (black line) and the K89A mutant (gray line). Data represent 
means and standard deviations of three independent experiments. (C) EMSA of 21-nt siRNAs 
containing 2-nt 3’ overhangs with MBP (lane 2; 8 µM) and 2-fold serial dilutions of WT 340R 
(lanes 3-8; starting at 2 µM), and the K89A and dsRBD100 mutants (lanes 9-13 and 14-18, 
respectively; starting at 8 µM). A representative experiment of three independent experiments is 
shown in panels A and C. (D) Quantification of the fraction bound siRNA at different protein 
concentrations for WT 340R (black line) and the K89A mutant (gray line). Data represent means 
and standard deviations of three independent experiments. (E) EMSA of 19-nt blunt dsRNA 
with decreasing amounts of recombinant proteins. Protein concentrations are as described in 
panel (C). (F) Quantification of the fraction bound 19-nt blunt dsRNA probe at different 
protein concentrations for WT 340R (black line) and the K89A mutant (gray line).
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manner (Figure 3E, lanes 3-8 and 9-13, respectively), with dissociation constants of 
1171 and 6112 nM, respectively (Figure 3F). The observation that both WT and K89A 
mutant 340R had similar binding affinities for siRNAs and 19-nt blunt dsRNA (Figure 
S3), indicate that the 2-nt 3’overhangs of siRNAs are not essential for efficient siRNA 
binding. Taken together, these results show that WT 340R efficiently binds both long 
and short dsRNA, as well as siRNA duplexes.
340R inhibits Dcr-2-dependent dsRNA processing
Our data show that 340R interacts with dsRNA and that the dsRBD and C-terminus 
are required for its VSR activity. The dsRNA-binding activity of 340R may inhibit 
RNAi at two stages. First, by binding to dsRNA, it may shield long dsRNA from 
processing by Dcr-2. Second, by sequestering siRNAs, it may prevent incorporation 
of small RNAs into RISC. We performed in vitro Dicer assays to test whether dsRNA 
processing is inhibited in lysates of IIV-6-infected cells. In these assays, we analyzed 
cleavage of a radiolabeled 126-nt dsRNA substrate into 21-nt siRNAs on denaturing 
polyacrylamide gels. In mock-infected cell lysates, dsRNA was efficiently processed 
into siRNAs (Figure 4A, lane 3), whereas siRNA production was completely blocked in 
lysates from IIV-6-infected cells (MOI of 1.0) (Figure 4A, lane 7). Using a mixture of 
IIV-6 and mock-infected cell lysates at different ratios, dsRNA processing was inhibited 
in a dose-dependent manner (Figure 4A, lanes 4-6). Similar results were observed in 
lysates from cells that were infected with IIV-6 at an MOI of 0.1 (Figure 4A, lanes 
9-13), albeit that Dicer activity was not completely blocked at this lower MOI (Figure 
4A, compare lane 13 with lane 7). Together, these results indicate that IIV-6 encodes an 
inhibitor of dsRNA processing.
We next tested our hypothesis that the 340R protein interferes with Dcr-2-mediated 
dsRNA processing. Long dsRNA was efficiently processed into siRNAs in non-
supplemented S2 cell extracts and in extracts supplemented with recombinant MBP 
(Figure 4B, lanes 3 and 4). WT 340R inhibited processing of long dsRNA in a dose-
dependent manner (Figure 4B, lanes 6-8). Likewise, the addition of recombinant DCV 
1A, a VSR that is known to bind long dsRNA (11), completely blocked dsRNA cleavage 
(Figure 4B, lane 5). In contrast, the K89A or dsRBD100 mutants could not prevent 
the production of siRNAs, even at the highest concentration tested (Figure 4B, lanes 
9-11 and 12-14, respectively). It is worthwhile noting that the K89A mutant does show 
dsRNA-binding activity in EMSAs (Figure 3A, lanes 11-14), but that it does not protect 
dsRNA from Dicer-mediated processing (Figure 4B, lanes 9-11). Altogether, these data 
indicate that WT 340R interferes with Dcr-2-dependent siRNA biogenesis and that 
efficient dsRNA binding is required to prevent Dcr-2 processing activity.
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340R does not inhibit AGO2 slicing activity
Having shown that 340R interferes with the initiation steps of the RNAi pathway, 
we wondered whether 340R also inhibits the effector phase of the RNAi response. 
We thus monitored slicing of a radioactively 5’ cap-labeled target RNA (44) in the 
presence or absence of 340R. Drosophila embryo lysates were incubated with a 492-nt 
Fluc target RNA sequence and a Fluc-specific siRNA that triggers target RNA cleavage 
into a 164-nt 5’ cleavage product (Figure 5A, lane 2). This specific cleavage product 
was not detected after incubation with a non-specific control siRNA (Figure 5A, lane 
1). In a first approach, we analyzed whether 340R interferes with RISC assembly and 
subsequent target RNA cleavage. To this end, we incubated recombinant proteins with 
embryo lysate before the addition of siRNAs (27). Using this approach, we observed that 
WT 340R efficiently inhibited target RNA cleavage (Figure 5A, lane 4). In contrast, the 
K89A and dsRBD100 mutants did not suppress slicing (Figure 5A, lanes 5 and 6), similar 
to MBP alone (lane 3). To differentiate between the effect of 340R on RISC assembly 
and target slicing, we next tested whether WT 340R affects slicing by interfering with 
a pre-assembled RISC. To allow mature RISC formation, we pre-incubated embryo 
extracts with siRNAs before the addition of 340R. Neither MBP alone (Figure 5B, 
lane 3) nor WT or mutant 340R (lanes 4-6) inhibited target RNA cleavage under 
these conditions. In contrast, the positive control Nora virus VP1 efficiently inhibited 
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Figure 4. 340R inhibits Dicer-dependent production of siRNAs. (A) Processing of radiolabeled 
long dsRNA into siRNAs in cytoplasmic extracts of S2 cells that were mock-infected or infected 
with IIV-6 at the indicated MOI. siRNA production was analyzed in lysates of mock-infected 
cells (lanes 3 and 9), IIV-6-infected cells (lanes 7 and 13), and in mixtures of infected and 
non-infected lysates at different ratios (1:3; 1:1; 3:1; lanes 4-6 and 10-12). Synthetic siRNA 
and unprocessed dsRNA were loaded on gel as size markers (lanes 1 and 2, respectively). (B) 
Processing of dsRNA into siRNAs was analyzed in non-supplemented S2 cell extract (lane 3), 
and in cell extracts supplemented with recombinant MBP (lane 4; 1 µM), DCV 1A (lane 5; 1 
µM), and increasing concentrations of WT 340R (lanes 6-8), and the K89A (lanes 9-11) and 
dsRBD100 (lanes 12-14) mutants (0.01 µM, 0.1 µM and 1 µM). Size markers for siRNA and 
dsRNA were loaded in lanes 1 and 2, respectively.
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AGO2-mediated target cleavage in both experimental approaches (Figure 5A and 5B, 
lane 7) (27). These results demonstrate that 340R does not inhibit the activity of a pre-
assembled mature RISC. Because 340R binds siRNAs (Figure 3C and 3D), we propose 
that 340R interferes with the RISC assembly process by preventing siRNA loading into 
AGO2.
IIV-6 340R rescues replication of a VSR-defective FHV replicon
To analyze whether the 340R-mediated VSR activity is sufficient to suppress an antiviral 
RNAi response, we investigated whether 340R can rescue replication of a VSR-defective 
FHV replicon (12,34). The WT replicon consists of RNA1 of FHV, which encodes the 
viral RNA-dependent RNA polymerase (RdRP) and expresses the B2 suppressor protein 
that antagonizes RNAi by binding dsRNA and siRNA duplexes (Figure 6A) (12,14,15). 
In the VSR-defective FHV replicon (FHV ΔB2), two point mutations were introduced 
that abolish B2 expression, resulting in an RNAi-dependent replication defect (Figure 
6A) (12,43,49).
We first analyzed whether CrPV 1A can rescue the replication defect of the FHV ΔB2 
replicon. We performed RT-qPCR analysis to determine FHV RNA levels and observed 
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Figure 5. 340R does not inhibit Slicer activity of pre-assembled RISC. (A) In vitro RNA 
cleavage (Slicer) assay in Drosophila embryo lysates to analyze the effect of 340R on RISC 
assembly and subsequent AGO2 catalytic activity. Embryo lysates were pre-incubated for 30 min 
with recombinant proteins (lanes 3-8) or protein storage buffer (lanes 1 and 2), followed by the 
addition of Fluc-specific siRNAs (siFluc, lanes 2-8) or non-specific control siRNAs (siCtrl, lane 
1). After another 30-min incubation, a radioactive cap-labeled Fluc target RNA was added to the 
reaction mixture. Target cleavage was analyzed on a denaturing gel after a further 2-h incubation. 
(B) Slicer assay to monitor the effect of WT 340R on Slicer activity of a pre-assembled RISC. 
Recombinant proteins (lanes 3-8) were added after RISC assembly for 30 min with siFluc (lanes 
2-4) or siCtrl (lane 1). After a further 30-min incubation, target RNA was added and the reaction 
was allowed to proceed for 2 h before analysis. Nora virus VP1 was analyzed at a concentration 
of 0.3 µM, all other proteins at 1.5 µM.
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that the FHV ΔB2 replicon replicates efficiently when CrPV 1A is expressed (~170-
fold increase over the empty vector control, Figure 6B), confirming that the FHV ΔB2 
replicon is restricted by an AGO2-dependent antiviral RNAi response. Next, we tested 
whether WT 340R and the K89A mutant can rescue FHV ΔB2 replication. Upon 
expression of WT 340R, FHV RNA levels were 20-fold higher than in cells transfected 
with the empty vector control (Figure 6B, P = 0.018), whereas the K89A mutant was 
unable to rescue FHV ΔB2 replication (~2-fold increase). In line with the results of the 
RNAi reporter assays (Figure 1), the putative RNase III 142R did not rescue FHV ΔB2 
replication. Together, our results show that 340R suppresses the antiviral RNAi pathway.
Discussion
In recent years, it has become clear that different classes of RNA viruses are targets of the 
RNAi pathway in Drosophila. The antiviral activity of the RNAi machinery is mediated 
by Dcr-2-dependent cleavage of viral dsRNA into vsiRNAs that guide AGO2-dependent 
slicing of viral single-stranded RNA (9,11,13,26,33,34,50). During the ongoing arms 
race between viruses and their hosts, viruses have evolved sophisticated mechanisms 
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Figure 6. 340R rescues VSR-deficient FHV replication. (A) Schematic representation of the 
WT and ΔB2 FHV replicons. FHV RNA1 is self-replicating and encodes the RNA-dependent 
RNA polymerase (RdRP). B2, the viral suppressor of RNAi, is expressed from a subgenomic RNA 
(upper panel). The FHV ΔB2 replicon lacks B2 expression due to point mutations (triangles) 
that disrupt the start codon (M1S) and introduce a premature stop codon (S58*) (bottom panel) 
(49). pMT, metallothionein promoter; HdV, Hepatitis delta virus. (B) FHV RNA levels in S2 
cells co-transfected with the FHV ΔB2 replicon and expression plasmids encoding the indicated 
viral proteins. FHV RNA levels were analyzed by qRT-PCR, normalized to Rp49 and presented 
as fold change relative to the empty vector control. Bars represent the means and standard 
deviations of three independent samples. Viral RNA levels were compared to the control (empty 
plasmid) with one-way ANOVA followed by a post-hoc Dunnett’s test. *P ≤ 0.05; ** P ≤ 0.01; *** 
P ≤ 0.001; ns, not significant.
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to suppress or evade host-based immune responses. The best-studied examples of viral 
antagonism of RNAi in Drosophila come from studies on RNA viruses, which encode 
VSRs that interfere with the initiation and effector phases of the RNAi pathway (9). 
DNA viruses also induce an RNAi response in Drosophila, which is initiated by processing 
of viral dsRNA substrates derived from overlapping convergent transcripts (35,36) or 
from structured regions within viral transcripts (51,52). However, it remained unclear 
whether DNA viruses inhibit this small RNA-based immune response in Drosophila. 
In this study, we show that the dsRBD-containing protein 340R from the DNA virus 
IIV-6 suppresses RNAi.
IIV-6 is a nucleocytoplasmic virus that can infect Drosophila-derived cells as well as 
adult flies (35,36,53,54). This linear dsDNA virus contains 211 putative ORFs, which 
are transcribed from either strand of the viral genome (45,46). We show that RNAi is 
inhibited in IIV-6-infected cells and demonstrate that the IIV-6-encoded 340R protein 
inhibits Dcr-2 processing and RISC loading through duplex RNA binding. However, 
we cannot exclude the possibility that IIV-6 produces additional VSRs that contribute 
to RNAi antagonism. The plant RNA virus Citrus tristeza virus, for example, encodes 
three distinct VSRs to inhibit the antiviral RNAi response at different levels (55). Studies 
on Xenopus laevis RNA-binding protein (Xlrbp) and Drosophila Staufen revealed that 
their dsRBDs alone are sufficient to bind dsRNA (56-58). Surprisingly however, the 
C-terminal deletion mutant dsRBD100, which contains the entire dsRBD, was unable to 
bind RNA duplexes and did not exert VSR activity. How the C-terminal region of 340R 
contributes to VSR activity remains an open question for further studies.
Viral RNase III proteins are conserved amongst all genera within the Iridoviridae family, 
suggesting that this protein has important functions within the viral life cycle (46). 
However, under our experimental conditions, the putative RNase III 142R did not show 
VSR activity in reporter assays and was not able to rescue FHV ΔB2 replication. These 
observations suggest that the IIV-6-encoded RNase III is not involved in suppression 
of the RNAi response. This is in contrast to the proposed VSR activity of the RNase 
III proteins from Heliothis virescens ascovirus-3e, a DNA virus that infects moths, 
and from the plant RNA virus Sweet potato chlorotic stunt virus (24,25). 142R is 
structurally similar to bacterial RNase III proteins that are involved in the processing of 
structured, non-coding RNAs and specific mRNAs (59). Similarly, Iridovirus-encoded 
RNase III proteins may be in involved in the processing of viral or cellular RNAs, rather 
than suppression of RNAi.
Viral dsRNA triggers a sequence-specific RNAi response in invertebrates, but may 
additionally induce a sequence-independent antiviral response in marine shrimp 
(Litopenaeus vannamei) and honey bees (Apis mellifera) (60,61). Notably, IIV-6 infects a 
broad range of invertebrate hosts under natural and experimental conditions, including 
5Chapter 5
140
honey bees and penaeid shrimp (53,62,63). Therefore, it will be interesting to analyze 
whether 340R (and perhaps 142R) antagonizes putative dsRNA-induced transcriptional 
responses in invertebrates.
In this study, we used RNAi reporter assays to detect VSR activity for candidate proteins. 
However, these assays have their limitations, since they may fail to identify cis-acting 
VSRs (64) and host-species specific VSRs (65). Moreover, these assays could identify VSR 
activity of dsRNA binding proteins that are unlikely to suppress RNAi under natural 
conditions (66). To analyze whether viral dsRNA-binding proteins function as VSRs 
in vivo, it is important to study replication of VSR-defective virus mutants in an RNAi 
competent host as well as in an RNAi-deficient host. Since no strategies are yet available 
to genetically manipulate IIV-6, the role of 340R in infection remains to be established. 
Nevertheless, we demonstrated that RNAi is suppressed in IIV-6-infected cells and 
that 340R, like other VSRs, rescues replication of FHV ΔB2 (12,13,34,43,47,67-69), 
suggesting that 340R is a bona fide VSR. We and others previously reported that the 
DNA virus IIV-6 is restricted by an antiviral RNAi response (35,36). Our finding that 
IIV-6 340R antagonizes RNAi provides further support for an antiviral RNAi response 
to DNA virus infection in insects.
Materials and Methods
Cells and viruses
Drosophila melanogaster S2 cells were cultured as described previously (27). DCV and 
IIV-6 were propagated and titered as described previously (11,35).
Plasmids
A proteinase K-treated IIV-6 virus stock was used as a template to amplify the 340R and 
142R coding sequences, using primers that contain flanking XbaI restriction sites and 
introduce a Drosophila Kozak sequence (Table S1). PCR products were subsequently 
cloned into the XbaI site of pAc5-V5-His B (Life Technologies), yielding plasmids 
that encode C-terminal V5 epitope-tagged proteins. ORF 340R mutant plasmids were 
generated by site-directed mutagenesis using the primers from Table S1. The orientation 
and sequence of the selected clones was confirmed by DNA sequencing. Plasmids 
pAWH CrPV-1A, pMT-Luc and pMT-Ren were described previously (11,26). The 
pMT Renilla hairpin plasmid was kindly provided by R. Zhou (37). Plasmids encoding 
FHV replicons were described previously (16).
Plasmids encoding maltose-binding protein (MBP) fusion proteins were generated for 
the production of recombinant protein in E. coli. The sequences coding for DCV 1A, 
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WT 340R and the 340R mutants K89A and dsRBD100 were PCR amplified and cloned 
as EcoRI-SalI fragments into pMAL-C2X (New England Biolabs) (see Table S1 for 
primer sequences).
RNAi reporter assays in S2 cells
The ability of IIV-6 to suppress RNAi-mediated silencing of firefly luciferase (Fluc) 
expression was analyzed as previously described for DCV (11). Briefly, 2.5 × 104 S2 cells 
were seeded in a 96-well plate and mock-infected or infected with IIV-6 or DCV at an 
multiplicity of infection (MOI) of 0.1 or 0.01. Twenty-four hours after infection, cells 
were co-transfected with 12.5 ng pMT-Luc, 3 ng pMT-Ren, 50 ng empty pAc5-V5-His 
B plasmid and 10 ng dsRNA targeting either Fluc (dsFluc) or green fluorescent protein 
(GFP) (non-specific control, dsCtrl), using Effectene Transfection Reagent (Qiagen). 
Twenty-four hours after transfection, expression of the Fluc and Renilla luciferase (Rluc) 
reporters was induced by addition of 0.5 mM CuSO4 to the culture supernatant. Cell 
lysates were prepared after an additional 18-h incubation and luciferase activities were 
measured using the Dual luciferase reporter system (Promega).
Reporter assays in which RNAi was induced by dsRNA feeding were performed in 
S2R+ cells in a 96-well format. 3.0 × 104 S2R+ cells were seeded and transfected the next 
day with 12.5 ng pMT-Luc, 3 ng pMT-Ren, and with either 50 ng pAc-VSR to express 
one of the viral proteins or with the empty pAc vector. Two days after transfection, 400 
ng dsRNA was added to the culture medium. Expression of reporter genes was induced 
at 8 h after dsRNA treatment and luciferase activities were measured the next day (38).
RNAi reporter assays in which RNAi was induced by Renilla hairpin RNA were 
performed in S2 cells. 3.0 × 105 S2 cells were seeded in a 24-well plate and transfected 
the next day with 12 ng pMT-Ren, 50 ng pMT-Luc, 200 ng pAc-VSR plasmid, and 
either with 75 ng of copper-inducible pMT hairpin-Renilla plasmid or, as non-silencing 
control, empty pMT plasmid. Expression of the Renilla hairpin RNA and the luciferase 
reporters was induced 2 days post-transfection by addition of copper sulfate to the 
culture supernatant and luciferase activities were measured at 18 h post-induction.
For the sequential co-transfection, 3.0 × 105 S2 cells were seeded in 24-well plates. The 
next day, S2 cells were transfected with 100 ng pCoBlast (Life Technologies) and 300 
ng of pAc-VSR plasmid. Forty-eight hours after transfection, the cells were transferred 
to 96-well plates in medium containing 25 µg/mL of blasticidin S (Life Technologies) 
to select for cells that express the viral proteins. The next day, a second transfection was 
performed with 12.5 ng pMT-Luc, 3 ng pMT-Ren, 50 ng pAc-empty carrier plasmid, 
and 2 pmol of Fluc-specific siRNA (siFluc) or non-silencing control siRNA (siCtrl). The 
reporters were induced 24 h post-transfection and luciferase activities were measured the 
next day. For all reporter assays in which Fluc expression was silenced, Fluc counts were 
5Chapter 5
142
normalized to Rluc counts and expressed as fold silencing relative to control (empty 
vector) treatment, and vice versa when Rluc expression was silenced (38).
Western blot analysis
To analyze protein expression from VSR expression plasmids, 3.0 × 105 S2 cells were 
seeded in a 24-well plate. Twenty-four hours after seeding, cells were transfected with 
500 ng of a VSR expression plasmid or an empty control plasmid using Effectene 
Transfection Reagent (Qiagen) and harvested at 3 days post-transfection. To analyze 
protein expression from VSR expression plasmids in our RNAi reporter assays, we 
pooled the cell lysates of 10 individual wells of a 96-well plate. Proteins were separated 
on a 12.5% denaturing polyacrylamide gel and transferred to an 0.2-µm nitrocellulose 
membrane (Bio-Rad). The membrane was stained by subsequent incubations in anti-V5 
mouse monoclonal antibodies (Life Technologies) and Alexa Fluor 680-conjugated 
goat anti-mouse antibodies (LI-COR Biosciences). As a loading control, the same 
membrane was probed with anti-α-tubulin antibodies (AbD Serotec) and Alexa Fluor 
800-conjugated goat anti-rat antibodies (LI-COR Biosciences). Bound antibodies were 
visualized on an Odyssey infrared imager (LI-COR Biosciences).
Homology modeling
To predict the protein structure of 340R, we generated a homology model using the 
YASARA & WHAT IF Twinset under default settings (39,40). The experimentally 
solved protein structure of TRBP2 (Protein database accession 3ADL) and Aquifex 
aeolicus RNase III (PDB 2NUG) were used as a template (41,42). The model contained 
residues 1-112 of 340R (out of a total length of 173 aa), of which residues 1-37 were 
modeled after Aa-RNase III and residues 20-112 after TRBP2.
Production and purification of recombinant proteins
Plasmids encoding MBP fusion proteins were transformed into the E.coli BL21 (DE3) 
strain and expression of recombinant proteins was induced with 1 mM IPTG at an 
OD600 of 1.2. The cultures were incubated for 3 h at 37 °C for pMAL-empty and 
pMAL-DCV 1A and for 4.5 h at 25 °C for pMAL-340R. Fusion proteins were affinity-
purified using amylose resin according to the manufacturer’s protocol (New England 
Biolabs). Recombinant proteins were transferred to a dialysis membrane (molecular 
weight cut-off 12-14 kDa) and dialyzed to buffer (20 mM Tris-HCl, 0.5 mM EDTA, 
5 mM MgCl2, 1 mM DTT, 140 mM NaCl, 2.7 mM KCl). Recombinant proteins 
were stored as aliquots at -80 °C in dialysis buffer containing 30% glycerol. Protein 
concentrations were determined by a Bradford assay (Bio-Rad).
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Electrophoretic mobility shift assays
Radiolabeled probes for EMSAs were generated as described before (43). Uniformly-
labeled 126-nt blunt dsRNA was generated by in vitro transcription of T7 promoter-
flanked PCR fragments using T7 RNA polymerase in the presence of α-32P-[UTP]. 
After annealing of the two radiolabeled RNA strands, unincorporated nucleotides were 
removed using a G-25 Sephadex column (Roche) and dsRNA was purified from an 8% 
native polyacrylamide gel. Synthetic 21-nt siRNAs containing 2-nt 3’ overhangs and 
19-nt blunt dsRNAs (43) were end-labeled with α-32P-[ATP] using T4 polynucleotide 
kinase (Roche) and purified on a G-25 Sephadex column.
EMSAs were performed as described previously (11). Briefly, radiolabeled 126-nt long 
dsRNA (5 ng), 19-nt dsRNA or siRNA duplexes (1 nM) were incubated with different 
concentrations of recombinant proteins for 1 h at room temperature. Long dsRNA and 
siRNA EMSAs were analyzed on 6% and 12% native polyacrylamide gels, respectively. 
Gels were exposed to a Kodak Biomax XAR film and radioactive signals were quantified 
with ImageJ software.
Dicer and Slicer assays
To analyze processing of long dsRNA into siRNA, we performed in vitro Dicer assays in 
Drosophila S2 cell lysate as described before (27,44). 11 × 106 S2 cells were seeded in T75 
flasks and one day after seeding, cells were either mock-infected or infected with IIV-6 at 
an MOI of 1.0 or 0.1. Two days post-infection, cells were harvested and homogenized 
in lysis buffer [30 mM HEPES-KOH, 100 mM KOAc, 2 mM Mg(OAc)2, 5 mM DTT 
and complete protease inhibitor mixture (Roche)] for 1 h on ice. Protein concentrations 
of S2 cell extracts were analyzed by a Bradford assay (Bio-Rad) and lysates were frozen at 
-80 °C. Before analyzing Dicer activity, cell extracts were thawed on ice and centrifuged 
for 30 min at 16,000 × g at 4 °C to remove cell debris.
To analyze AGO2 target RNA cleavage, we performed in vitro Slicer assays in Drosophila 
embryo lysates as described previously (27,44).
FHV replicon assay
S2 cells were seeded in a 24-well plate at a density of 3.0 × 105 cells per well. The next 
day, cells were transfected with 100 ng of plasmid encoding either the WT FHV replicon 
or the B2-deficient replicon (FHV ΔB2) along with either 300 ng of pAc-VSR plasmid 
or empty control plasmid. Two days after transfection, 0.5 mM CuSO4 was added to 
the culture medium to induce transcription of the FHV replicon. The following day, 
cells were harvested and total RNA was isolated using Isol-RNA Lysis reagent. RNA 
was treated with DNase-I (Life Technologies) and cDNA synthesis was performed using 
TaqMan Reverse Transcription Reagents (Life Technologies) and a strand-specific FHV 
5Chapter 5
144
primer tagged with a 5’ T7 promoter sequence (43). Following cDNA synthesis, qPCR 
analysis was performed using a combination of a T7 promoter primer and an FHV-
specific forward primer. Data were normalized to Rp49 (RpL32), for which strand-
specific qRT-PCR assays were run in parallel (43), and presented as fold change relative 
to empty vector control.
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Supporting Information
Figure S1. Increasing the expression of 142R, 340R L35Y, 340R AA92LL, and 340R 
dsRBD100 does not result in detectable VSR activity. Left panels, RNAi reporter assays in 
S2R+ cells transfected with luciferase reporter plasmids and either a control plasmid (empty) or 
increasing amounts (50 to 400 ng) of expression plasmids encoding 142R (A), the 340R point 
mutants L35Y (B) and AA92LL (C), or 340R dsRBD100 (D). In all panels, WT 340R (25 and 
50 ng) was included as a positive control. RNAi was induced by addition of long Fluc dsRNA 
(dsFluc) to the culture supernatant. Fluc counts were normalized to Rluc counts and expressed 
as fold silencing relative to control treatment (dsCtrl). Bars in all panels represent the means 
and standard deviations of three independent samples. Difference in RNAi efficiency compared 
to controls (dark gray bars) was analyzed by one-way ANOVA followed by a post-hoc Dunnett’s 
test. *P ≤ 0.05; **P ≤ 0.01; ***P ≤ 0.001. Right panels, Western blot analyses of V5 epitope-
tagged VSR constructs from cell lysates of the corresponding RNAi reporter assays. Proteins 
were detected using anti-V5 antibodies (α-V5). A polyclonal anti-α-tubulin (α-Tub) antibody 
was used as a loading control. Molecular mass (in kDa) is indicated on the left of the image. The 
predicted molecular weights for 340R WT and the point mutants L35Y and AA92LL are 23 
kDa. The predicted molecular weights for 340R dsRBD100 and 142R are 14.7 kDa and 37 kDa, 
respectively.
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K86A
B
F63A
C AA92LLD
L35Y
Figure S2. Homology models of WT and mutant 340R in complex with dsRNA. In all 
panels, the WT residue is shown in green and the mutant residue in red. The RNA is presented 
in ball-and-stick view with all atoms shown. (A) The conserved residue L35 is located in alpha 
helix 1 (α1), with its side-chain buried in the core of the protein. Putative RNA interacting 
residues are located in α1, on the opposite side of L35. The L to Y substitution is likely to 
disturb the local structure, thereby affecting RNA interactions. (B) The highly conserved residue 
F63 is surface-exposed, with its side-chain positioned towards the dsRNA, and was proposed 
to properly position the long flexible dsRNA-interacting Lysine side-chains in Xlrbpa (56). 
Indeed, mutational analysis of Xlrbpa F145, which corresponds to F63 in 340R, revealed that 
this residue is required for efficient RNA binding (70). (C) As for K89 (Figure 2B), the side-
chain of residue K86 is positioned towards the phosphate backbone of the RNA. The K86A 
substitution is likely to abolish the interaction between the positively-charged Lysine and the 
negatively-charged phosphates. (D) The AA92LL substitutions are located in the core of the 
protein and are expected to severely disturb the local structure and thereby affect the interaction 
with dsRNA-binding region 3.
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Figure S3. 340R binds 21-nt siRNAs and 19-nt blunt dsRNA with similar affinities. 
Quantification of the fraction bound 21-nt siRNA (black line) and 19-nt blunt dsRNA (gray 
line) at different protein concentrations of WT 340R (A) and the K89A mutant (B). Data points 
for siRNA shifts (black lines) represent means and standard deviations of three independent 
experiments. Please note that both panels are merged images of Figure 3D and 3F.
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Cloning into pAc5.1-V5-HIS B & site-directed mutagenesis
Construct Forward primer (5’–3’) Reverse primer (5’–3’)
142R AGTTCTAGAAACATGGAAAACAATATTGAAAATTTTGATC GGTTCTAGATTACATAAAAGCTTTAAACCTGTCTGG
340R-WT AGTTCTAGAAACATGGAAAAACAAAAAGATAACGTAACTTC GGTTCTAGATTAAATATCGTCTATATCAACAGAGTCTTC
340R-dsRBD100 AGTTCTAGAAACATGGAAAAACAAAAAGATAACGTAACTTC GGTTCTAGATAATTCTTTAATAGTTTTAAATGCTGC
340R-K86A GGTAGCGGTTTATCCATGGCCGAAGCCAAAAAAAATGC GCATTTTTTTTGGCTTCGGCCATGGATAAACCGCTACC
340R-K89A CATGAAAGAAGCCGCAAAAAATGCAGC GCTGCATTTTTTGCGGCTTCTTTCATG
340R-F63A GATCATTCTCCAACGGCTAATATTGAATGTCG CGACATTCAATATTAGCCGTTGGAGAATGATC
340R-AA92LL CCATGAAAGAAGCCAAAAAAAATCTCCTCTTTAAAACTAT ATAGTTTTAAAGAGGAGATTTTTTTTGGCTTCTTTCATGG
340R-L35Y CAATTGGATTTTACAACGAATTTTGTC GACAAAATTCGTTGTAAAATCCAATTG
Cloning into pMAL-C2X
Construct Forward primer (5’–3’) Reverse primer (5’–3’)
DCV 1A AGTGAATTCATGGAATCTGATAAAAGTATGGCC GGTGTCGACTTAAACGGGTCCAGGGTTAGTCTC
340R-WT AGTGAATTCATGGAAAAACAAAAAGATAACGTAACTTC GGTGTCGACTTAAATATCGTCTATATCAACAGAGTCTTC
340R-K89A AGTGAATTCATGGAAAAACAAAAAGATAACGTAACTTC GGTGTCGACTTAAATATCGTCTATATCAACAGAGTCTTC
340R-dsRBD100 AGTGAATTCATGGAAAAACAAAAAGATAACGTAACTTC GGTGTCGACTTATAATTCTTTAATAGTTTTAAATGCTGC
Table S1. Primers used for cloning and site-directed mutagenesis
Introduced restriction sites of XbaI, EcoRI and SalI are underlined.
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Abstract
The siRNA pathway is an essential antiviral mechanism in insects. Whether other RNA interference pathways are involved in antiviral defense remains unclear. Here, we report in cells derived from the two main vectors for 
arboviruses, Aedes albopictus and Aedes aegypti, the production of viral small RNAs 
that exhibit the hallmarks of ping-pong derived piwi-associated RNAs (piRNAs) 
after infection with positive or negative sense RNA viruses. Furthermore, these 
cells produce endogenous piRNAs that mapped to transposable elements. Our 
results show that these mosquito cells can initiate de novo piRNA production and 
recapitulate the ping-pong-dependent piRNA pathway upon viral infection. The 
mechanism of viral-piRNA production is discussed.
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Introduction
Arboviruses are maintained in a transmission cycle between hematophagous arthropod 
vectors and vertebrate hosts. Within their arthropod vector, arboviruses encounter several 
anatomical and immunological barriers that determine the potential of the virus to be 
transmitted. RNA interference (RNAi) is a major antiviral defense mechanism in insects 
(1-8). A hallmark of the insect antiviral RNAi response is the activation of the pathway 
by cleavage of viral double-stranded RNA (dsRNA) into 21 nucleotides (nt) viral small 
interfering RNAs (vsiRNA) by Dicer-2 (Dcr-2). Once produced, vsiRNAs guide the 
sequence-specific recognition and cleavage of viral target RNAs by an Argonaute-2 
(AGO-2) containing RNA induced silencing complex.
The siRNA and piRNA (piwi-interacting RNA) pathways are both gene regulatory 
mechanisms guided by small silencing RNAs in association with an Argonaute family 
member. piRNAs differ from siRNAs in several aspects (9): i) piRNAs are generated 
in a Dicer-independent manner from single-stranded precursors and display a broader 
size range of ~25-30 nt; ii) piRNAs associate with the PIWI subclass of the Argonaute 
family, in flies consisting of piwi, Argonaute-3 (AGO3) and aubergine (aub); iii) PIWI 
proteins and their associated piRNAs are highly enriched in gonadal tissues, where 
they protect the germline from activation of transposable elements (TE). Nevertheless, 
piRNA expression in somatic tissues has recently been reported (10).
Two mechanisms have been proposed for the biogenesis of piRNAs (9). First, a pool of 
piRNAs is processed from single-stranded RNA precursors transcribed by chromosomal 
loci that consist of remnants of TEs. This generates primary piRNAs with a 5’ uridine 
bias (U1) that are usually antisense to TE transcripts. Cleavage of complementary 
transposon RNA by primary piRNAs initiates the second biogenesis pathway: the 
ping-pong amplification cycle that involves AGO3 and aub (9). This amplification 
loop gives rise to the signature of ping-pong-dependent piRNAs: a strong U1 bias for 
aub-associated piRNAs and a bias for adenosine at the tenth position (A10) of AGO3-
associated piRNAs. PIWI-associated piRNAs have a strong strand bias: AGO3 associates 
with sense TE piRNAs, whereas piwi and aub associate with antisense TE piRNAs (11, 
12).
While the siRNA pathway is well characterized as an antiviral defense mechanism in 
insects, the involvement of the piRNA pathway has been recently suggested. Indeed, 
the potential of the primary piRNA pathway to recognize and process viral RNAs was 
shown in Drosophila ovarian somatic sheet cells (OSS cell line) (13) where in addition 
to the typical Dcr-2-dependent 21-nt siRNAs, a broader peak of ~25 to 30-nt piRNAs 
with a U1 bias was observed. These cells are capable of producing primary piRNAs but 
are incapable of ping-pong amplification, due to the lack of aub and AGO3 expression 
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(14). The existence of viral piRNAs has also been suggested in mosquito, but only based 
on the size range of the viral small RNAs population (15-17).
Here, we show for the first time that mosquito cells infected with (+) and (-) RNA 
arboviruses produce viral small RNAs with the hallmarks of ping-pong amplification. 
These results show that mosquito tissue culture faithfully recapitulates the piRNA 
pathway from an exogenous trigger and may combine RNAi pathways to control a 
viral infection. These observations have important implications for our understanding 
of insect innate immunity.
Results
Multiple viral small RNAs species in mosquito cells
The C6/36 (18) and U4.4 (19) cell lines were cloned from the same cell population 
isolated from Aedes albopictus larvae (20). C6/36 cells are devoid of Dcr-2 activity 
(17), but produce virus-derived small RNA that are longer than vsiRNAs, which were 
proposed to be viral-derived piRNAs (vpiRNAs) (15, 17). Nevertheless, the absence of 
functional Dcr-2 activity in C6/36 (17) may have biased these results. To study whether 
Dcr-2 competent mosquito cells naturally produce vpiRNAs, we analyzed viral small 
RNAs following infection of U4.4 cells. In contrast to C6/36 cells, the U4.4 cells exhibit 
a functional Dcr-2 activity (Figure 1). Synthetic 32P-labelled dsRNA was effectively 
processed into 21-nt small RNA in U4.4 cell extracts (Figure 1A), and dsRNA directed 
against firefly luciferase efficiently silenced plasmid-driven luciferase expression (Figure 
1B). Altogether, these data show that U4.4 cells possess a functional siRNA pathway 
that should be able to produce vsiRNAs upon virus infection.
To analyze the impact of Dcr-2 activity on the overall virus-derived small RNA 
population in A. albopictus cells, we infected U4.4 cells with Sindbis virus (SINV), a (+) 
RNA arbovirus, expressing GFP as a reporter of viral replication. Small RNAs ranging 
from 19 to 30-nt in length were recovered from infected cells and deep-sequenced. 
Consistent with the Dcr-2 activity detected, the size distribution of virus-derived small 
RNAs displayed a sharp peak at 21-nt (Figure 1C) that corresponds to vsiRNAs. In 
addition, a broader Gaussian distribution that peaks at 27-28 nt was observed (Figure 
1C), which has previously also been reported in C6/36 cells (15, 17).
Aedes albopictus cells produce vpiRNA through a ping-pong mechanism
We next analyzed the viral small RNA population that peaks at 27-28 nt. Similar to 
vsiRNAs (Figure 2A), these small RNAs are distributed across the viral genome, but 
with an enrichment at the 5’ end of the highly expressed SINV-GFP subgenomic RNA 
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(Figure 2B). They display a strand bias, with more than 69% of the reads mapping to 
the sense strand of the viral genome. 
OSS cells only produced sense primary vpiRNAs that display a strong U1 bias. In 
contrast, 25 to 29-nt viral small RNAs from SINV-GFP-infected U4.4 cells originate 
from both viral RNA strands and display the following nucleotide bias (Figure 2C): 
vpiRNAs that mapped on the sense strand exhibit a strong A10 bias, while vpiRNAs that 
mapped on the antisense strand displayed a strong U1 bias. Furthermore, the 5’ ends of 
complementary vpiRNAs are most frequently separated by 10-nt (Figure 2D), which 
is characteristic of the ping-pong mechanism for piRNA generation (11). We therefore 
propose that these viral small RNAs represent ping-pong derived vpiRNAs.
Viral small RNA profiles from SINV-infected C6/36 cells display a similar profile with 
a size ranging from 19 to 30-nt (15, 17). We therefore infected C6/36 with SINV-
GFP and sequenced the viral small RNA population. Similar to the U4.4 cells, SINV-
derived small RNAs 
from infected C6/36 
cells exhibited all the 
hallmarks of ping-
pong amplification 
(data not shown). 
Furthermore, the 
25-29 nt vpiRNA 
in C6/36 were 
Figure 1. Aedes albopictus U4.4 cells are Dcr-
2 competent and produce two populations of 
viral small RNAs. (A) Dicer assay in uninfected 
U4.4 cells. Lane 3 shows processing of a 113-
bp dsRNA substrate into 21-nt siRNAs after 
incubation in a U4.4 cell extract. Synthetic 
siRNA (21-nt) and input dsRNA (113-nt) are 
used as size markers in lanes 1 and 2, respectively. 
(B) RNAi reporter assay. Co-transfection of 
firefly luciferase specific dsRNA with reporter 
plasmids encoding firefly and Renilla luciferase 
into U4.4 cells results in silencing of the firefly 
luciferase reporter. GFP dsRNA was used as 
non-specific dsRNA control. Renilla luciferase 
activity was used as internal control to normalize 
the firefly luciferase activity. Error bars represent 
the standard deviations of three individual 
samples. (C) Size distribution of the small RNA 
reads that match the genome of SINV-GFP 
with 0 mismatches.
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resistant to β-elimination, suggesting that they are associated with a PIWI protein 
and 2’-O-methylated at their 3’ terminal nucleotide (Table 1), similar to piRNAs in 
Drosophila and Bombyx mori (21, 22). Altogether, these results show that upon virus 
infection U4.4 and C6/36 cells produce vpiRNA through a ping-pong amplification 
mechanism. Furthermore, as C6/36 cells are deficient in Dcr-2 activity, these results 
suggest that the piRNA pathway is not a backup mechanism when the antiviral siRNA 
pathway is defective.
Ping-pong derived vpiRNAs in (-) RNA virus infection
Given the fundamental differences in replication strategies of (+) and (-) RNA viruses, 
we next analyzed a published dataset from C6/36 cells infected with La Crosse virus 
(LACV) (15), an arbovirus with a tri-segmented single-stranded (-) RNA genome (23). 
The viral RNA segments serve as templates for transcription of viral mRNAs and for the 
synthesis of full-length viral complementary RNA. Transcripts from the three segments, 
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Figure 2. U4.4 cells produce vsiRNAs and vpiRNAs through a ping-pong mechanism upon 
(+) ssRNA arbovirus infection. Profile of 21-nt vsiRNAs (A) and 25-29 nt (B) SINV-GFP-
derived small RNAs allowing 0 mismatch during alignment. Viral small RNAs that mapped to 
the sense and antisense strand of the SINV-GFP genome are shown in red and blue, respectively. 
(C) Conservation and relative nucleotide frequency per position of 25-29 nt SINV-GFP-derived 
reads that mapped to the sense (top) and the antisense (bottom) strands of the SINV-GFP 
genome. The overall height of the nucleotide stack indicates the sequence conservation; the 
height of the nucleotides within each stack represents their relative frequency at that position. 
n indicates the number of reads used to generate each logo. (D) Frequency map of the distance 
between 25-29 nt small RNAs that mapped to opposite strands of the SINV-GFP genome. The 
peak at position 9 on the sequence (the first nucleotide being position 0) indicates the position 
of maximal probability of finding the 5’ end of a complementary small RNA.
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Large (L), Medium (M) and Small (S), accumulate at different levels (S>M>L) (24). The 
absolute number of 25-29 nt virus-derived small RNAs did not follow the differential 
accumulation of each transcript; however, the number of reads normalized for the 
length of the segments did mirror the much greater mRNA levels of the S segment [20] 
(S segment 257.3 reads/nt >> L segment 37.5 > M segment 19.5). The relative amounts 
of vpiRNA mapping on each strand of the viral segments differed among the three 
segments, with ratios of sense over antisense vpiRNAs of 20.3, 4.3, and 0.7 for S, M 
and L, respectively (Figure 3A-C). This strand bias of vpiRNA followed the previously 
estimated gradient of mRNA over viral genome ratios from highly (S) to lower (L) 
expressed transcripts [20].
Analysis of the nucleotide biases indicated that all segments presented a U1 bias on the 
genomic (-) strand and an A10 bias for the antigenomic (+) RNA strand (Figure 3A-C). 
In addition, complementary vpiRNAs are enriched for those in which the 5’ ends are 
separated by exactly 10 nucleotides (Figure 3D-F). Thus similar to the (+) RNA virus 
SINV, LACV viral RNAs are targets for ping-pong-dependent vpiRNA biogenesis with 
U1 vpiRNAs originating from the negative strand, regardless of viral genome polarity 
and relative abundance of transcript.
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Figure 3. Aedes albopictus C6/36 cells produce ping-pong-dependent vpiRNA upon (-) RNA 
virus infection. (A), (B), and (C) Conservation and relative nucleotide frequency per position 
of the 25-29 nt LACV-derived reads that mapped to the antigenomic sense (top) and genomic 
antisense (bottom) strands of the LACV genome segments L, M and S, respectively. n indicates 
the number of reads used to generate each logo. (D), (E), and (F). Frequency map of the distance 
between 25-29 nt reads that mapped to opposite strands of the LACV genome segments L, M 
and S, respectively. The peak at position 9 on the sequence (the first nucleotide being position 
0) indicates the position of maximal probability of finding the 5’ end of a complementary small 
RNA.
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Aedes aegypti Aag2 cells produce vsiRNA and vpiRNA with a ping-
pong signature 
A. albopictus and A. aegypti are the major vectors for arboviruses within the Aedes genus 
of culicine mosquitoes. To test whether vpiRNA production also occurs in cells from A. 
aegypti, we analyzed small RNAs in the Aag2 cell line (25) after infection with SINV-
GFP.
We observed a size distribution of virus-derived small RNAs with a sharp peak at 21-nt 
and a broader Gaussian distribution that peaks at 28-nt (Figure 4A). Similar to previous 
observations of Alphavirus-infected Aag2 cells (26), the 21-nt vsiRNAs mapped across 
the viral genome in similar proportions over viral sense and antisense strands (Figure 
4B). The viral small RNAs of 25 to 29-nt are distributed across the viral genome, but 
enriched at the 5’ end of the highly expressed SINV subgenomic RNA (Figure 4C). 
Furthermore, these small RNAs display the hallmarks of ping-pong-dependent piRNAs 
(Figure 4D-E) as observed in A. albopictus cells. Together, our results show that three 
different cell lines derived from the two major mosquito vectors for arboviruses have a 
functional PIWI pathway and produce ping-pong derived piRNAs after infection with 
Sindbis virus.
The PIWI gene family has greatly expanded in A. aegypti. In addition to a single Ago3 
orthologue, the A. aegypti genome encodes seven Piwi/Aub orthologues (27). Based 
on their clustering with Anopheles gambiae Ago4 and Ago5, A. aegypti Piwi1 through 
Piwi4 belong to the Ago4 clade, whereas Piwi5 to Piwi7 belong to the Ago5 clade. 
Our observation of ping-pong derived vpiRNAs in mosquito cells implies that PIWI 
proteins from the different clades are expressed in these cells. Indeed, we readily detected 
in Aag2 cells transcripts from multiple PIWI family members, including Piwi4, Piwi5, 
Piwi6, and Ago3 (Figure 4F).
To address a potential germline source of the Aag2 cells, we analyzed the expression of 
Nanos in Aag2 cells, but we were unable to detect any transcripts by RT-PCR (data not 
shown). While this result does not rule out a germline origin of the cell line, we do note 
that the identification of piRNAs with a ping-pong signature in somatic tissues in flies 
implies that a functional PIWI pathway is present in the soma of insects (10).
Aedes aegypti Aag2 cells produce transposon-derived piRNAs with a 
ping-pong signature
Our results imply that the piRNA pathway targets replicating RNA viruses in mosquito 
cells. The majority of piRNAs in Drosophila and other animals were described to map 
to transposable elements. As the genome sequence of A. aegypti is available (28), we 
analyzed whether Aag2 cells engage in ping-pong-dependent amplification of TE derived 
piRNAs. We mapped the non-viral small RNAs to a dataset that contain full-length 
6Ping-pong amplification of viral piRNAs
161
non-composite transposons sequences (http://tefam.biochem.vt.edu/tefam/index.
php). TE-derived small RNAs display a sharp 21-nt peak and a broader peak centering 
around 27-nt, which is suggestive of TE targeting by the Aedes siRNA and piRNA 
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Figure 4. Aedes aegypti Aag2 cells produce vsiRNA and vpiRNA with a ping-pong signature 
upon arbovirus infection. (A) Size distribution of the small RNA reads that match the genome 
of SINV-GFP with 0 mismatches. Profile of 21-nt vsiRNAs (B) and 25-29 nt (C) SINV-GFP-
derived small RNAs allowing 0 mismatch during alignment. Viral small RNA that mapped to 
the sense and antisense strand of the SINV-GFP genome are shown in red and blue, respectively. 
(D) Conservation and relative nucleotide frequency per position of 25-29 nt SINV-GFP-derived 
reads that mapped to the sense (top) and antisense (bottom) strands of the SINV-GFP genome. 
n indicates the number of reads used to generate each logo. (E) Frequency map of the distance 
between 25-29 nt small RNAs that mapped to opposite strands of the SINV-GFP genome. The 
peak at position 9 on the sequence (the first nucleotide being position 0) indicates the position 
of maximal probability of finding the 5’ end of a complementary small RNA. F. Expression of 
PIWI family members in Aag2 cells analyzed by RT-PCR. cDNA synthesis was performed in the 
presence (+) or absence (-) of reverse transcriptase (RT). The -RT samples are included as controls 
for contamination of RNA preparations with chromosomal DNA. The coding sequences of 
Piwi1 and Piwi3 are 95% identical at the nucleotide level. Two different primer sets that amplify 
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specific PCR amplification product.
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pathways (Figure 5A). In contrast to TE-derived endo-siRNAs, the vast majority of TE 
piRNAs derive from retrotransposons and not from DNA transposons (Figure 5A). For 
most retrotransposons, the 25-29 nt TE RNAs display a strong over-representation of 
antisense reads (Figure 5B-C). The sequence depth of our library did not allow us to 
analyze ping-pong signatures in individual TEs. We therefore analyzed sequence logos 
of 25-29 nt small RNAs of the entire retrotransposon dataset (Figure 5D). A strong U1 
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Figure 5. Aedes aegypti Aag2 cells produce transposon-derived piRNAs with a ping-pong 
signature. (A) Size distribution of the small RNA reads that match with 0 mismatches against an 
Aedes aegypti transposon dataset that contain full-length non-composite transposons sequences 
(TEfam: http://tefam.biochem.vt.edu/tefam/index.php). (B) Heat map for 25-29 nt small 
RNAs that mapped to individual retrotransposons with more than 1000 reads. Read count 
and log-transformed ratios of antisense/sense small RNAs are presented. (C) Profile of 25-29 
nt reads that mapped to the transposon Copia Ele56 (TF000691) allowing 0 mismatch during 
alignment. Transposon-derived piRNAs that mapped to the sense and antisense strand of the 
transposon sequence are shown in red and blue, respectively. (D) Conservation and relative 
nucleotide frequency per position of 25-29 nt reads that mapped to the sense (top) and the 
antisense (bottom) strands of the entire transposon dataset. n indicates the number of reads used 
to generate each logo.
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bias for antisense small RNAs and an enrichment of A10 in sense small RNAs imply 
that, similar to Drosophila, TEs are processed by the piRNA pathway in a ping-pong- 
dependent manner in Aag2 cells.
Discussion
Antiviral RNAi activity in insects has thus far only been attributed to the siRNA 
pathway. The identification of vpiRNAs in Drosophila OSS cells (13) and in A. aegypti 
and A. albopictus cells (this study) strongly suggests that the piRNA pathway constitutes 
another facet of the antiviral RNAi response in insects. Unlike the siRNA pathway, 
the piRNA pathway is highly enriched in the gonads where it plays a critical role in 
the control of transposition in the germ line. Because arboviruses can be transmitted 
vertically in arthropod vectors (29), an antiviral piRNA response in the gonads may 
constitute an antiviral mechanism to limit vertical transmission of arboviruses in insect 
vectors. In addition, a putative somatic piRNA pathway may represent an important 
aspect of vector competence. While the relevance of the piRNA pathway in controlling 
virus infections awaits experimental validation, it is likely that a pathway that efficiently 
cleaves viral RNA affects virus replication. Hence, the piRNA pathway should be 
considered as an intrinsic component of the antiviral RNAi response in insects. Moreover, 
U4.4 and Aag2 cells emerge as an attractive model to dissect piRNA biogenesis and the 
interplay between siRNA and piRNA pathways.
Contrary to the OSS cell line that only produces primary vpiRNAs (13), U4.4, Aag2 and 
C6/36 cells produce primary and secondary vpiRNAs through a ping-pong mechanism. 
In OSS cells, vpiRNAs map predominantly to the positive strand of the genome of (+) 
RNA viruses and display the expected U1 bias for primary piRNAs. In U4.4, Aag2 and 
C6/36 cells however, the nucleotide bias signature is inverted, regardless the polarity 
of the viral genome. The vpiRNAs that derive from the (-) strand (i.e. the antigenomic 
strand of SINV and the genomic RNA strand of LACV) present a U1 bias, whereas 
those that derive from the (+) strand display an A10 bias. This disparity between OSS 
cells and mosquito cells is unlikely to be due to differences in piRNA biogenesis, as 
our results on TE piRNAs in Aag2 and observations in Bombyx Mori BmN4 cells (30) 
suggest that basic features of piRNA biogenesis are conserved among insects. It is then 
most likely that this inversion is based on intrinsic features of the viral lifecycle. 
The +/- strand ratio is uneven in ssRNA viruses. In (+) RNA viruses, the (+) strand is over-
represented compared to the negative strand that serves as template for the production of 
progeny viral RNA. In many (-) RNA viruses, the (+) viral RNA strand that corresponds 
to viral transcript is over-represented compared to the genomic (-) strand, although 
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the relative amounts of transcripts are variable. In LACV, there is a gradient of +/- 
strand ratio between highly (S segment) and slightly (L segment) expressed transcripts. 
In both (+) and (-) RNA viruses, the genome and the intermediates of replication 
are shielded from cytoplasmic components, contrary to viral RNAs that engage in 
translation. Interestingly, primary vpiRNAs are produced from the (-) strand, regardless 
viral genome polarity. Moreover, in most cases, the ratio between U1 and secondary A10 
vpiRNAs follows strand stoichiometry. According to these observations, we propose two 
non-mutually exclusive hypotheses for the production of vpiRNAs through a ping-pong 
mechanism. The first hypothesis is based on the relative amounts of (+) and (-) strands 
during viral replication. For primary vpiRNAs that are produced from the abundant (+) 
strand, the generation of secondary vpiRNAs from the (-) strand is limited due to the 
relative limited amount of viral (-) RNA strands. Conversely, the production of primary 
vpiRNAs from the (-) strand may allow the generation of abundant secondary vpiRNAs 
from the abundant (+) strand. According to this hypothesis, as the (+) strand is more 
abundant than the (-) strand, the second ping-pong mechanism supersedes the first one. 
As a second hypothesis, the production of primary vpiRNAs from the (-) strand may 
result for a differential accessibility of the viral RNAs by piRNA pathway components. 
We propose that the PIWI protein that is responsible for primary piRNA biogenesis 
can better access viral (-) RNAs, and that the PIWI proteins that are responsible for 
secondary piRNA biogenesis can mostly access viral (+) RNAs. This may be due to 
spatial restriction of piRNA pathway proteins or to a differential accessibility of PIWI 
proteins to the viral RNAs engaged in replication and in translation.
Finally, we show that viruses trigger the piRNA and the siRNA pathways in a similar 
way as transposons. This suggests that the RNAi pathways only discriminate common 
features of parasitic nucleic acids rather than their origin.
Materials and Methods
Cell culture, virus production and infection
A. albopictus U4.4 cells and A. aegypti Aag2 cells ((19, 25), kindly provided by G.P. 
Pijlman, Wageningen University, the Netherlands) were cultured at 28 °C in Leibovitz 
L-15 medium (Invitrogen) supplemented with 10% heat inactivated fetal calf serum 
(FCS, Invitrogen), 2% Tryptose Phosphate Broth Solution (Sigma) and 1% Non-
Essential Amino Acids (Invitrogen). BHK-21 cells (American Type Culture Collection) 
were cultured in DMEM medium (Invitrogen) supplemented with 10% FCS 
(Invitrogen), and maintained at 37 °C in 5% CO2. In vitro transcribed RNA from 
recombinant SINV expressing the Green Fluorescent Protein (31) was transfected into 
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BHK-21 cells. Virus titer was determined by plaque assay on BHK-21 cells. 2 × 106 
U4.4 were infected with SINV-GFP for 2 hours in culture medium at a multiplicity 
of infection of 1. Cells were harvested 2 days post-infection, when 80-90% of the cells 
were positive for GFP expression.
RNAi reporter and Dicer assays
RNAi reporter assays were adapted from (32), using 3 × 105 U4.4 cells per well of a 
24-well plate, 156 ng of pMT-Luc and pMT-Ren plasmids (6), and 0.625 ng of either 
firefly luciferase or GFP dsRNA. Dicer activity was determined in cell extracts from 
uninfected U4.4 cells as previously described (33), using 100 counts per seconds of an 
uniformly 32P-radiolabeled 113-bp dsRNA substrate.
Small RNA library preparation and analysis
Small RNA libraries were prepared as described (34) and sequenced on a Genome 
Analyzer IIx (Illumina). Virus-derived small RNAs were analyzed using Paparazzi (35). 
piRNA signatures were calculated using in-house Perl scripts from 25-29 nucleotide-
long virus-derived small RNA as previously described (11). Nucleotide frequencies per 
position were displayed using the WebLogo program (36). 19-30 nt reads from the Aag2 
small RNA library were aligned with 0 mismatch against the Aedes aegypti transposon 
dataset available at TEfam (http://tefam.biochem.vt.edu/tefam/). The aligned reads were 
processed similarly to the virus-derived small RNA with in-house Perl scripts. Sequences 
were submitted to the Sequence Read Archive at the National Center for Biotechnology 
Information under accession number SRA047263.
RT-PCR
Total RNA was isolated from a confluent 75 cm2 flask of Aag2 cells using Isol-RNA 
Lysis  Reagent (5 Prime) according to manufacturer’s recommendations. cDNA syn-
thesis was performed on 1µg of DNase-I (Invitrogen)-treated total RNA using an oli-
go-dT primer and TaqMan reverse transcriptase (Roche). PCR was performed using 
the following primers: F-AaeNanos, CAAACGTGAAGCGGAAGATT; R-AaeNanos, 
AATCAACGATGGATCGGATT; F-AaePIWI1/3a, TGTAGGGGAAGTAATG-
CATCG; R-AaePIWI1/3a, TCTACGGCAATGGTATCTGCT; F-AaePIWI1/3b, GG-
CCGTTAGCGAGTCTCAT; R-AaePIWI1/3b, GGCAGAACCTTCGTGGTAAG; 
F-AaePIWI2, ATGAAAGCCGGGAAGGTC; R-AaePIWI2, CTGCTACCATTGC-
CATTTCC; F-AaePIWI4, TGACCGTTACTCTCAAGGGCGCTACCGT; R-AaePI-
WI4, GACCGTTCACGGCCACCTGCCGAT; F-AaePIWI5, GCCATACATCG-
GGTCAAAAT; R-AaePIWI5, TGAGGTTGTTGCTTCTGAGGT; F-AaePIWI6, 
TAATCCACAGGAAGGCTCCA; R-AaePIWI6, CTCCTCCATTGTCCGATCCT; 
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F-AaePIWI7, GGAGGTCGTGGAGGTAACAA; R-AaePIWI7, CCTTCCAATCAC-
GATTGCTT; F-AaeAgo3, TCGGTTTACCGCCAGCTGGGAGTTTTG; R-AaeA-
go3, AGGTTATCTCAGCGGGAAAATCATGTCGCT
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The RNA interference (RNAi) pathway is considered to be the primary antiviral pathway in insects, including the fruit fly Drosophila melanogaster and the major vector mosquitoes Aedes aegypti and Aedes albopictus (reviewed in chapter 1) (1, 
2). Recent studies suggested that another small RNA silencing mechanism, the piRNA 
pathway, is also implicated in antiviral defense. The studies in this thesis focused on 
the role of small RNA-based antiviral defense mechanisms in insects. In the following 
sections I will discuss our findings in relation to recent literature. First I address the 
antiviral RNAi pathway in insects and then I will describe other dsRNA-induced 
responses as well as alternative nucleic acid sensing pathways. I will also discuss the 
mammalian and nuclear antiviral RNAi responses and finally speculate on the role of 
virus-derived piRNAs in antiviral defense.
The antiviral RNAi pathway in insects
Viral dsRNA substrates
The production of dsRNA is a hallmark of viral infection, as dsRNA is normally not 
detected in uninfected, healthy cells (3). Single-stranded (ss) RNA viruses produce large 
amounts of essential dsRNA replication intermediates during their viral life cycle, which 
feeds into the RNAi pathway. In insects, the detection of viral dsRNA induces an antiviral 
RNAi response, which is characterized by the production of Dicer-2 (Dcr-2)-dependent 
viral small interfering RNAs (vsiRNAs). In chapter 2 we revealed that vsiRNAs are 
generated in flies that are persistently infected with the positive-strand (+) RNA virus 
Nora virus. Indeed, vsiRNAs of positive and negative polarity were recovered in equal 
ratios and were uniformly distributed across the viral genome, indicating that viral 
replication intermediates are the major source for vsiRNA biogenesis. Other putative 
Dcr-2 substrates from RNA viruses include highly structured ssRNA molecules or viral 
dsRNA genomes (reviewed in chapter 1). In chapter 3 we demonstrated that DNA 
viruses also produce viral dsRNA that is recognized and processed by Dcr-2. This was 
somewhat surprising, as DNA viruses do not rely on dsRNA intermediates for efficient 
virus replication. Nevertheless, we revealed that the DNA virus Invertebrate iridescent 
virus 6 (IIV-6) produces convergent overlapping transcripts that have the potential to 
base pair and form dsRNA substrates for Dcr-2-dependent vsiRNA biogenesis (chapter 
3). In addition, structured ssRNA substrates may also be processed during DNA virus 
infections (discussed in chapter 4) (4). Together, these studies demonstrate that all 
major classes of viruses produce dsRNA substrates, which are processed into vsiRNAs to 
elicit an antiviral RNAi response.
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vsiRNA biogenesis 
Whilst all classes of insect viruses seem to produce dsRNA during their life cycle, it 
remains unclear when and where viral dsRNA is accessible to Dcr-2. RNA viruses shield 
their genomic material to avoid recognition by the host defense system: negative-strand 
(-) RNA viruses replicate in ribonucleoprotein (RNP) complexes (5, 6), double-stranded 
RNA viruses replicate within the viral capsid or, in some instances, in RNPs (7-9), 
whereas (+) RNA virus replication occurs in virus-induced intracellular membranous 
vesicles (10, 11).
A dsRNA-specific immunostaining revealed that following infection with many (+) 
RNA and DNA viruses, but not (-) RNA viruses, viral dsRNA is readily detected 
in the cytoplasm of mammalian cells (3). Likewise, in Drosophila cells infected with 
the (+) RNA virus Flock House virus (FHV), Drosophila C virus (DCV) or Cricket 
paralysis virus, dsRNA is successfully precipitated using a dsRNA-specific antibody 
(12). However, dsRNA immunoprecipitation from cells infected with the (-) RNA virus 
vesicular stomatitis virus (VSV) was not successful. Nevertheless, Dcr-2-dependent 
vsiRNAs could be recovered from VSV-challenged flies by cloning and deep sequencing 
of small RNAs, indicating that dsRNA is produced during (-) RNA virus infection. 
Using a similar approach, we demonstrated that vsiRNAs could be recovered from adult 
Drosophila infected with the (+) RNA virus Nora virus or the dsDNA virus IIV-6 (chapter 
2 and chapter 3, respectively) as well as from Sindbis-infected mosquito cells (chapter 
6). Several small RNA-profiling studies independently revealed vsiRNA production by 
all classes of viruses that infect insects, including mosquitoes and Drosophila (reviewed 
in chapter 1). Thus, even though virus replication occurs in enclosed viral factories 
and some viruses additionally encode suppressor proteins to protect their genome (see 
below), vsiRNAs are readily detectable during virus infection. Clearly, the production of 
vsiRNAs is a key feature of an antiviral RNAi response and suggests that viral dsRNA is 
somehow accessible for Dcr-2-dependent processing.
Dcr-2-independent processing of viral dsRNA
Dcr-2 requires its dsRNA-binding cofactors R2D2 and Loquacious (Loqs)-PD for 
processing of endogenous and experimentally introduced exogenous dsRNA (13-16), 
while Dcr-2 alone seems sufficient to process viral dsRNA during RNA virus infection 
(17, 18). However, at present it remains unclear whether Dcr-2 requires other, yet 
unidentified, dsRNA-binding proteins for the detection and processing of viral dsRNA. 
Remarkably however, low levels of viral small RNAs were still observed from virus- 
infected Dcr-2 knockout flies or from Dcr-2 depleted cells (chapter 3) (4, 12), which 
suggests that in the absence of Dcr-2 other nucleases might be involved in vsiRNA 
biogenesis. The miRNA-producing enzyme Dcr-1 is an obvious candidate, as it cleaves 
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dsRNA substrates in vitro (19-21) and produces small RNAs from an inverted repeat 
transgene in Dcr-2 mutant flies (22). Therefore, it remains to be established whether the 
Drosophila encoded Dicer proteins have redundant roles in vsiRNA biogenesis, as was 
observed for the plant-specific Dicer-like (DCL) enzymes (23-26). However, the lethal 
phenotype of Dcr-1 mutant flies thus far restricted such in vivo studies. Interestingly, 
several studies revealed that the biogenesis of a vertebrate conserved miRNA (miR-451) 
was independent of Dcr-1, but required the miRNA-processing enzyme Drosha as well 
as AGO2 catalytic activity (27-29). It will be interesting to study whether viral small 
RNAs can also be generated from highly structured regions in a similar manner, by 
comparing viral small RNA profiles from AGO2 and Dcr-2 double knockout flies to 
those of Dcr-2 knockout flies.
Functionality of vsiRNAs
The production of Dcr-2-dependent vsiRNAs is a hallmark of the antiviral RNAi re-
sponse, but it remains unknown whether the total pool of generated vsiRNAs contrib-
utes to RNA silencing. We, for example, showed that in infected flies, IIV-6-derived 
vsiRNAs were highly uneven distributed across the genome, with strong clustering to 
small, defined regions (hotspot). However, the abundance of vsiRNAs within these 
hotspot regions did not seem to correlate with the efficiency of silencing of sensor con-
structs carrying fragments of the IIV-6 genome (chapter 3). Likewise, hotspot vsiRNAs 
derived from mosquito cells infected with the (+) RNA virus Semliki Forest virus were 
inefficient at mediating antiviral RNAi when compared to coldspot vsiRNAs (30). Nev-
ertheless, the vsiRNA-mediated gene silencing indicates that at least some vsiRNAs are 
incorporated into a functional RISC. Notably, vsiRNA-mediated silencing of a reporter 
plasmid that harbored a VSV-specific sequence required AGO2 activity (12).
AGO2 immunoprecipitation studies followed by deep sequencing of small RNAs are 
required to analyze the fraction of IIV-6-derived vsiRNAs that are loaded into RISC. 
In addition, it will be interesting to perform AGO1 immunoprecipitation studies, as 
crosstalk seems to occur between the miRNA and siRNA pathways (31). Indeed, endog-
enous miRNAs could be recovered from AGO2 immunoprecipitates (32-34), where-
as endogenous (endo-) siRNAs are sometimes (e.g. in R2D2 mutants) misloaded into 
AGO1 (13, 35). Interestingly, AGO1 also seems to exhibit Slicer activity when the in-
corporated miRNA exhibits full complementarity to the target RNA (36, 37). However, 
thus far it remains unknown whether cross loading of vsiRNAs into AGO1 occurs and, 
if so, whether AGO1-mediated slicing of viral target RNA contributes to the antiviral 
potential of the RNAi machinery. Of note, vsiRNAs are rarely recovered from AGO1 
precipitates of Drosophila cells that are persistently infected with FHV (32). Remarkably 
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however, in some cases vsiRNA levels are slightly increased upon AGO1 depletion of 
virus-infected Drosophila cells (4, 38). These observations could hint at a direct or indi-
rect antiviral function of the miRNA pathway. For example, the miRNA pathway can 
normally silence cellular genes (or perhaps viral transcripts) that support efficient virus 
replication. Consequently, disruption of the miRNA pathway would lead to increased 
virus replication, providing more viral RNA substrates for Dcr-2, which results in in-
creased vsiRNA levels.
Alternative source of vsiRNA production
In cultured Drosophila cells that are persistently infected with FHV or American Noda 
virus (ANV), viral replication intermediates as well as defective viral RNAs, appear to be 
the major dsRNA substrates for vsiRNA biogenesis (38-42). Defective interfering (DI) 
RNAs arise during aberrant replication of the parental virus and contain large deletions 
of genes that are required for efficient replication and encapsidation. Nevertheless, DI 
RNAs are replicated by the parental virus-encoded RNA-dependent RNA polymerase, 
and even replicate more efficiently due to their smaller genome size. Indeed, DI RNAs 
derived from ANV (RNA2) account for half the amount of total vsiRNA production 
in Drosophila ovarian somatic sheet cells (39). Reporter-based assays revealed that 
FHV-derived vsiRNAs failed to silence complementary target sequences, suggesting 
that the majority of FHV-derived vsiRNAs are not incorporated into AGO2 (38). This 
study suggested that the dicing of viral replication intermediates by itself might limit 
virus infection, while the generated vsiRNAs could provide a decoy strategy for RISC 
saturation in order to maintain a persistent infection. Alternatively, defective RNAs 
can mediate persistence by interfering with replication of full-length genomic RNA 
directly. However, in vitro and in vivo studies both revealed that a fraction of FHV-
derived vsiRNAs is 3’ end modified and associated with AGO2 (32, 43). Moreover, 
FHV viral RNA levels were increased following AGO2 depletion of persistently infected 
cells, indicating that AGO2 contributes to control persistent infections (32, 38, 43). 
In contrast to persistently infected cell lines, DI RNAs are thus far not recovered from 
persistently infected flies, which argues against a physiological function for DI RNAs 
during authentic virus infections in vivo.
Different infection models
The RNA viruses Sigma virus, DCV and Nora virus are natural fly pathogens that 
can cause persistent infections, whereas several other viruses efficiently replicate in 
Drosophila upon experimental infection (44). Remarkably, Drosophila is often used as 
a model organism to study arthropod-borne (arbo) virus infection via intra-thoracic 
injection, while arboviruses orally enter mosquitoes during an infectious blood meal and 
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start to replicate in midgut epithelial cells. Following oral ingestion, a virus first needs 
to cross the epithelial barriers of the digestive tract in order to establish a productive 
infection. It is believed that active immune responses within intestinal epithelial cells, 
including Jak-Stat, ERK, and Toll-signaling pathways, provide antiviral defense (45-47). 
However, most studies on antiviral RNAi were performed by intra-thoracic or intra-
abdominal virus injection of adult flies, thus bypassing the various immunity pathways 
that comprise the antiviral midgut barrier. It will, however, be interesting to study the 
relative contribution of the antiviral RNAi pathway after natural infection routes. This is 
for example already being studied in Caenorhabditis elegans larvae, in which Orsay virus 
(a positive-strand RNA virus) infection is potently suppressed by the RNAi pathway 
(48). Interestingly, flies can also be orally infected (47, 49) (and our unpublished 
observations), which provides useful avenues to study (arbo)virus-host interactions 
under more physiological conditions. Nevertheless, experimental injection of insects 
may also resemble a natural route of virus infection. For example, the hemolymph of 
RNAi-competent honeybees can be infected with deformed wing virus (DWV) during 
feeding activities of the parasitic mite Varroa destructor (50). Interestingly, Varroa-
mediated virus transmission is suggested to be a major cause of honeybee colony 
collapse, with DWV being one of the key players. In addition, it has been suggested that 
parasitic mites or wasps are potential vectors for the transmission of viruses (e.g. Sigma 
virus) to Drosophila (51). Taken together, both experimental injection and oral infection 
methods provide useful models to study the molecular mechanisms that are involved in 
RNAi-mediated immunity in insects.
Viral counter-defense
The dicing of viral RNA substrates could in theory be sufficient to control virus 
infections. Nevertheless, several lines of evidence illustrate that both the initiation and 
effector steps of the RNAi pathway are required to induce a potent antiviral response. 
First, in vivo studies revealed that flies or mosquitoes that are mutant or depleted for the 
core RNAi components Dcr-2, R2D2, or AGO2 are hypersensitive to virus infection. 
Second, several viruses encode suppressor proteins that inhibit the RNAi pathway at 
distinct steps. For example, Drosophila or mosquito-restricted RNA viruses can bind 
RNA duplexes and thereby prevent Dcr-2 processing of viral dsRNA and inhibit 
siRNA loading into RISC (reviewed in chapter 1) (52-55). Our observation that the 
DNA virus IIV-6 encodes a suppressor protein that interferes with Dcr-2 processing 
activity (chapter 5), supports the notion that dicing contributes to antiviral defense. In 
addition, two unrelated (+) RNA viruses, Nora virus and Cricket paralysis virus, encode 
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a suppressor protein (VP1 and 1A, respectively) that interferes with RISC enzymatic 
activity (chapter 2) (56). The observation that AGO2 slicing mutants, that still contain 
a functional Dcr-2 protein, are more sensitive to VSV infection further underscores that 
AGO2-dependent slicing activity is essential for antiviral defense (17). Finally, Dcr-2, 
R2D2 and AGO2 are amongst the fastest evolving genes within the Drosophila genome, 
which suggests that genes involved in the initiation or effector phase of the RNAi 
pathway are involved in the ongoing arms race between viruses and their hosts (57, 58).
Host counter-counter-defense
In plants, virus infections can induce host counter-counter-defense or secondary defense 
responses, which resembles effector-triggered immunity (ETI) to non-viral pathogens 
(59). The plant immune system is composed of two layers for microbe detection. In the 
first layer, pattern-recognition receptors detect pathogen-associated molecular patterns 
(PAMPs) to induce PAMP-triggered immunity (PTI). As a countermeasure, plant 
pathogens evolved effector molecules that are secreted into host cells to antagonize the 
PTI response and to induce virulence. The second layer of plant immunity is composed 
of resistance proteins, which recognize the effector molecules and provide a protein-based 
guard mechanism to inactivate these PTI suppressors. This process of effector-triggered 
immunity (ETI) results in disease resistance and leads to a hypersensitive response (59). 
Likewise, virus infection also seems to trigger a secondary response in plants. However, 
this second layer of antiviral defense seems primarily small RNA-based and refers to the 
induction of resistance genes, which are normally silenced by endogenous small RNAs. 
When viral effector molecules (VSRs) attenuate the first layer of viral defense (RNAi), 
the resistance genes will be derepressed leading to the induction of a hypersensitive, 
secondary response (60). Several recent studies described different examples of counter-
counter defense against plant viruses. For example, the plant-encoded miR-482 targets 
a primary disease resistant gene, resulting in the secondary amplification of RDR6 and 
DCL4-dependent trans-acting siRNAs (tasiRNAs) that simultaneously repress multiple 
resistance gene family members (61-63). Infection of plants with turnip crinkle virus 
(TCV) and cucumber mosaic virus (CMV), which both encode proteins that antagonize 
AGO1 function, resulted in mRNA expression of this specific class of resistance 
genes (63). Likewise, AGO2 itself is repressed by endogenous miR-403 in uninfected 
Arabidopsis (64), but suppression of AGO1 function during infection results in increased 
AGO2 protein levels that contribute to antiviral defense (65, 66). The antiviral effector 
DCL2 seems to be controlled by small tasiRNAs in a similar fashion (61). Alternatively, 
virus-induced expression of the tobacco encoded calmodulin-like protein rgs-CaM 
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provides a protein-based secondary defense in plants. Indeed, this host protein targets 
VSRs, together with rgs-CaM itself, for autophagy-mediated degradation to enhance 
the antiviral RNAi response (67). Thus far, counter-counter-defense mechanisms have 
not been observed for insects, which can partially be explained by the fact that insects 
lack secondary siRNA biogenesis pathways. However, resistance genes could directly be 
repressed by endo-siRNAs. As such, the presence of a viral protein that antagonizes the 
RNAi pathway could result in the expression of genes that are normally repressed by 
endo-siRNAs. Notably, abundant endo-siRNAs that mapped to the 3’UTR of AGO2 
were identified by analyzing small RNA profiles that were recovered from Drosophila 
cells. These endo-siRNAs were generated from bidirectional overlapping transcripts in 
an AGO2 and Dcr-2-dependent manner (15). Therefore, it is tempting to speculate 
that AGO2 transcript levels would increase when the RNAi pathway is antagonized. It 
will be interesting to monitor whether AGO2 levels are increased during virus infection 
of adult flies. We could for example compare AGO2 transcript and protein levels in 
uninfected flies to that of flies that are persistently infected with DCV or Nora virus. 
Taken together, it will be interesting to study the induction of immune genes in virus-
infected Drosophila or mosquitoes, especially because it remains unknown whether 
secondary defense mechanisms contribute to antiviral immunity in insects.
Mammalian RNAi
The detection of viral dsRNA in mammalian cells by the intracellular pattern-recognition 
receptors RIG-I and MDA5 triggers an interferon (IFN)-mediated innate immune 
response, which induces the production of antiviral defense genes (68). An important 
downstream effector molecule of the IFN pathway is the dsRNA-dependent protein 
kinase R (PKR). In addition, intracellular viral dsRNA can activate PKR directly, leading 
to translational shutdown via eIF-2α phosphorylation, which results in the inhibition 
of virus replication. Recently, it was shown that RNAi also possesses antiviral activity 
in specific stages and lineages of mammalian cells infected with encephalomyocarditis 
virus (EMCV) or Nodamura virus (NoV), two unrelated positive-strand RNA viruses 
(69, 70). Because cytoplasmic RIG-I, MDA5, PKR and Dicer all bind intracellular viral 
dsRNA, it will be interesting to determine whether these proteins compete for the same 
dsRNA substrate, whether they operate together or explore specific and non-redundant 
roles within an infected cell. From the virus perspective, the binding of dsRNA by 
viral immune antagonists provides a very efficient strategy to evade both IFN-regulated 
and small RNA-guided innate immune responses. Indeed, it has been demonstrated 
that several proteins from mammalian RNA and DNA viruses sequester dsRNA to 
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support efficient virus replication by antagonizing IFN-induced responses (68, 71-73). 
An intriguing example is the dsRBD protein E3L from vaccinia virus, a dsDNA virus. 
E3L inhibits the dsRNA-activated PKR and 2’ 5’-oligoadenylate synthetase (OAS)/
RNaseL-mediated antiviral responses in mammalian cells and antagonizes the dsRNA-
induced RNAi response in cultured Drosophila cells (68, 74). It will be interesting 
to analyze whether viral dsRNA-binding proteins contribute to antagonize an RNAi 
response during natural infection of the vertebrate host. For DNA viruses, the recovery 
of vsiRNAs in infected mammalian cells has not been reported to date, despite the 
observation that dsRNA is produced during DNA virus infection (3). By contrast, virus-
derived miRNAs are readily detected in herpesvirus-infected cells (75, 76). Therefore, 
it remains to be tested whether DNA viruses induce an antiviral RNAi response in 
mammals, as was observed for plants and insects that lack adaptive immune responses 
(chapters 3 and 4) (77).
The existence of a natural antiviral RNAi response in mammals, especially in somatic 
cells, is still being debated (78). For example, a recent study reported an alternative 
role for AGO2 in antiviral defense (79). Specifically, it was demonstrated that RISC 
activity was reduced through post-translational modification of AGO2 following virus 
infection of somatic cells. The authors proposed that RISC inactivation results in the 
release of miRNA-mediated suppression of antiviral defense genes (ISGs, interferon 
stimulated genes) in order to enhance the antiviral response. Notably, the induction 
of ISGs in mammals shows a striking similarity to secondary defense in plants (see 
above). Another recent report implicated a role for cytoplasmic Drosha, but not Dicer, 
in antiviral defense against Sindbis virus in IFN-sensitive somatic cells (80). Despite 
these controversial reports, the discovery of mammalian antiviral RNAi under specific 
experimental conditions provides new insights into innate antiviral immunity.
Other dsRNA-induced responses
It is believed that, in addition to viral dsRNA, other viral components are required to 
induce a potent immune response in Drosophila and mosquitoes, because injection of 
exogenous dsRNA does not induce a sequence non-specific antiviral response (81-83). 
However, in penaeid shrimp and in the non-Dipteran insect Apis mellifera (honeybee), 
dsRNA induces both sequence-specific and sequence-independent antiviral responses 
(84-91). For example, in the shrimp Litopenaeus vannamei injection of long dsRNA, 
regardless of sequence specificity, induces protection against the dsDNA virus white 
spot syndrome virus and the (+) RNA virus Taura syndrome virus (85). Similar results 
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were obtained in honeybees, in which dsRNA injection protected against infection 
with the (+) RNA virus Sindbis virus (91), indicating that dsRNA induces sequence-
independent immune responses. At the same time, it remains unclear how well conserved 
this sequence-independent response is across invertebrate animals. Nevertheless, shrimp 
and honeybees provide useful model organisms to study the molecular mechanisms of 
dsRNA-induced antiviral responses. Moreover, it will be interesting to analyze whether 
the RNAi pathway and the sequence non-specific immune responses are interconnected 
in these invertebrate species.
Other nucleic acid sensing pathways
It is generally believed that the production of viral dsRNA is a central trigger of an innate 
immune response, as dsRNA is not detected in uninfected, healthy cells (3, 12). However, 
endo-siRNAs are detectable by small RNA sequencing studies, indicating that dsRNA is 
produced in uninfected cells (14, 15, 92-95), albeit that endo-siRNA production seems 
to depend on Dcr-2 along with its cofactor Loqs-PD, whereas vsiRNAs are produced in 
a Loqs-PD-independent manner (17). Therefore, a key question to the initiation of the 
RNAi pathway is whether and how Dcr-2 acquires substrate specificity for viral RNA 
(non-self ) versus host-derived (self ) RNA substrates.
Insights from several studies led to the hypothesis that host-mediated modifications of 
cellular RNAs may be involved in the evasion of the RNAi machinery. For example, 
adenosine deaminase proteins that act on RNA (ADARs) could play a role in editing 
cellular dsRNA substrates to antagonize an RNAi response. Specifically, ADARs can 
convert adenosine into inosine within dsRNA, such as secondary structured mRNA 
or convergent overlapping transcripts, which alters the codon sequence and disrupts 
dsRNA structures. It was proposed that the latter could destroy complementarity 
between the siRNA guide-strand and the target mRNA or might affect Dicer dsRNA-
binding and processing (96-98). In addition, ADARs might compete with Dicer itself 
for dsRNA substrate binding.
On the other hand, host-mediated modification of viral nucleic acids may also be an 
effector mechanism of an antiviral immune response. A recent study, for example, showed 
that in DCV-infected flies the RNA methyltransferase Dnmt2 associates with viral RNA. 
In addition, it was observed that Dnmt2 mutant flies displayed increased susceptibility 
to DCV infection, which correlated with increased viral RNA and proteins levels. The 
authors therefore suggested that Dnmt2 not only methylates cytosine within tRNA 
substrates but also might modify viral RNA substrates (49). However, the molecular 
mechanisms by which Dnmt2 and ADAR proteins obtain substrate specificity, if any, 
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remain unknown.
Nuclear RNAi
While RNAi is a post-transcriptional gene silencing (PTGS) mechanism that operates 
in the cytoplasm to control mRNA expression, it also plays a crucial role in the defense 
against viruses (40, 99). However, there is growing evidence that small RNAs and RNAi 
pathway components additionally play important roles in transcriptional gene silencing 
(TGS) in the nucleus. An initial study demonstrated that sequestration of endo-siRNAs 
by nuclear expression of the viral suppressors of RNAi, FHV B2 and Tombusvirus 
P19, resulted in the loss of heterochromatin marks in somatic tissues of adult flies 
and larvae (100). Likewise, Dcr-2, R2D2 and AGO2 mutant flies, showed aberrant 
repressive chromatin marks and a concomitant release of silencing of reporter genes 
that were integrated in heterochromatin-rich pericentromeric regions. Together, these 
findings provide indirect evidence for the involvement of the endo-siRNA pathway in 
heterochromatin formation. Because several insect viruses encode proteins that bind 
siRNAs to antagonize RNAi (reviewed in chapter 1), it will be interesting to analyze 
whether these VSRs induce epigenetic changes during an authentic infection. Recent 
studies provided direct evidence for a role of nuclear RNAi in Drosophila. One study 
revealed that small RNA-loaded AGO2 as well as Dcr-2 associate with transcriptionally 
active, euchromatic loci and seem to control RNA Pol II activity (101). By contrast, 
another study revealed that AGO2-mediated transcriptional repression relies on 
chromatin binding and repressive chromatin formation (102). The exact mechanism 
of RNAi-mediated TGS thus remains controversial and is still poorly understood. 
Nevertheless, these studies suggest that in analogy to Schizosaccharomyces pombe, 
C.elegans and higher plants (103), the RNAi pathway functions in TGS in Drosophila 
and perhaps in other insects.
Are nuclear RNAi components also involved in the silencing of insect viruses, such as IIV-
6, which replicate in the nucleus? For plants it was proposed that both PTGS and TGS 
contribute to antiviral defense against DNA viruses. Geminiviral dsDNA intermediates, 
which are produced by rolling-circle amplification of the ssDNA genome, associate 
with cellular histone proteins to form viral minichromosomes. The cytoplasmic RNAi 
machinery likely processes convergent overlapping transcripts that are produced from 
these minichromosomes (104, 105). On the other hand it was proposed that epigenetic 
silencing of geminiviruses relies on small RNA-directed DNA methylation of the viral 
genome, which involves nuclear DCL3 and AGO4 (106, 107). Geminiviruses encode 
proteins to counteract PTGS as well as TGS responses, which underscores that plant 
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DNA viruses are targeted by two distinct small RNA-based pathways (60). Whether 
TGS has an antiviral role in insects remains thus far elusive.
Virus-derived piRNAs
While seminal studies revealed that the RNAi pathway contributes to antiviral defense 
in Drosophila and mosquitoes (reviewed in chapter 1), not much was known about 
other small RNA-based defense mechanisms in insects. The recovery of virus-derived 
PIWI-interacting RNA (piRNA) sized small RNAs from persistently infected Drosophila 
ovarian sheet cells for the first time hinted at a possible antiviral function for the piRNA 
pathway (39). Endogenous, single-stranded small RNAs of 25-30 nt that associate with 
proteins of the PIWI family are at the core of the piRNA pathway. In Drosophila, the 
piRNA pathway operates in germline tissues to maintain genome integrity by repressing 
transposon levels (103, 108). We performed small RNA profiling studies of arbovirus-
infected mosquito cells (chapter 6). Intriguingly, we noted that besides vsiRNAs, virus-
derived small RNAs of ~25-30 nt that exhibit characteristic piRNA signatures were 
generated. Several other studies additionally reported the production of viral piRNAs 
(vpiRNA) in cells and somatic tissues of mosquitoes (109-112). This suggests that, in 
addition to the antiviral RNAi pathway, the piRNA pathway is involved in antiviral 
defense in mosquitoes. The mechanism by which vpiRNAs might contribute to the 
control of arbovirus infection in somatic cells is an exciting field for further study. Thus 
far, it remains unknown whether different small RNA-based pathways operate together, 
or whether the piRNA pathway serves as a back-up mechanism upon inhibition of 
the RNAi pathway. Alternatively, the piRNA pathway could function independently to 
induce an antiviral immune response. 
For a long time it was assumed that arboviruses do not antagonize the RNAi pathway, 
as VSR activity could lead to pathogenesis and death of the arthropod vector, thereby 
preventing efficient virus transmission. Indeed, the introduction of FHV B2 in 
recombinant Sindbis virus induced pathogenicity and death of infected mosquitoes, 
suggesting that expression of B2 in RNAi-competent mosquitoes would not allow 
successful transmission and thus is disadvantageous for virus spread (113, 114). 
However, recent reports suggested that some arboviruses suppress the RNAi pathway 
in mosquitoes (reviewed in chapter 1). In this perspective, it will be interesting to test 
whether the piRNA-pathway displays increased antiviral activity when antiviral RNAi is 
antagonized. If the piRNA pathway indeed has antiviral potential, one could speculate 
that arboviruses suppress the piRNA pathway in order to establish a productive infection, 
which is required for successful virus transmission. A recent study suggested that FHV 
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B2 suppressed the production of viral piRNAs (112). Specifically, Dcr-2 deficient cells 
showed increased cell death when B2 was expressed in a recombinant Chikungunya 
virus (CHIKV-B2) as compared to the parental virus. In addition, a mild reduction 
in viral piRNA levels was observed upon CHIKV-B2 infection. Therefore, the authors 
suggested that FHV B2 inhibits piRNA biogenesis in mosquitoes.
Alternatively, in case the piRNA-pathway is not directly involved in antiviral defense, 
piRNAs could serve as a memory factor to prime an efficient immune response following 
successive virus challenge. In line with this hypothesis, it has been shown that piRNAs 
mediate transgenerational epigenetic inheritance in nematodes and flies (115-119).
Future directions
Over the last few years, it has become increasingly clear that the RNAi pathway is an 
important determinant for insect antiviral immunity. This small RNA-based antiviral 
response is, however, not the sole line of host defense, as protein-based innate immune 
responses, including the Toll, Imd and Jak-Stat signaling pathways, also seem to 
contribute to control of virus infection (44). The studies in this thesis deepened our 
understanding of small RNA-based antiviral defense mechanisms in Drosophila and 
mosquitoes. Nevertheless, many questions remain unanswered. For example, how do 
viruses for which no VSR has been identified, such as VSV and Sindbis virus, establish 
a productive infection? Do these viruses antagonize other antiviral signaling pathways? 
And, how do the VSR-competent viruses Nora virus and DCV maintain a persistent 
infection in flies? It also remains largely unknown when and how viral RNA substrates 
are detected for vsiRNAs or vpiRNA biogenesis. Another key questions that remains 
unanswered is how arboviruses establish a persistent, non-pathogenic infection in RNAi-
competent mosquitoes. Is persistence in mosquitoes mediated by antiviral siRNAs 
and piRNAs that are present in the soma? Experimental techniques to study antiviral 
immunity in mosquitoes are limited, which is in contrast to the extensive genetic toolbox 
in Drosophila. However, it will be important to study the course of arbovirus infection in 
its natural host. As such, experimental infection models and genetic tools in mosquitoes 
will significantly contribute to our understanding of virus-vector interactions, which 
might lead to improved strategies to control the transmission of pathogenic arboviruses. 
The recently described Crispr/Cas9 mutagenesis system could provide a perfect tool for 
targeted genome editing in mosquitoes (120, 121).
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Summary
Viruses are small infectious agents that can only replicate inside the cells of organisms, including bacteria, plants and animals. The viral genome consists of ribonucleic acid (RNA) or deoxyribonucleic acid (DNA), which can be single-
stranded (ss) or double-stranded (ds). A protein shell, called the capsid, protects the viral 
genome, while in some cases viral nucleic acids are shielded by both a capsid and a lipid 
membrane. Following entry, a virus releases its genomic material and uses the host cell 
metabolic machinery for replication to produce new infectious virus particles. Progeny 
viruses are subsequently released from the infected host cell to infect naive, neighboring 
cells.
An infected cell senses the invading viral pathogen and triggers an antiviral immune 
response to inhibit virus replication and spread. A major antiviral response in insects is 
the RNA interference (RNAi) pathway (Figure). RNAi is triggered by the detection of 
dsRNA, which is produced during virus infection but is absent in non-infected, healthy 
cells. The cellular enzyme Dicer-2 recognizes viral dsRNA and cleaves it into viral 
small interfering RNAs (vsiRNAs), thereby degrading these viral dsRNA substrates. 
The produced vsiRNAs are loaded into the Argonaute-2 protein, which is the central 
component of the RNA-induced silencing complex (RISC). Within RISC, the siRNA-
loaded Argonaute-2 recognizes and cleaves complementary viral ssRNA. Thus, the RNAi 
pathway interferes with virus replication by the degradation of viral dsRNA by Dicer-2 
and by the sequence-specific cleavage of viral ssRNA by Argonaute-2 (Chapter 1).
Insect viruses have evolved diverse counter-defense strategies to evade or suppress this 
small RNA-based immune response. For example, the RNA virus Drosophila C virus 
(DCV), which is a natural Drosophila (fruit 
fly) pathogen, encodes the 1A protein that 
inhibits the antiviral RNAi response by 
binding viral dsRNA, thereby preventing 
its cleavage by Dicer-2. In contrast, the 1A 
protein of the RNA virus Cricket Paralysis 
virus (CrPV), a family member of DCV, 
inhibits the RNAi response by antagonizing 
Argonaute-2 cleavage activity. Thus, both 
DCV and CrPV have evolved suppressors 
of RNAi (VSRs) to antagonize this small 
RNA-based antiviral immune response.
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Figure. Antviral defense and viral counter-
defense in insects.
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Insects are vectors for the transmission and spread of many important human and 
animal viruses. Mosquitoes and other blood-feeding insects (e.g. ticks) transmit 
arthropod-borne (arbo) viruses, some of which are associated with debilitating disease 
and worldwide epidemics (e.g. Dengue virus). Arbovirus-mediated disease is likely to 
increase due to the ongoing global spread of arboviruses, the emergence of new virus 
strains (which may adapt to new vectors), and the adaptation of vector species to new 
habitats. It is thus important to study the mechanisms of antiviral immunity in insects 
to uncover novel components and regulators of immune pathways and to define new 
strategies to restrict transmission and spread of pathogenic viruses. The fruit fly is host 
to a number of RNA viruses and its versatile toolkit provides a powerful model to study 
antiviral immunity in insects.
In this thesis we describe small RNA-based antiviral defense mechanisms in insects. 
In Chapter 2, we used Nora virus, a natural Drosophila pathogen, to study virus-host 
interactions. We detected Nora virus-derived vsiRNAs in persistently infected adult flies, 
which suggests that Nora virus is a target of the Drosophila antiviral RNAi machinery. 
Nevertheless, the observation that Nora virus establishes a persistent, non-lethal infection 
in flies suggests that this RNA virus is able to evade or to potently suppress the RNAi 
machinery. Therefore, we studied whether Nora virus encodes a protein that inhibits the 
RNAi response. We found that Nora virus VP1 suppresses RNAi in cultured cells as well 
as in adult flies. Moreover, we generated recombinant Sindbis virus and revealed that 
VP1 increases pathogenicity in infected flies in an RNAi-dependent manner. Using a 
series of biochemical assays (electrophoretic mobility shift assay, Dicer assays, and Slicer 
assays) that monitor individual steps of the RNAi pathway, we subsequently showed 
that Nora virus VP1 specifically prevents the sequence-specific cleavage (slicing) of an 
ssRNA substrate. Together, these results demonstrate that Nora virus is both a target 
and suppressor of RNAi. In addition, this study provides support that the Argonaute-
2-mediated Slicer activity of RISC contributes to the antiviral potential of the RNAi 
machinery.
In Chapter 3, we investigated whether a dsDNA virus, Invertebrate iridescent virus 6 
(IIV-6), induces an antiviral RNAi response in Drosophila. We first showed that flies 
that lack the core RNAi components Dicer-2 and Argonaute-2 are more susceptible 
to IIV-6 infection, suggesting that the antiviral RNAi pathway controls DNA virus 
infection. Indeed, using small RNA cloning and next-generation sequencing technology, 
we identified Dicer-2-dependent vsiRNAs in IIV-6-infected flies. This observation 
was particularly interesting because DNA viruses do not rely on a dsRNA replication 
intermediate for the production of new viral genomes. Therefore, other dsRNA sources 
must be processed by Dicer-2. We performed small RNA profiling studies, strand-
specific RT-PCR assays and Northern blot analyses to identify the dsRNA substrates for 
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vsiRNA biogenesis. Using these techniques, we demonstrated that sense and antisense 
transcripts are generated in vivo and in vitro during IIV-6 replication. These results 
support a model in which base pairing between convergent overlapping transcripts 
generate the viral dsRNA substrate for vsiRNA production by Dicer-2. With this study, 
we were the first to show that RNAi provides antiviral defense against DNA viruses 
in Drosophila. A number of recent publications have now analyzed vsiRNA profiles in 
DNA virus infections in Drosophila and other invertebrate model systems, which we 
reviewed in Chapter 4. These studies further underscore that convergent transcripts 
are the main source of vsiRNAs. In addition, some DNA viruses may produce ssRNAs 
with strong secondary structures that could also serve as dsRNA substrates for vsiRNA 
production by Dicer-2. Together, these studies demonstrate that an antiviral RNAi 
response is mounted against distinct DNA viruses in different invertebrates.
Having found that DNA viruses induce an antiviral RNAi response in Drosophila 
(Chapter 3), we next wondered whether DNA viruses, like RNA viruses, evade this small 
RNA-based response. In Chapter 5, we investigated whether IIV-6 encodes a suppressor 
of RNAi. Using reporter-based assays, we demonstrated that the RNAi pathway is 
suppressed in IIV-6-infected cells and we mapped the RNAi suppressive activity to the 
dsRNA-binding protein 340R. Site-directed mutagenesis studies subsequently indicated 
that the dsRNA-binding activity of 340R is required for suppression of RNA silencing. 
Using biochemical assays, we revealed that 340R indeed binds dsRNA and thereby 
prevents its cleavage into siRNAs by Dicer-2. Moreover, we showed that 340R also 
binds siRNAs and thereby blocks the incorporation of siRNAs into RISC. Thus, 340R 
interferes with RISC assembly and, as a consequence, inhibits target RNA cleavage by 
Argonaute-2. Finally, we showed that 340R is able to rescue replication of an RNA virus 
(Flock House virus) replicon that lacks its viral suppressor of RNAi. The results from 
Chapter 3 and Chapter 5 reveal that, in analogy to RNA viruses (Chapter 2), DNA 
viruses are targets and suppressors of an antiviral RNAi response.
In Chapter 6, we analyzed the small RNA profiles of mosquito cells infected with different 
classes of RNA viruses. Interestingly, we observed that, besides vsiRNAs, another class 
of small RNAs was produced in these cells. These virus-derived small RNAs were ~25-
30 nucleotides in size, exhibited typical signatures of piwi-interacting RNAs (piRNAs), 
and were produced in a Dicer-independent manner. Furthermore, we showed that the 
siRNA and piRNA pathways also target endogenous transposons. Taken together, this 
study revealed that parasitic nucleic acids initiate the de novo production of piRNAs and 
siRNAs in mosquito cells.
In Chapter 7, I discussed our findings in relation to recent literature and in a broader 
context. Finally, I speculated on the role of virus-derived piRNAs in antiviral defense in 
mosquitoes.
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Samenvatting
Virussen zijn microscopisch kleine ziekteverwekkers die zich alleen kunnen vermenigvuldigen in de cel van gastheerorganismen, zoals bacteriën, planten en dieren. De genetische informatie van virussen (het virale genoom) bestaat 
uit ribonucleïnezuren (RNA) of deoxyribonucleïnezuren (DNA), die enkelstrengs (es) 
of dubbelstrengs (ds) kunnen zijn. Een eiwitmantel, genaamd het capside, beschermt 
het virale genoom. In sommige gevallen worden de virale nucleïnezuren afgeschermd 
door zowel een capside als een lipide membraan. Nadat een virus een gastheercel is 
binnengedrongen komen de virale nucleïnezuren vrij in de cel. Voor de vermenigvuldiging 
van het virale genoom wordt gebruik gemaakt van de biochemische processen van de 
gastheercel. Dit leidt uiteindelijk tot de productie van nieuwe infectieuze virusdeeltjes die 
de geïnfecteerde cel verlaten om vervolgens gezonde, aangrenzende cellen te infecteren.
Echter, een geïnfecteerde cel kan een viraal pathogeen detecteren en een antivirale 
immuunreactie aanzetten om vermenigvuldiging en verspreiding van het virus tegen te 
gaan. Een belangrijke antivirale respons in insecten is het RNA interferentie (RNAi)-
mechanisme (Figuur). RNAi wordt geïnduceerd door de detectie van dsRNA dat wordt 
geproduceerd tijdens een virusinfectie, maar dat normaal gesproken niet aanwezig is 
in gezonde, niet-geïnfecteerde cellen. Het cellulaire enzym Dicer-2 herkent het virale 
dsRNA en knipt dit in kleinere dsRNA moleculen, die virale kleine interfererende 
RNA’s (viral small interfering RNA’s, vsiRNA’s) worden genoemd. Door deze Dicer-2-
gemedieerde knip worden de virale dsRNA moleculen afgebroken. De geproduceerde 
vsiRNA’s worden vervolgens ingebouwd in een groter eiwitcomplex: het “RNA-induced 
silencing complex” (RISC), waarin het Argonaute-2 eiwit een belangrijke rol speelt. De 
vsiRNA die ingebouwd is in RISC herkent 
complementaire virale esRNA target 
sequenties die vervolgens worden geknipt 
door Argonaute-2. Het RNAi-mechanisme 
kan de vermenigvuldiging van het virus dus 
remmen via het knippen van viraal dsRNA 
door Dicer-2 en middels het knippen 
van viraal target RNA door Argonaute-2 
(Hoofdstuk 1).
Insectenvirussen hebben echter diverse 
strategieën ontwikkeld om het RNAi-
mechanisme te ontwijken. Zo produceert 
het RNA virus Drosophila C virus 
(DCV), een natuurlijke ziekteverwekker in 
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Figuur. Het antivirale RNAi-mechanisme 
in insecten en virale strategieën om RNAi 
te onderdukken.
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Drosophila (de fruitvlieg), het 1A eiwit dat een antivirale RNAi respons remt door viraal 
dsRNA te binden. Hierdoor wordt voorkomen dat viraal dsRNA wordt geknipt door 
Dicer-2. Het 1A eiwit van het RNA virus Cricket Paralysis virus (CrPV), een familielid 
van DCV, remt daarentegen de RNAi respons door de sequentie-specifieke knip van 
Argonaute-2 te blokkeren. Dus DCV en CrPV produceren verschillende 1A eiwitten 
die de antivirale RNAi respons onderdrukken (virale “suppressor” van RNAi, VSR).
Insecten verspreiden belangrijke humane en dierlijke virussen. Muggen en andere 
bloedzuigende insecten (bijv. teken) dragen arbovirussen (virussen die worden 
overgedragen door geleedpotigen, arthropoda) over. Sommige van deze virussen 
veroorzaken slopende chronische ziektes en wereldwijde epidemieën (zoals bijv. Dengue 
virus, ook wel knokkelkoorts genoemd). Door de continue globale verspreiding van 
arbovirussen, het ontstaan van nieuwe virusstammen (die zich zouden kunnen aanpassen 
aan nieuwe overdragers) en de aanpassing van insecten aan een nieuwe leefomgeving 
is het waarschijnlijk dat het aantal ziektes dat wordt veroorzaakt door arbovirussen 
toeneemt. Het is daarom belangrijk om de mechanismen van antivirale immuniteit in 
insecten te bestuderen om zo de belangrijke componenten en besturingsmechanismen 
van immuunreacties te ontdekken én om nieuwe strategieën te bedenken om het 
overbrengen en verspreiden van pathogene virussen te beperken. Drosophila melanogaster 
is een veelzijdig modelorganisme waarvoor veel genetische tools beschikbaar zijn. 
Daarnaast is de fruitvlieg gastheer van een aantal natuurlijke RNA virussen. Dit maakt 
de fruitvlieg een krachtig model om antivirale immuniteit in insecten te bestuderen.
In dit proefschrift beschrijven we de op kleine RNA’s gebaseerde antivirale afweer in 
insecten (“Small RNA-based antiviral defense in insects”). In Hoofdstuk 2 hebben we 
het natuurlijke fruitvlieg pathogeen Nora virus gebruikt om virus-gastheer interacties 
te bestuderen. In persistent geïnfecteerde volwassen fruitvliegen konden we vsiRNA’s 
afkomstig van het Nora virus detecteren. Dit impliceert dat Nora virus het antivirale 
RNAi-mechanisme in Drosophila induceert. Echter, de observatie dat Nora virus een 
persistente, niet-lethale infectie in vliegen veroorzaakt doet vermoeden dat dit RNA 
virus het antivirale RNAi-mechanisme omzeilt of krachtig remt. We hebben daarom 
bestudeerd of Nora virus een eiwit produceert dat de RNAi respons blokkeert. We 
hebben Nora virus VP1 geïdentificeerd als het eiwit dat de RNAi respons onderdrukt, 
zowel in gekweekte cellen als in volwassen vliegen. Daarnaast hebben we recombinant 
virus gemaakt en vonden we dat VP1 de pathogeniteit (ziekteverwekkend vermogen) 
in vliegen verhoogt; dit bleek volledig afhankelijk van RNAi. Door gebruik te maken 
van een aantal biochemische assays die individuele stappen van het RNAi-mechanisme 
monitoren, hebben we vervolgens laten zien dat het VP1 eiwit het sequentie-specifiek 
knippen van een esRNA target molecuul door Argonaute-2 blokkeert. Deze resultaten 
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tezamen tonen aan dat een antivirale RNAi respons wordt geïnduceerd, maar ook wordt 
onderdrukt door Nora virus.
In Hoofdstuk 3 hebben we onderzocht of een dsDNA virus, “Invertebrate iridescent 
virus 6” (IIV-6) een antivirale RNAi respons in Drosophila induceert. Allereerst 
hebben we laten zien dat fruitvliegen die het Dicer-2 of Argonaute-2 gen missen (de 
kern componenten van het RNAi- mechanisme) gevoeliger zijn voor IIV-6 infectie. 
Dit suggereert dat het antivirale RNAi-mechanisme DNA virusinfecties controleert. 
Inderdaad, door gebruik te maken van kleine RNA-klonerings- en “next-generation” 
sequentie-technologieën konden we Dicer-2 afhankelijke vsiRNA’s identificeren in IIV-
6 geïnfecteerde vliegen. Deze observatie was met name interessant omdat DNA virussen 
voor de productie van nieuwe virale genomen niet afhankelijk zijn van een dsRNA 
replicatie intermediair. Er moeten dus andere dsRNA moleculen geknipt worden door 
Dicer-2 voor de productie van vsiRNA’s. We hebben verschillende studies (kleine RNA 
profielstudies, streng-specifieke RT-PCR assays en Northern blot analyses) uitgevoerd 
om het dsRNA substraat voor vsiRNA productie te identificeren. Met behulp van 
deze technieken hebben we laten zien dat transcripten met een positieve (sense) en 
negatieve (antisense) polariteit worden gemaakt tijdens IIV-6 replicatie. Deze resultaten 
ondersteunen een model waarin basenparing tussen overlappende sense en antisense 
transcripten het virale dsRNA genereren dat als substraat dient voor de productie van 
vsiRNA’s. Dit was de eerste studie die liet zien dat RNAi zorgt voor antivirale afweer 
tegen DNA virussen in Drosophila.
In een aantal recente publicaties zijn de vsiRNA profielen in DNA virus infecties in 
Drosophila en andere ongewervelde model systemen geanalyseerd. Deze studies, die we 
hebben besproken in Hoofdstuk 4, onderstrepen dat overlappende sense en antisense 
transcripten de voornaamste bron zijn voor vsiRNA productie. Bovendien produceren 
sommige DNA virussen esRNA’s met een sterke secundaire structuur. Dergelijke 
structuren kunnen ook dsRNA substraten vormen voor vsiRNA productie door Dicer-2. 
Deze studies tezamen demonstreren dat een antivirale RNAi respons wordt geïnitieerd 
tegen verschillende DNA virussen in verschillende invertebraten.
Nadat we vastgesteld hadden dat DNA virussen een antivirale RNAi respons in 
Drosophila induceren (Hoofdstuk 3), vroegen we ons af of DNA virussen deze kleine 
RNA-gemedieerde respons onderdrukken. In Hoofdstuk 5 hebben we daarom 
onderzocht of IIV-6 een suppressor van RNAi (VSR) produceert. Door gebruik te maken 
van een RNAi-sensor experiment hebben we laten zien dat het RNAi-mechanisme 
wordt onderdrukt in IIV-6 geïnfecteerde cellen. Daarnaast hebben we het door IIV-6 
gecodeerde dsRNA-bindend eiwit 340R geïdentificeerd als de suppressor van de RNAi 
respons. Door het 340R eiwit op specifieke plekken te muteren konden we aantonen 
dat de dsRNA bindingsactiviteit van 340R noodzakelijk is voor het remmen van RNAi. 
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Met biochemische assays hebben we vervolgens laten zien dat 340R inderdaad dsRNA 
bindt en dat hierdoor het knippen van dsRNA door Dicer-2 geremd wordt. Bovendien 
hebben we laten zien dat 340R ook siRNA’s bindt en daardoor het inbouwen van siRNA’s 
in RISC waarschijnlijk blokkeert. 340R remt dus het laden van RISC, waardoor ook 
het knippen van een RNA target door Argonaute-2 wordt geremd. Tot slot hebben we 
aangetoond dat 340R de replicatie van een RNA virus replicon (Flock House virus), dat 
zijn virale suppressor van RNAi mist, kan herstellen. De resultaten van Hoofdstuk 3 
en Hoofdstuk 5 laten zien dat DNA virussen, net als RNA virussen (Hoofdstuk 2), de 
antivirale RNAi respons zowel induceren als onderdrukken.
In Hoofdstuk 6 hebben we kleine RNA profielen geanalyseerd van muggencellen die 
geïnfecteerd waren met RNA virussen van verschillende klassen. Tot onze verbazing 
vonden we dat er behalve vsiRNA’s ook nog andere kleine RNA’s werden geproduceerd. 
Deze virus-specifieke RNA’s waren ~25-30 nucleotiden lang, vertoonden typische 
signaturen van piwi-geassocieerde RNA’s (piRNA’s: kleine RNA’s die binden aan 
zogenaamde PIWI eiwitten), en werden onafhankelijk van Dicer geproduceerd. 
Daarnaast hebben we laten zien dat siRNA’s en piRNA’s ook van endogene transposons 
afkomen. Deze studie laat zien dat in muggencellen de herkenning van ‘vreemde’ 
nucleïnezuren de productie van nieuwe siRNA’s en piRNA’s induceert. In Hoofdstuk 
7 bediscussieer ik onze bevindingen in relatie tot de recente literatuur en in een bredere 
context. Tot slot speculeer ik over de rol van virus-specifieke piRNA’s in de antivirale 
afweer in muggen.
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Na vier jaar promotieonderzoek ligt het boekje er dan eindelijk. Dit is een mooie mijlpaal om eens terug te kijken op mijn promotietijd en om een aantal mensen in het bijzonder te bedanken.
Allereerst wil ik mijn copromotor Ronald van Rij bedanken voor de plezierige tijd op 
het lab. Je bent een toegankelijk en enthousiast persoon die altijd tijd vrij maakt voor 
de wetenschap. Ik heb onze samenwerking als zeer prettig ervaren en ontzettend veel 
van je geleerd de afgelopen jaren! Tijdens onze wekelijkse bespreking bedachten we 
nieuwe experimenten en hebben we vele leuke en interessante discussies gevoerd over 
nieuwe projecten of spannende hypotheses. Je stimuleerde me om mijn eigen ideeën te 
volgen, maar je bleef sturend en meedenkend. Daarnaast stond je kantoordeur altijd 
wagenwijd open en kon ik altijd langskomen met kleine vragen of om over het vervolg 
van mijn wetenschappelijke carrière te praten. Ook heb je me ontzettend geholpen bij 
de verschillende beursaanvragen; gelukkig is dit niet voor niets geweest. Nogmaals dank 
voor alles: dankzij jou ben ik een betere en kritischere wetenschapper geworden!
Op deze plaats wil ik ook Joep Galama bedanken. Dank voor je tijd en belangstelling 
gedurende dit promotietraject en leuk dat je mijn promotor wil zijn.
Dank aan al mijn collega’s op het lab, die er voor hebben gezorgd dat ik een ontzettend 
leuke tijd heb gehad. Koen, de afgelopen 4,5 jaar zijn we U-genootjes geweest en hebben 
we intensief samengewerkt. Dit is ook wel te zien aan het aantal papers in dit boekje 
waar je coauteur op bent. Je bent een fijne collega om mee samen te werken en je bent 
heel precies in je werk, zowel experimenteel als met het schrijven van papers. Je was een 
belangrijke raadgever wanneer ik tegen technische problemen aanliep en we hebben 
geregeld leuke, inhoudelijke discussies gehad. Ik wens je het allerbeste toe in je verdere 
carrière! Leuk dat je mijn paranimf wil zijn.
Joël, je bent al bijna een jaar niet meer werkzaam op het lab, maar je bent toch degene 
die veel experimenten heeft opgezet waar wij nu allemaal nog profijt van hebben. Kijk 
alleen maar naar de Dicer en Slicer assays in dit boekje! Ook hebben we prettig samen 
gewerkt bij hoofdstuk 2 van dit proefschrift en was je altijd bereikbaar voor discussies 
over resultaten. Ik was altijd onder de indruk van je kennis van de vakliteratuur. Dank 
voor alles en veel succes en plezier bij je werkzaamheden in Wageningen.
Gijs, ik sta er altijd van te kijken hoeveel werk jij op een dag verzet en hoe makkelijk alles 
jou afgaat. Je staat voor iedereen klaar en niets is je te veel gevraagd. Daarnaast ben je als 
analist ook meedenkend met anderen en ben je een goede troubleshooter. Bedankt voor 
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al die keren dat je vliegen voor me hebt geteld in de weekenden.
Sarah, you started your PhD one year after I started and especially in your first year we 
nicely collaborated on the EHMT project. I also learned a lot from you about Drosophila 
genetics and I enjoyed our many conversations in the flyroom. You are a very social 
person and a real science geek, in a positive way! Thanks for all the interest you always 
showed and I wish you all the best with the last bits and pieces of your thesis!
Pascal, jij bent als AIO verder gegaan aan het piRNA project. Het zal je waarschijnlijk 
niet verbazen dat ik jouw werk met bovengemiddelde interesse volg. Je bent een 
prettige collega die bijdraagt aan een gezellige sfeer in het lab en iemand die in is voor 
verschillende activiteiten, die je vaak ook nog eens (samen met Sarah) organiseert. Ik 
wil je ook bedanken voor je expertise en hulp bij de Northern blots en voor je analyses 
van kleine RNAs.
Susan, you are still at the very beginning of your PhD and I am looking forward to 
your work on the mammalian RNAi pathway. It was nice to chat with you in the early 
mornings, even though for you it wasn’t early morning anymore, as you already had 
spent a few ours in the lab. I wish you all the best with your future PhD and regret that 
I cannot enjoy your baking skills anymore.
Erika and Bas, we only spent a short time together in the lab, but I think that both of 
you are nice colleagues and contribute to the pleasant atmosphere in the lab. I wish both 
of you all the best.
Rob, sinds kort ben je als PhD-student het RNAi-team komen versterken. Het is fijn 
om te weten dat iemand het IIV-6 werk vervolgt. Heel veel succes en ik zal je nog wel 
wat IIV-6 spam mail bezorgen.
Over the last years I had a lot of fun with the RNAi-team during all the coffee and lunch 
breaks. I also enjoyed the activities that we had after work as well as the ‘celebration’ 
activities at café Jos. I hope to catch up with you at any possible occasion.
Op deze plaats wil ik ook mijn oud-collega’s van de onderzoeksgroep van Frank van 
Kuppeveld bedanken. Ik heb de helft van mijn promotietijd met jullie doorgebracht, 
voordat jullie hele lab van Nijmegen naar Utrecht verhuisde. Hierdoor werd het wel wat 
minder druk op onze afdeling, maar was het helaas ook meteen een stuk rustiger aan de 
koffietafel...
Beste Frank, ik mis de maandagochtenden dat ik binnenkwam en dat we eerst de 
voetbaluitslagen van het afgelopen weekend bespraken. Hoogtepunt was de foto die je 
me liet zien waar Sjaak Swart naast jou mocht poseren. Je was altijd oprecht geïnteresseerd 
in het werk van de RNAi-groep en je hebt vanuit een andere invalshoek altijd veel input 
gehad tijdens de algemene werkbesprekingen! Ook dank voor je tijd en moeite voor het 
schrijven van de referentiebrieven voor de verschillende beursaanvragen, ondanks dat je 
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nu een nog drukkere baan hebt als professor.
Hilde, Lonneke, Kjerstin, Qian, Martijn, Jeroen, en Rachel, het was fijn om jullie als 
collega’s te hebben en ik wens iedereen veel succes met ieders carrière. Via deze weg wil 
ik jullie nogmaals bedanken voor het spekken van de pot voor Hilde’s baby pool en de 
EK pool. Lucian and Cristina, it was nice to have you as colleagues and good luck to 
both of you with the last steps of your PhD program.
I would also like to thank our collaborators from Paris, France. Nicolas, Hervé and 
Carla, thanks for the nice collaboration that resulted in two nice publications: chapters 
3 and 6 of this thesis. Carla, it was nice to meet you in person several times. You are an 
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